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The Pelican Project is a study in the Netherlands with the objective to 
improve health-related quality of life and asthma control of children 
with asthma.
This thesis ‘Meeting the needs of children with asthma’ presents 
and discusses research on the validity of the Pelican instrument (a health- 
related quality of life questionnaire) and the effectiveness of patient-
centered care based on this instrument. The studies were carried out 
from 2008 to 2014 at the Department of Primary and Community Care
at Radboudumc Nijmegen.
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CASE 
 
It’s Wednesday afternoon. Paediatrician doctor Janssen’s clinic is running late 
when Benjamin and his mother enter the consultation room. Benjamin is a 
boy, aged 10, who lives with his parents in the Southern province Noord-
Brabant in the Netherlands. He comes from a family with low socioeconomic 
status and has no siblings. His father is currently unemployed and his mother 
is an administrative assistant. Benjamin suffers from asthma from early age 
on and visits the paediatrician on a regular basis. Although he uses 
medication to control his asthma, he is still experiencing daily asthma 
symptoms, such as breathlessness and coughing during physical activity.  
After shaking hands with mother, doctor Janssen asks Benjamin how things 
have been lately. Benjamin shrugs and answers: ‘Fine’. ‘The usual’, Benjamin’s 
mother adds. Doctor Janssen tries again and asks the boy: ‘Still playing 
soccer?’. ‘Uhu’, the boy confirms while nodding. His mother takes over the 
conversation and answers ‘Yeah, well, he has soccer training once every week 
and plays matches on Saturdays. But you know, he can’t finish a complete match 
due to his asthma. So next year, he will probably switch to goal keeper training. 
That might be better for him.’ Paediatrician: ‘That would perhaps be an option 
indeed. So, Benjamin, do you have asthma symptoms during other activities as 
well?’ While fidgeting the loose sole of his shoe, he answers: ‘Uhm… yes’. 
Mother adds: ‘Ow, you know how that boy is, he can’t sit still, not even for a 
second. But he’s used to it, you know, having to wheeze and cough.’ Doctor 
Janssen turns to the mother and discusses Benjamin’s complaints, while the 
boy stares out of the window. After fifteen minutes, mother and Benjamin 
leave the consultation room and pick up the prescription medication for his 
asthma at the pharmacy. 
 
 
Figure:  
Drawing by Benjamin. 
 
Text balloons left: ‘Gasp’, ‘Puff’,  
‘Wait a sec’  
Text balloons right: ‘Hurry up then’ 
 
 
 
 
 
 
 
Foot note: The content and personal details of this case were adjusted for instructional purpose. 
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INTRODUCTION 
 
The Pelican project was launched in 2003 in response to a growing demand 
for patient-reported outcome measures (PROMs) in health care in addition to 
physiological outcomes. Examples of clinical and physiological outcomes in 
asthma care are peak flow variability. Research has, however, suggested that 
there is only a weak correlation between clinical outcomes and the effect that 
a chronic illness, such as asthma, has on everyday life. (1)  
Since available treatment options in medical care nowadays lead to 
improved life expectancy of patients with chronic conditions, there is an 
increased need for evaluation of the patients’ well-being in daily life. One of 
the most frequently used PROMs in asthma care nowadays is called Health-
Related Quality of Life (HRQL). (2) In general, HRQL can be considered as an 
individual’s subjective experience related to health, disease, disability and 
impairment.  
The aim of the Pelican project is to measure HRQL in children with 
asthma and improve it by means of a patient-centred and tailored treatment. 
The project started with the development of a web-based asthma-related 
quality of life questionnaire for children aged 6-11 years, called ‘the Pelican 
instrument’. The acronym Pelican stands for ‘Paediatric Electronic quality of 
Life Instrument for Children with Asthma in the Netherlands’. The items in 
the questionnaire are based on the outcome of focus group meetings with 
children with asthma. Exact details on the development of the instrument can 
be found elsewhere. (3) 
This thesis, called ‘The Pelican Project: Meeting the needs of children 
with asthma’, consists of follow-up studies after the development of the 
Pelican instrument. It describes the validation of the instrument and the 
evaluation of a patient-centred intervention based on the patient’s outcome 
on this instrument. The research described in this thesis was carried out at 
the Department of Primary and Community Care at Radboudumc (Nijmegen) 
from 2008 to 2014. 
 
In this thesis, the author aims to: 
 Present information on the validation of the Pelican instrument in 6-
11 year old children with asthma in the Netherlands  
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 Report on the effects of applying the Pelican instrument by means of a 
patient-centred care programme in primary and specialised health 
care in the Netherlands 
 Explore the possibilities and bottlenecks of a patient-centred 
intervention based on the Pelican instrument 
 Discuss whether and, if so, how the Pelican instrument should be 
implemented in daily medical care of childhood asthma 
 
 
ASTHMA: EPIDEMIOLOGY AND DIAGNOSIS 
 
Asthma according to the Global Initiative for Asthma (GINA):  
A chronic inflammatory disorder of the airways. The chronic inflammation is 
associated with airway hyper responsiveness that leads to recurrent episodes of 
wheezing, breathlessness, chest tightness, and coughing, particularly at night or 
in the early morning. These episodes are usually associated with widespread, 
but variable airflow obstruction in and out of the lungs, that is often reversible 
either spontaneously or with treatment.’ (4) 
 
Overall, asthma affects 235 million people worldwide. (5) In the 
Netherlands, asthma is one of the most common chronic diseases among 
children, with a prevalence of 1-6%. (6-8) Before puberty, asthma is more 
common in boys than in girls, in higher age groups the opposite is true. While 
asthma occurs in low- to high-income countries, the majority of asthma-
related deaths occur in low- and lower-middle income countries. Trends in 
asthma prevalence and predictions of future development remain uncertain 
because of insufficient data. 
Diagnosing asthma in childhood proves difficult because of the lack of 
a gold standard diagnostic test. Therefore, diagnosis is often based on a 
combination of the child’s symptoms, medical history, physical examination 
and lung function tests. Due to difficulty of lung function tests for young 
children, diagnosis of asthma is usually not set under the age of five. Children 
under the age of five with asthma resembling symptoms are called ‘early’ or 
‘happy wheezers’ and a large group of these children outgrow these 
problems. 
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The pathogenesis of asthma is still not completely understood. The strongest 
risk factors are a combination of genetic predisposition with environmental 
exposure to inhaled substances and particles that may provoke allergic 
reactions or irritate the airways. These substances and particles are called 
‘triggers’. Most commonly known triggers are indoor allergens (such as house 
dust mites, molds), outdoor allergens (such as pollen), tobacco smoke, 
chemical irritants, air pollution and some drugs. Furthermore, physical 
exercise, temperature changes and strong emotional arousal (for example 
anger or fear) are seen as triggers for hyper responsiveness of the airways as 
well. (9) 
 
Table 1: Prevalence of childhood asthma in the Dutch Continuous 
Morbidity Registry of four family practices in Nijmegen (2008) 
 
Age-group BOYS 
% 
GIRLS 
% 
0-4 YRS 3.97 1.43 
5-9 YRS 4.53 1.81 
10-14 YRS 5.82 3.88 
15-19 YRS 4.04 5.42 
 
 
ASTHMA OUTCOMES 
 
Various measures are used to quantify health status in asthma patients. (10) 
The most frequently used physiological measures are lung function (as a 
measurement of airflow obstruction and volume) and fraction of exhaled 
Nitric Oxide (FeNO; which reflects airway inflammation). Frequently used 
patient-reported outcomes (PROMs) to assess the impact of asthma on 
patients are asthma control and HRQL. The physiological measures correlate 
poorly with functional capacity and well-being of patients as measured by 
PROMs. (11) The disease burden reported by patients with similar 
physiological outcomes varies widely, illustrating the subjective perception of 
health and disease. Asthma control and HRQL should be assessed routinely to 
better understand to what degree specific conditions affect the lives of 
children with asthma and their families. (12)  
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GINA guidelines regard the patient’s asthma status as ‘well controlled’ 
when he or she is able to avoid troublesome symptoms at night and day, use 
little or no reliever medication, have productive and physically active lives, 
have (near) normal lung function and avoid serious exacerbations (i.e. 
episodes of progressive increase in shortness of breath, cough, wheezing, or 
chest tightness, or some combination of these symptoms, accompanied by 
decreases in expiratory airflow that can be quantified by measurement of 
lung function). (4) Poor disease management causes aggravation of 
symptoms and results in more frequent exacerbations. These latter are 
associated with impaired HRQL and are responsible for three quarters of the 
total costs of asthma. (2, 13-15) HRQL is usually measured in physical, 
emotional, cognitive and social dimensions (World Health Organisation, 
1948) and is often divided in generic quality of life and disease-specific 
quality of life. (16, 17) Generic quality of life instruments aim to measure 
quality of life of patients regardless of their physical condition. Disease-
specific instruments measure aspects that are relevant to patients with a 
particular disease. While generic instruments allow comparison between a 
wide range of populations and interventions and have a better discriminative 
validity, disease-specific instruments show better evaluative validity and are 
thus more likely to detect clinically relevant changes within patients over 
time (a.k.a responsiveness). (18, 19) 
 
Although using PROMs is advocated, it poses a number of challenges. 
Specifically with regard to  PROMs in paediatric patients, the question is 
raised ‘Who to ask: the child or its caregivers?’ Parents administering a 
questionnaire, are more likely to comprehend the questions, estimate time 
periods more accurately and answer reliably. (20, 21) However, previous 
research shows a substantial discrepancy between the parent’s and child’s 
perception of the child’s asthma, suggesting parents are unable to assess their 
child’s perception. Using such proxy-rated instruments may thus result in 
over- or underestimation of children’s true health outcomes. (22) During 
medical consultations concerning a pre-adolescent child, communication in 
large part takes place between the health care provider and the parent, 
under-exposing the child’s view in disease management plans. We deem this 
undesirable. Preferably, if possible, the individual concerned (in this case the 
child itself) should be the source of health status information. Using both 
parent-reports and child-reports is considered best practice for applying 
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PROMs in school-aged paediatric patients. (32, 33) Developing a parent-
version of the Pelican instrument to complement the results of the child 
needs to be considered. The current manuscript, however, is limited to the 
validation and implementation of the child-administered Pelican instrument. 
Particular methodological concerns are raised when performing 
measurements in children. Children completing instruments independently 
must be able to comprehend the questions and response categories. 
Developmental stages of children need to be taken into account. Literature 
suggests that Likert scales (with a maximum 4 to 5 response levels) are 
preferred above visual analogue scales or numeric scales for children. 
Furthermore, a self-administered questionnaire for children should not be 
time-consuming and should take attention span into account. Another 
concern would be children’s inability to recall their past functioning for 
longer than one week, limiting the time-frame. (23, 24) 
Previous research has shown that children between the age of 6 and 
12 are capable of completing questionnaires independently and are 
considered good content experts for patient-reported outcomes. (21, 25, 26) 
Currently, there are three frequently used self-administered HRQL 
questionnaires for childhood asthma: Paediatric Asthma Quality of Life 
Questionnaire with standardised activities (PAQLQ-s, (27)), Pediatric Quality 
of Life Inventory 4.0 (PedsQL-Asthma, (28)) and Disability Kids (DISABKIDS 
asthma module, (29, 30)). In general, these three tools have adequate 
psychometric characteristics and are practical to implement. (31)  
Our newly developed Pelican instrument (a screenshot can be found 
in the Appendices) is a web-based self-administered asthma-specific HRQL 
measure for children aged 6-11 years old. The main reason for developing a 
new instrument is that currently used HRQL instruments have been 
developed based primarily on the view of parents and professionals. Since 
HRQL is a subjective experience of health and disease, we deem it of utmost 
importance that item-selection is based on the opinion of patients themselves 
as well. That is why item-selection of the Pelican instrument was based on 
information gained during focus-group meetings with children. (3) Another 
reason for developing a new instrument was that existing instruments were 
developed for scientific purposes to compare effectiveness of different 
asthma treatments and are not necessarily suited for treatment of individual 
patients. There was a need for an instrument that represents concrete 
asthma-related problems of individual patients that could be used as an easy 
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starting point for patient-centred care. The Pelican instrument serves both 
scientific and treatment purposes because it consists of two parts. The 
standardised part with questions on HRQL enables calculation of Total and 
Domain scores. The individual part allows the child to select a Top 3 from the 
‘default’ items plus one individual open text item, representing the asthma-
related aspects that bother the child mostly in daily life. When completing the 
Pelican instrument, children are assisted by an audio-support system that 
reads the questions out loud and by response categories on a 5-point Likert 
scale that are visualised with emoticons. (3) 
 
 
ASTHMA TREATMENT 
 
Asthma management in the Netherlands is conducted according to evidence-
based guidelines. Primary and specialised health care have separate 
guidelines for paediatric asthma management. Family practitioners (FP) 
provide care according to NHG guidelines (Dutch College of Family 
practioners’ Association; Nederlandse Huisartsen Genootschap) and 
Paediatricians in outpatient clinics work according to NVK guidelines (Dutch 
Association of Paediatrics; Nederlandse Vereniging voor Kinderartsen). (34-
36) In the Netherlands, children are usually primarily treated by the FP and 
are referred to a paediatrician in specialised health care when efforts to 
improve asthma control are not sufficient or presentation of symptoms is 
complex. The general objective is to treat children with asthma no longer than 
necessary in specialised health care settings and refer them back to a FP 
when feasible.  
Since asthma is a chronic disease, the mainstay of asthma 
management is to obtain optimal asthma control and improve HRQ by 
avoiding asthma triggers and improving physical condition. (34) When non-
pharmaceutical interventions do not sufficiently reduce asthma symptoms, 
drugs are prescribed. Daily maintenance medication, usually inhaled 
corticosteroids, are used to control the underlying airway inflammation and 
prevent symptoms and exacerbations. Due to the intermittent nature of 
asthma patients experience periods of increased symptoms during exposure 
of triggers. These symptoms are treated with reliever medications 
(bronchodilators) to dilate the airways by relaxation of surrounding smooth 
muscles. Bronchodilators can be short-acting or long-acting. The aim of 
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medication therapy management is to reach the lowest possible dose of both 
maintenance and reliever medication in order to minimize the risk of side-
effects and optimize user-friendliness of therapy. (35,36) 
 
Lack of appropriate treatment and insufficient therapy adherence are 
the most important reasons for poor asthma control in many settings. (37, 
38) Taking into account the needs and abilities of patients in asthma 
management, is likely to improve medication adherence and asthma 
outcomes. This, however, requires patient’s active involvement in decision-
making during consultation and self management at home. Self management 
refers to the individual’s ability to manage the symptoms, treatment, physical 
and psychosocial consequences of a disease. (39) If patients (children and 
their families) are willing and able to self manage their illness properly, it is 
expected that risks of exacerbations and health care costs are minimised. (40) 
Self management treatment is based on the Behaviour Change Theory, 
explaining the mechanisms of behavioural change (in our case disease 
management behaviour) in humans. The theory suggests that a combination 
of appropriate knowledge, attitudes and self-efficacy regarding asthma 
management leads to appropriate disease management behaviour and 
improved health outcomes. Changing early elements in the model, would 
eventually lead to changed disease outcomes. (41, 42) 
 
 
 
 
 
 
Figure 2: Health Behaviour Change Model 
 
Important components of asthma self management programmes are 
tailored asthma monitoring, education, action plans and regular medical 
visits. (13, 43) A Cochrane review suggested that self management 
programmes that included all four components were considered optimal, 
showing reduction in unscheduled health care visits, nocturnal symptoms, 
lung function and improvements in asthma-related quality of life. (44, 45)  
Knowledge 
Attitude 
Management 
behaviour 
Self efficacy Health 
outcomes 
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Another Cochrane review of 32 studies assessed the effectiveness of 
educational programmes specifically in childhood asthma. These programmes 
were diverse, usually nurse-led in a clinic or school, and given either 
individually or in groups. This review demonstrated that these programmes 
are associated with moderate improvement in airflow obstruction (forced 
expiratory volume in one second; FEV1), functional status (including quality 
of life) and reduction in days of school absence, days of restricted activity, 
emergency room visits and nights disturbed by asthma. Effects of education 
programmes were more profound in children with moderate-severe asthma 
compared to children with mild-intermittent asthma for most outcomes. Both 
individual and group programmes had similar beneficial effects. (52) More 
recent systematic reviews, show potential yet inconsistent effects of 
educational programmes in childhood asthma. (53-56) Studies using internet-
based self-management programmes are upcoming for young and adult 
asthma patients, but results are still inconclusive. (57-61) 
Written action plans ought to be integrated in wider health care 
programmes and should not be used separately. Although previous studies 
have indicated the effectiveness of written action plans in adults and children 
with asthma, implementation of action plans in daily health care is scarce. 
(46-48) Reluctance towards action plans by patients and care providers 
might emanate from regarding them time-consuming, impractical and 
complex. (49) Therefore, action plans should be user-friendly and agree with 
the patient’s view on asthma and management strategies. (50, 51) 
 
 
PATIENT-CENTRED CARE IN THE PELICAN PROJECT 
 
For our study, we have developed a patient-centred care intervention (PCC) 
for children with asthma based on tailored monitoring with the Pelican 
Instrument and self management principles.* In this thesis, this particular 
PCC is studied for its effectiveness with regard to improving HRQL in patients 
treated in primary and specialised health care in the Netherlands. An impor- 
 
*Foot note: In this thesis, the patient-centred care programme based on the Pelican instrument 
will be described with two different names; Patient-centred care (PCC) and Individualised self 
management (ISM) support. 
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tant difference between self management programmes in previous studies 
and the Pelican project, is that earlier programmes often did not use PROM’s 
and provided standard training with fixed educational topics. The PCC 
programme in the Pelican project adjusts asthma management to the needs 
and skills of the individual child and its family.  
 
We believe that guiding a patient in self management is not achieved 
by delivering a standard programme, but by a continuous process in which 
asthma management is optimised to the individual and is based on shared 
decision making (Table 2). (62, 63) Starting point for treatment are concrete 
asthma-related problems as measured with the Pelican instrument. If asthma 
is managed properly and does not cause further problems for the individual 
child, there is usually no need for intervention. Otherwise, when the child 
indicates to experience reduced HRQL, the nurse explores the child’s needs to 
resolve this. Depending on the necessity, tailored education, written action 
plans and regular visits are part of the PCC. Using the Pelican instrument, the 
nurse regularly monitors and evaluates whether PCC was effective or needs 
adjustment. Furthermore, if necessary the nurse can provide education or 
support for motivational obstacles encountered by parents and child, creating 
a cycle of continuous treatment.  
It is important to realize that PCC in children differs from PCC for 
adult patients. Active patient involvement requires patients to be aware of 
their own needs and the severity of their illness and to have sufficient 
cognitive abilities to make management decisions. In case of childhood 
asthma, patients usually lack the cognitive and decisive skills to be held 
responsible for disease management. Therefore, parents play a crucial role in 
asthma treatment of their children. As illustrated in the case description on 
page 12, a common pitfall for health care professionals is to primarily focus 
communication on the parent(s), resulting in loss of potentially important 
information from the child. We therefore advise to involve both the parent 
and child in all components of asthma management. Communication aims at 
co-ownership of all stake holders in disease management and the child is 
playfully prepared for taking own responsibility in treatment decisions. (64-
66) Previous research suggests that involving children actively in their 
treatment and asking asthma-related questions increases children's asthma 
management self-efficacy and ultimately improve outcomes, such as HRQL, 
health care utilization, symptom days and missed school days. (67) 
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Table 2: Usual care versus Patient-Centred Care (PCC) in paediatric 
asthma care 
 
Issue Usual Care PCC 
Relationship between 
patient and care 
provider 
Care provider is the 
expert who tells the 
patient what to do. 
Patient has a more 
passive role. 
Shared expertise and 
collaborative partnership: 
the child and parent are 
expert about own 
experiences and 
complaints, the 
professional is expert 
about the disease. Child 
and parent are active. 
Identifying problems By the care provider, 
based on the complaints 
history of the patient. 
By the child’s response in 
the Pelican instrument 
Goal The patient complies with 
instructions. Non-
compliance is a deficit of 
the patient. 
Patient (and parent) sets 
goals, care provider 
coaches to make informed 
choices. Inability to 
achieve goals requires 
modification of strategies. 
Changing behaviour By external motivation. By internal motivation of 
parent and child: they gain 
understanding and 
confidence to adjust 
behaviour. 
Solving problems Care provider is leading in 
solving problems. 
Care provider teaches 
skills for problem-solving 
and supports patient and 
parent in formulating and 
execution of a tailored 
written action plan. 
Principal and 
responsible party for 
outcomes 
Care provider is 
responsible for solving 
problems. 
Care provider, parent and 
child share responsibility 
for solving problems and 
outcomes. 
Source: adapted from Bodenheimer (62) 
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OUTLINE OF THESIS 
 
The overall aim of the studies presented in this thesis is the validation and 
effectiveness of a quality of life instrument (Pelican instrument) for childhood 
asthma in primary and specialised care in the Netherlands.  
CHAPTER 2 Validity, reliability and discriminative capacity of an 
electronic quality of life instrument (Pelican) for childhood asthma in the 
Netherlands deals with the validation process of the Pelican instrument. This 
covers the psychometric properties of the instrument in a paediatric asthma 
patient study population, such as validity, reliability, responsiveness and 
minimal clinical important difference. 
CHAPTER 3 Pelican: a quality of life instrument for childhood asthma. 
Study protocol of two randomised controlled trials in primary and specialised 
care in the Netherlands describes the design of two studies looking at the 
effectiveness of a patient-centred care (PCC) treatment programme based on 
the Pelican instrument and self management principles.  
CHAPTER 4 Pelican: A cluster-randomised controlled trial in Dutch 
family practices to assess a self management support intervention based on 
individual goals for children with asthma reports the results of a randomised 
controlled trial towards the effectiveness of PCC in improving HRQL in 
children with asthma. The child’s response on the Pelican instrument is the 
starting point for asthma management guided by a practice nurse in family 
practices.  
CHAPTER 5 Pelican: Integrating individual treatment goals in 
outpatient management of elementary school-aged children with asthma; A 
randomised controlled trial reports the results of another randomised 
controlled trial looking at the effectiveness of the same PCC treatment, but in 
this case in paediactric outpatient clinics. The aim of this study was the same 
as that of the primary care trial that is reported in chapter 5. 
CHAPTER 6 Pelican: Process evaluation of patient-centred care for 
children with asthma based on an online tool analyses the requirements and 
bottlenecks when implementing the Pelican-based PCC in the primary and 
specialised care settings as observed in the two randomised controlled trials. 
CHAPTER 7 General Discussion presents an overall conclusion of the 
previous chapters and a discussion about the findings as reported in this 
thesis. Special attention will be paid to whether the Pelican instrument should 
or should not be implemented in daily paediatric asthma care in a primary 
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and specialised health care setting in the Netherlands and how this should be 
done (if applicable). Finally, at the end of this thesis summaries in English and 
Dutch, acknowledgements, my curriculum vitae and several appendices are 
included. 
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ABSTRACT 
 
PURPOSE: To assess psychometric properties of the Pelican instrument, an 
online Dutch self-administered Quality of Life instrument for childhood 
asthma for scientific and clinical use. 
 
METHODS: A cohort study was done in two asthma populations and healthy 
children. One asthma population had assessment at start, 4 and 8 weeks. The 
other asthma population and healthy children had one assessment. All 
children were aged 6–11 years. Children completed the Pelican instrument, 
Paediatric Asthma Quality of Life Questionnaire, feeling thermometer and 
Childhood Asthma Control Test. Lung function and fraction exhaled nitric 
oxide were measured. Parents completed Functional Status II, Asthma Control 
Questionnaire, Childhood Asthma Control Test questionnaires and symptom 
diaries. We assessed interpretability, structural validity, internal consistency, 
reliability, construct and discriminative validity of the Pelican instrument. 
 
RESULTS: Eighty-five asthmatic (mean age 8.5 years) and 49 healthy children 
(mean age 8.4 years) participated. The Pelican instrument has 5 domains with 
21 items after factor analysis. Internal consistency was 0.89 (CI 0.85–0.92), 
domain reliability showed Cronbach’s a’s from 0.64 to 0.76 and item-to-scale 
correlations from 0.61 to 0.81. Test– retest reliability was confirmed ICC = 
0.88 (CI 0.79–0.93). Construct validity was demonstrated by significant 
moderate correlations with other relevant asthma outcomes like PAQLQ (r = -
0.59, p<0.01). Discriminative capacity between controlled or uncontrolled 
asthma (t = 3.20, p<0.01, Δ = 0.64) and asthma versus healthy subjects (t = 
6.31, p<0.01, Δ = 0.94) was found. 
 
CONCLUSIONS: The psychometric properties of the Pelican instrument were 
acceptable in Dutch paediatric asthma patients from 6 to 11 years old. 
 
KEYWORDS: Psychometric properties, Asthma Children, Health-related 
Quality of Life (HRQL), Reliability, Validity 
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INTRODUCTION 
Asthma is a chronic respiratory disease characterised by recurrent 
breathlessness and wheezing. It is the most common chronic disease in 
childhood in Western countries and represents a significant burden for the 
child, family and society. (1-3) Treatment goals of physicians often differ from 
those of asthma patients. While physicians prioritise reduction of mortality 
and morbidity, patients want to minimise the impact of asthma on their daily 
life and functioning. (4) Therefore, optimal health-related quality of life 
(HRQL) is an essential treatment outcome besides clinical and physiological 
measures. (5-7) HRQL is an individual’s subjective experience that relate to 
health, disease, disability and impairment, which is usually measured in 
physical, emotional, cognitive and social dimensions. (8) Existing asthma-
related HRQL questionnaires are the Paediatric Asthma Quality of Life 
Questionnaire (PAQLQ), Pediatric Quality of Life Inventory (PedsQL), How 
Are You (HAY), Childhood Asthma Questionnaire (CAQ-B) and DISABKIDS (9-
13). Items of these questionnaires are mostly based on opinions of 
professionals and parents (10-12, 14) and are formulated in terms of 
frequency of appearance (such as the PedsQL) which refers to health status 
but not HRQL according to the above-mentioned definition. (5, 10, 15) The 
only questionnaire that determines the subjective feeling of the patient (HAY) 
consists of 115 questions, which is time-consuming and demanding for a 
child. (12) Because HRQL should represent subjective experience, patients 
should be involved in item-selection. (5) Another limitation is that existing 
questionnaires were developed to compare treatment groups in scientific 
studies (16, 17) and are generally not considered suitable for individual 
patient care. In addition, they require quiet surroundings and health care 
personnel for completion and scoring, which is time consuming and 
unpractical. 
 For those reasons, we developed the Paediatric Electronic quality of 
Life Instrument for Children with Asthma in the Netherlands (Pelican). (18) 
This instrument exists of two parts: a standardised part that is suitable for 
scientific purpose and individualised part for patient care. In this study, the 
Pelican instrument was tested in Dutch children with asthma to assess the 
psychometric properties of the Pelican instrument according to the Classical 
Test Theory. (19) First of all, the validity of the standardised part (structural 
and construct validity) and the individual part of the questionnaire were 
assessed. In addition, we investigated interpretability, internal consistency, 
test-retest-reliability and discriminative validity. 
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METHODS 
 
Study design and subjects 
A cohort study was performed with three study populations. All populations 
were children from the Netherlands from 6 to 12 years old. In- and exclusion 
criteria were assessed in a questionnaire completed by parents. Recruitment 
strategies and measurements differed between study populations. 
 Written informed consent was obtained from the parents after 
providing written information about the study. (20) In accordance with the 
guidelines on scientific research, underage subjects could be withdrawn from 
the study at any time when they or their parents objected. (21) The study was 
approved by the Ethics Committee on Research involving Human Subjects in 
the region Arnhem-Nijmegen, the Netherlands (CMO 2008/097, 
www.cmoregio-a-n.nl/). 
 
Asthma population I 
Children from urban and rural areas with physician-diagnosed asthma who 
had used inhaled asthma medication for at least 6 weeks during the previous 
year were included. Children were excluded if they (a) had a comorbid 
condition that significantly influences HRQL (e.g., diabetes, congenital heart 
condition), (b) did not understand or speak the Dutch language or (c) were 
unable to attend a regular school class (i.e., surrogate marker for a learning 
disorder). Children were recruited through invitations by family practices, 
newspaper advertisements and pharmacies and were stratified on age (6 
until 8; 9 until 11 years) and asthma severity (based on the Global Initiative 
for Asthma classification). (22)  
 
Asthma population II 
Participants of a holiday camp for children with asthma organised by ‘De 
Luchtballon’ foundation in the Netherlands were recruited by an invitation 
letter. In- and exclusion criteria were the same as for Asthma population I.  
 
Healthy children 
Healthy children were recruited from a primary school in an urban area. To 
exclude undiagnosed asthma or allergy, children were screened using pre- 
and post-bronchodilator spirometry and a standardised proxy-questionnaire.  
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Power calculation 
A power calculation based on the test-retest reliability coefficient (Intraclass 
Correlation Coefficient) of 0.8 with a 95% CI and α=0.05 shows that 100 
children with asthma are needed to validate the instrument. 
 
The Pelican Instrument 
The Pelican instrument is an online Dutch self-administered asthma-specific 
HRQL questionnaire. When developing the Pelican instrument, we generated 
a list of possible items (constructed by literature, existing HRQL instruments 
and an expert panel). This list was as a discussion guide during focus group 
meeting with children with asthma. The content of the Pelican instrument 
based on qualitative analyses of statements of children during focus group 
meetings. Exact details of the development of the Pelican instrument can be 
found elsewhere. (18) The standardised part exists of core items that provide 
domain and total scores of HRQL. The provisional version of the Pelican 
instrument consisted of 22 questions clustered into 5 domains (Symptoms, 
Triggers, Limitations due to Activities, Mental and Emotional Impact, Impact 
on Social Life). (18) The questions assess the level of discomfort caused by 
various asthma-related aspects in daily life and are read out loud so the child 
does not necessarily require reading ability. Questions are answered on a 5-
point Likert scale, visualised by coloured emoticons (ranging from score 1 
‘Not bad at all’ to score 5 ‘Very bad’). (23, 24) An escape answer category was 
added, meaning ‘I don’t know’ or ‘I don’t have’.  
In the individual part, the child is allowed to select a maximum of 
three personal problems related to asthma from the ‘core’ items and can add 
one completely new personal problem. This set of personal problems is an 
easy starting point for communication and treatment in patient care.  
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Measurements  
All measurements were applied as described by the original developers. 
Demographic characteristics of participants and their families were inquired 
with a questionnaire that was completed by the parents before the first 
assessment. 
 In asthma study population I, children completed the Pelican 
instrument and Paediatric Asthma Quality of Life Questionnaire (PAQLQ). The 
PAQLQ is the most commonly used HRQL instrument in childhood asthma 
and shows good psychometric properties. (14) Moreover, the children filled 
out an 11-point feeling thermometer (0 – 10) “To what extent do you worry 
about asthma?” anchored “Not at all” and “Very much”. Asthma control was 
assessed with the proxy-rated Asthma Control Questionnaire (ACQ) and the 
partly proxy-rated, partly self-administered Childhood Asthma Control Test 
(C-ACT), that both show good psychometric properties. (25, 26) Fraction of 
exhaled Nitric Oxide (FeNO) level was measured as a marker of airway 
inflammation by a 6-second exhalation in a hand-held device with an 
electrochemical sensor (NIOX MINO® Airway Inflammation Monitor; 
Aerocrine AB, Solna, Sweden) according to American Thoracic 
Society/European Respiratory Society guidelines (ATS/ERS). FeNO level 
assessment took place prior to spirometry. (27) Lung function indices, i.e. 
forced expiration volume in 1 second (FEV1) and forced vital capacity (FVC) 
before and 15 minutes after inhalation of 400 µg salbutamol by Volumatic® 
spacer, were measured according international ATS/ERS guidelines by a 
certified lung function technician using a spirometer with child-incentive 
(SpiroPerfect®, WelchAllyn, Delft, The Netherlands). (28) Parents filled out a 
questionnaire regarding general and asthma-specific functional status (FS II) 
of their child. (29) All measurements took place at baseline, 4 and 8 weeks at 
a regional primary care diagnostic centre. Conditions during measurements 
were similar concerning type of administration, environment and 
instructions given to children. Symptoms and medication use were recorded 
in a diary by the parents weekly.  
 Asthma study population II completed the same measurement tools, 
with the exception of the ACQ, symptom diaries, FSII, FeNO and lung function 
assessment. Study instruments were administered one time at the start of a 
holiday camp.  
We asked healthy control children to complete the Pelican instrument 
while ignoring the words ‘because of asthma’ in the questions and to focus 
only on their experience of a daily life event in the question, e.g. ‘How do you 
feel about children sometimes making fun of you or bulling you (because you 
have asthma)?’. FeNO and lung function were assessed according to the same 
protocol as in the children with asthma. Assessment took place once. 
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Semi-structured interviews 
A random sample of 14 children from Asthma population I was selected for a 
semi-structured interview after the first assessment of the Pelican instrument 
with the objective to investigate ease of application; user-friendliness, 
relevance and comprehensibility of concepts such as ‘shortness of breath’ and 
‘wheezing’, questions and answers. The interviewers (AG and SW) were 
unaware of the answers from the children on the Pelican instrument. We 
evaluated the agreement between answers given in the Pelican instrument 
and the response of the children on the same questions during interviews. 
Interviews were audio recorded, transcribed fully, analysed and coded by two 
independent reviewers. When no consensus was achieved, a third reviewer 
was consulted. 
 
Statistical analyses 
Data were analysed using SPSS (version 18.0; SPSS Inc., Chicago, IL, USA) and 
significance was defined as p <0.05. 
 
Interpretability 
Interpretability could not be assessed with response rates and missing data of 
items. This was due to the fact that the digital Pelican instrument was 
programmemed that all items were obligatory to be completed. If children did 
not know how to answer a question or a question did not apply to them, they 
could select the escape answer (meaning: I don’t know/I don’t have). 
Inacceptable or inappropriate items could be detected by high response rates 
of the escape answer and this should not be higher than >50% per item. 
Furthermore, response distribution and floor and ceiling effects were 
investigated per item. A percentage above 25% of the upper and lower 
response category was considered as a floor or ceiling effect (30). For this 
analysis, the results of the first measurements in Asthma population I and II 
were used. 
 
Structural validity 
The original Pelican instrument consisted of 22 items divided over 5 domains 
(Symptoms, Triggers, Limitations due to Activities, Mental and Emotional 
Impact, Impact on Social Life) based on theory (18). Exploratory principles 
component factor analysis using a promax oblique rotation with 
communalities ≥ 0.45 and the Kaiser criterion (i.e., eigenvalue >1.0) was 
applied to investigate the correlations between the items. Items with poor 
factor loading were reconsidered and final decision to in- or exclude items 
was based on consensus of an expert panel of 2 clinicians and 3 researchers. 
For this analysis, the results of the first measurements in Asthma population I 
and II were used. 
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Internal consistency 
Internal consistency was measured by uncorrected item-scale correlations 
and Cronbach’s α’s per domain and for the entire instrument. A value 
between 0.70-0.95 is considered as evidence of good internal consistency 
(30). For this analysis, the results of the first measurements in Asthma 
population I and II were used. 
 
Test-retest reliability 
Test-retest reliability was assessed in children in the asthmatic group with 
‘steady asthma control’ (<3 points difference on C-ACT score) (31). The mean 
Intra Class Correlation (ICC) was calculated for the Pelican scores of visits 1 
and 2 in Asthma population I. An ICC of ≥ 0.85 between scores of the Pelican 
instrument in children with steady asthma control was considered a good 
test-retest reliability (30).  
 
Construct validity 
Cross-sectional construct validity was defined by convergent and divergent 
validity (32). Convergent validity assesses the relationship between two 
different instruments measuring the same construct and was primarily 
investigated by comparing the results of the Pelican instrument to those of 
the PAQLQ with Pearson or Spearman rank correlations (depending on 
normality distribution). We anticipated moderate to strong correlations. 
Divergent validity assesses the relationship with instruments measuring 
other constructs which have proven to be different from the construct under 
study, such as FeNO or lung function (FEV1) measurements which are 
expected to be weakly correlated to HRQL (33). Correlations of α < 0.3 were 
considered to be weak, correlations of α = 0.3–0.6 were considered to be 
moderate, and correlations of α > 0.6 were considered to be strong (30). For 
the hypotheses underlying the correlations, see Table 1. For this analysis, the 
results Asthma population I was used. 
 
Discriminative validity 
Discriminative validity was assessed by differences in Pelican total score 
between subjects with well controlled asthma (C-ACT > 19) and subjects with 
uncontrolled asthma (C-ACT ≤ 19) and between subjects with or without 
asthma by independent samples t-tests and Δ Pelican score. For this analysis, 
the results Asthma population I and healthy control children were used. 
 
Individualised part of the Pelican instrument 
The individualised part of the Pelican was considered valid when selected 
items that were considered most relevant by children, were scored 
significantly higher in the standardised part of the instrument by children 
than unselected items. Moreover, the concordance of aspects of asthma that 
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bothered children most according to the interviews was compared with the 
selected items in the individual part of the Pelican instrument in order to 
determine the validity of this part of the questionnaire. 
 
 
RESULTS 
 
Study participants  
The study population consisted of 85 subjects with asthma (including 9 
subjects from asthma study population II) and 49 school aged healthy 
children. Figure 2 shows the recruitment process and Table 2 summarizes 
demographic and clinical characteristics. 
 
Semi-structured interviews 
Fourteen children, aged 7 to 11 (mean 8.3), participated in semi-structured 
interviews. All children understood how to complete the digital questionnaire 
and use the answer categories, including the escape answer (Table 3). Eight of 
fourteen children mentioned that it was sometimes difficult to choose 
between response categories alike, especially since they weighed both 
frequency and severity of the item in their response. Children had no 
difficulties with the language used and thought all items were relevant (even 
if it did not apply to themselves, they thought it would be relevant for other 
children with asthma). We observed that the children’s answers on the 
Pelican instrument corresponded to their answers during the interviews 
(72.7%). However, it appeared that understanding of one of the Pelican 
instrument’s provisional questions was insufficient and answered 
inconsistently by children (<50% corresponding answers). Therefore, this 
item was deleted from the final version and not included in analyses. (18) 
Correspondence of three children (two non-Western ethnic origin) between 
the Pelican instrument and the interview were low (<50%) (Table 2).  
 
 
  
Figure 1: Flowchart of participant recruitment 
Asthma study population I   Asthma study population II   Healthy controls 
 
 
 
  
Analysed Visit 1-2 (n=47)  
Analysed Visit 2-3 (n=43) 
 Test-retest reliability 
 
Children with asthma 
recruited by general 
practices, newspaper 
advertisements and 
pharmacies 
Children with asthma 
recruited at an asthma 
camp 
Healthy children 
recruited at an 
elementary school 
Children assessed for 
eligibility (n=119) 
 
 Children assessed for 
eligibility (n= 67) 
 
Excluded  (n=30) 
 (age n=11, no asthma n=5, no 
medication n=7, insufficient 
Dutch language n=1, more than 
one of previous reasons n=6)  
Excluded  (n= 0) 
 
 
 Children assessed for 
eligibility (n= 10) 
 
Excluded  (n= 12) 
(Not meeting age inclusion 
criteria n=  12)  
Children assessed for eligibility 
Cross sectional Analyses 
Excluded  (n=13) 
 Technical problems (n= 4)  
 Declined before first visit (n=9)  
(no complaints n=2, no time n=1,  
other health problems n=1, lack of 
interest n=2, lost contact n=1, 
participation too much burden n=2)   
 
 
Excluded (n= 1) 
 Child admitted random and 
unserious responding to 
Pelican instrument (n=1) 
Analysed  (n=9) 
 Factor analysis & Internal 
Consistency  
 
 
Longitudinal Analyses 
Analysed  (n=49) 
 Discriminative validity 
 
 
 
Excluded (n=6) 
 Airflow reversibility (n=3) 
 Declined before first visit 
(n=3) 
Analysed  (n=76) 
 Factor analysis & Internal 
Consistency 
 Construct & Discriminative Validity 
Excluded Visit 1-2 (n=29)  
 Data unavailable (n=6) 
 Changed asthma status (n=23) 
Excluded Visit 2-3 (n=43) 
 Data unavailable  (n=7) 
 Changed asthma status (n=26) 
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Table 1: Hypothesised and final cross-sectional construct validity of the 
Pelican instrument with other constructs with Spearman rank 
correlations 
* p<0.05, ** p<0.01. 
Rationale/Hypothesised correlations: ґ >.60, ғ .30-.60, ь <.30 
 Pelican 
Total 
α 
Symptoms 
 
α 
Activities 
 
α 
Triggers 
 
α 
Social/ 
Emotional 
α 
Feeling thermometer .53** ґ     
PAQLQ total score -.59** ґ     
PAQLQ domain 
symptoms 
 -.55** ґ    
PAQLQ domain emotions     -.53** ь 
PAQLQ domain activities   -.28* ґ   
FSII disease specific -.22 ғ     
ACQ .17 ғ .25* ғ    
C-ACT -.38** ғ -.42** ь    
Lung function (FEV1pre) -.10 ь -.11 ь    
FeNO  .28* ғ  .10 ь  
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Table 2. Demographic and clinical characteristics of the analysed study 
population at baseline 
 Asthma study 
population I* 
Asthma study 
population II 
Healthy children 
 N Mean SD N Mean SD N Mean SD 
Age (years)  76 8.5 (   1.65) 9 10.33 (  0 .87)  49      8.4 (   1.98) 
Gender male, n (%) 76 46  (60.50) 9 7.00 (77.78)  49   26 (53.10) 
Ethnicity, n (%)  76      49   
 Dutch  35 (46.00)     45 (91.80) 
 Caucasian  3 (  3.95)     0 (  0.00) 
 Non-Caucasian  8 (10.53)     4 (  8.20) 
 Unknown  30 (39.47)     0 (  0.00) 
FeNO  68 20.50 (14.79)    39 10.54 (  7.33) 
FEV1 pre  73 1.70 (   0.41)    49 1.89 (  0.43) 
FEV1 post  75 1.77 (  0.40)    49 1.93 (  0.43) 
Allergy, n (%)  76      49   
 Yes  73 (92.40)     11 (22.40) 
 No  3 (  3.80)     38 (77.60) 
 Unknown  3 (  3.80)     0 (  0.00) 
Rhinitis, n (%)  76         
 Yes  29 (36.70)       
 No  32 (40.50)       
 Unknown  18 (22.80)       
Medication, n (%)  76   9      
 ICS only  7 (  8.97)  0 (  0.00)    
 Bronchodilator 
only 
 8 (10.26)  1 (11.11)    
 Combined 
medication 
 62 (79.49)  8 (88.89)    
 No medication  1 (  1.28)  0 (  0.00)    
PAQLQ  7
6 
4.67 (  1.11) 9 5.97 (  0.85)    
Pelican  7
6 
2.70 (  0.82) 9 2.76 (  0.95)    
ACQ  7
4 
0.78 (  0.58)       
C-ACT  7
4 
21.03  (  3.93) 9 15.00 (  1.80)    
Abbreviations: ACQ Asthma Control Questionnaire, C-ACT Child Asthma Control Test, FEV1 Forced 
expiration volume in one second before (pre) and after (post) bronchodilatation, ICS Inhaled 
Corticosteroids, n number, PAQLQ Paediatric Asthma Quality of Life Questionnaire, SD Standard Deviation 
* Asthma study population I was assessed in a regional diagnostic centre, asthma study population II was 
recruited and assessed on a asthma camp 
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Table 3: Correspondence of answers between the Pelican instrument 
and interview 
 
Child Sex Age 
(Years) 
Ethnicity ACQ6 
(1) 
% of 
correspond-
ding answers 
% of non-
corresponding 
use of blue smiley 
(n° of blue items) 
(2) 
Top 3 priorities 
(3) 
1 F 8 Dutch 0.00 90.9 0.0 (6) Corresponding 
2 M 8 Dutch 0.83 87.5 21.4 (14) Corresponding 
3 M 10 Dutch 3.00 80.0 11.1 (9) Corresponding 
4 M 8 Dutch 0.00 85.0 11.1 (9) Corresponding 
5 M 9 Dutch 0.17 78.6 12.5 (8) 
Not 
corresponding 
6 F 9 Dutch 0.00 82.4 0.0 (8) Corresponding 
7 M 10 Turkish 0.00 47.1 100.0 (5) 
Not 
corresponding 
8 M 11 Dutch 1.67 77.8 20.0 (10) Corresponding 
9 F 10 Dutch 0.67 85.0 33.3 (6) Corresponding 
10 M 7 Dutch 2.00 47.4 100.0 (6) Corresponding 
11 F 10 Dutch 2.00 63.2 100.0 (4) Corresponding 
12 F 8 Dutch 2.17 84.6 25.0 (4) Corresponding 
13 M 8 Dutch 0.00 68.4 28.6 (14) 
Not 
corresponding 
14 F 9 Moroccan - 40.0 50.0 (4) 
Not 
corresponding 
TOT     72.7 36.6  
Abbreviations: ACQ6 Asthma Control Questionnaire with 6 items (without lung function measure) 
(1) ACQ6: degree of asthma control 0 to 6 points. <1: asthma-control is considered as good. >1 asthma-control 
is considered bad. 
(2) Number and percentage of questions where the answer in the interview matches with what was filled in in 
the Pelican-instrument. 
(3) If the children in the interview mention the same item on the question: "What do you find the worst thing 
about having asthma" as they chose at the individual part with the balloons, it will be considered as correct, 
if children mention another item the individual question is not filled in correctly. 
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The standardised part of the Pelican instrument 
 
Interpretability 
No items showed more that 50% response with the escape answer. No child 
discontinued completion of the instrument, resulting in a 100% completion 
rate. Floor and ceiling effects were detected in three items. Detailed results 
are presented in Table 4. 
 
Structural validity 
The remaining 21 items of the Pelican instrument were subjected to a rotated 
explorative factor analysis and revealed six components with eigenvalues >1. 
To aid in the interpretation of these components, varimax rotation was 
performed. Results showed six factors, that were reviewed by an expert 
panel. The six-component model showed one factor that existed of only one 
item. The expert panel could not support this model with theory and 
therefore factor analyses was forced in a five-component model (as was the 
case in the conceptual model of the provisional version of the Pelican 
instrument). Items still showed good loading, thus the grouping of five factors 
was maintained, explaining 57% of the variance. Although one item ‘How do 
you feel about having to use your inhaler every day’ had low factor loadings (< 
0.4), we kept the item in the instrument because children and experts 
consider this a clinical important issue. See figure 1, for the final version of 
the Pelican instrument.  
 
Internal consistency 
Cronbach’s α of the total Pelican score was 0.89 (CI 0.85-0.92) and domain 
consistency showed Cronbach’s α’s between 0.64 and 0.76 (p < 0.05). Three 
domains of the Pelican instrument showed Cronbach’s α’s above 0.70, but the 
domains ‘Social and emotional aspects’ and ‘Triggers’ had Cronbach’s α’s 
slightly below the 0.70 threshold (i.e., 0.64 and 0.67 respectively). Item-to-
scale correlations varied between 0.61 – 0.81. 
 
Test-retest reliability  
Data of asthma control, measured by the C-ACT, were available of 70 subjects 
for the first two visits (e.g visit 1 and 2). 47 Patients showed steady asthma 
control with an ICC of 0.88 for the Pelican score (CI 0.79-0.93; p<0.01) (Table 
5).  
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Standardised part 
Domain Activities 
1. How do you feel about not being able to run as fast as other children your age 
because of your asthma?  
2. How do you feel about being less good at sports and games (like cycling, 
 football or playing tag) because of your asthma?  
3. How do you feel about being less good at gym because of your asthma?  
4. How do you feel about being less good at swimming because of your asthma? 
 
Domain Symptoms 
5. How do you feel about wheezing when you are breathing? 
6. How do you feel about having to cough? 
7. How do you feel about getting a sore throat because of your asthma?  
8. How do you feel about getting out of breath? 
9. How do you feel about having an asthma attack? 
 
Domain Triggers 
10. How do you feel about being bothered by cigarette smoke? 
11. How do you feel about your asthma getting worse when the weather changes?  
12. How do you feel about not being allowed to keep or caress pets/animals?  
13. How do you feel about being affected by (house) dust?  
 
Domain Asthma management 
14. How do you feel about having to use an inhaler for your asthma?  
15. How do you feel about having to use your inhaler every day?  
16. How do you feel about needing an inhaler all the time?  
17. How do you feel about having to go to the doctor or hospital for your asthma?  
 
Domain Social/emotional impact 
18. Do you ever feel different from other children because of your asthma?  
19. How do you feel about sometimes losing track of school projects and tasks 
caused by your asthma?  
20. How do you feel about children sometimes teasing you or making silly remarks 
because you have asthma?  
21. How do you feel about sometimes missing a school activity because of your 
asthma?  
22. How do you feel about having to remember lots of things because of your 
asthma? (eliminated from the final version based on interviews) 
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Individualised part 
 
Select a personal top-three out of the items that are most detrimental to you 
about having asthma. 
  
List of items: Shortness of breath, Sore throat, Coughing, Wheezing, Cigarette smoke, 
Changes in the weather, Dust/house mite, Being bullied by other children, 
Gymnastics, Running, Sports and games, Taking an inhale, Going to the 
doctor/hospital, Missing school activities, Not being allowed to have pets or stroke 
them, Projects and tasks 
 
Is there an asthma-related problem that did not occur in the list of items but is 
detrimental to you about having asthma? Please write this problem down.  
__________________________________________________________ 
__________________________________________________________ 
 
How do you feel about this problem because of your asthma? 
 
Answer categories  Item scoring 
I don’t know/ I don’t have  1 
Not bad at all    1 
Not so bad    2 
Don’t really mind   3 
Bad     4 
Very bad    5 
 
Computer animation 
The child can complete the instrument with or without a storyline computer 
animation. When the child chooses to complete the questionnaire with the animation, 
it sees a story about a locomotive that suffers from asthma.  
 
Scoring 
Overall HRQL score is calculated by the mean of all items and domain scores are 
calculated by the mean of all items within that domain. 
 
Missing values 
Missing values are not accepted by the digital program. 
 
Figure 1: Theoretical model of the Pelican Instrument 
 
* Translation was done literally from Dutch version of the Pelican instrument to British English. Cultural 
adaption was not applied in this process, therefore official translation and cultural adaption procedures 
should be followed. This might lead to differences between final English versions of the Pelican instrument 
and the one represented in this article. 
   
CHAPTER 2 | PSYCHOMETRIC PROPERTIES OF THE PELICAN INSTRUMENT 
Page | 45  
 
 
 
 
 
 
 
 
 
 
 
Table 4: Internal consistency of standardised part, items most 
frequently chosen in the individualised part of the Pelican instrument 
and response distribution on item level in Dutch children with asthma 
 
Domain/item 
Uncorrected 
Item-to-
scale 
correlations   
 
 
(N=85) 
 
α (CI) ¹ 
Most 
detri-
menttal 
item at 
visit 1  
 
(N=76) 
 
% 
Frequenc
y items  
in top 3 
during 
visit 1 
(N=76) 
 
% 
Response distribution at visit 1 (N=76) ² 
 
 
0 
% 
1 
% 
2 
% 
3 
% 
4 
% 
5 
% 
 
Total 
 
Asthma management  
Visits to doctors/hospital 
Taking medication 
Daily medication use 
Dependency on medication 
Missing days at school 
 
Activities  
Running 
Sport-activities 
Physical education 
Swimming 
 
Triggers 
No pets 
Seasonal changes 
Dust/ House dust mite 
Cigarette smoke 
 
Symptoms 
Wheezing 
Coughing 
Sore throat 
Shortness of breath 
Asthma attack 
 
Social and emotional 
limitations  
Being bullied, left out and 
not believed 
Feeling different from peers 
Difficulty to concentrate 
 
.89 (.85-.92) 
 
.76 (.67-.84) 
.72 
.73 
.76 
.60 
.66 
 
.76 (.67-.84) 
.76 
.81 
.75 
.67 
 
.67 (.54-.77) 
.72 
.71 
.81 
.61 
 
.71 (.60-.79) 
.73 
.64 
.63 
.71 
.71 
 
.64 (.48-.75) 
 
.72 
 
.62 
.77 
 
 
 
 
1.3 
2.5 
0.0 
0.0 
0.0 
 
 
3.8 
0.0 
0.0 
0.0 
 
 
7.6 
1.3 
5.1 
21.5 
 
 
6.3 
7.6 
12.7 
22.8 
0.0 
 
 
 
7.6 
 
0.0 
0.0 
 
 
 
 
10.1 
8.9 
0.0 
0.0 
7.6 
 
 
12.7 
12.7 
2.5 
0.0 
 
 
30.4 
10.1 
16.5 
31.7 
 
 
16.5 
11.5 
22.8 
14.8 
0.0 
 
 
 
17.7 
 
0.0 
1.3 
 
23.5 
 
 
10.2 
4.5 
6.8 
12.5 
15.9 
 
 
20.5 
28.4 
36.4 
36.4 
 
 
29.5 
20.5 
21.6 
11.4 
 
 
30.7 
1.1 
28.4 
17.0 
34.1 
 
 
 
47.7 
 
33.0 
47.7 
 
12.3 
 
 
19.3 
26.1³ 
19.3 
10.2 
22.7 
 
 
13.6 
21.6 
12.5 
18.2 
 
 
9.1 
6.8 
6.8 
12.5 
 
 
8.0 
           
13.6 
5.7 
2.3 
0.0 
 
 
9.1 
 
13.6 
6.8 
 
10.8 
 
 
14.8 
15.9 
21.6 
18.2 
10.2 
 
 
11.4 
12.5 
11.4 
10.2 
 
 
6.8 
11.4 
10.2 
6.8 
 
 
10.2 
11.4 
5.7 
13.6 
4.5 
 
 
 
0.0 
 
11.4 
9.1 
 
16.6 
 
 
30.7 
33.0 
31.8 
11.4 
15.9 
 
 
12.5 
15.9 
19.3 
15.9 
 
 
6.8 
21.6 
25.0 
13.6 
 
 
15.9 
27.3 
5.7 
8.0  
5.7 
 
 
 
10.2 
 
15.9 
6.8 
 
21.6 
 
 
14.8 
12.5 
17.0 
27.3 
27.3 
 
 
35.2 
11.4 
13.6 
12.5 
 
 
17.0 
26.1 
23.9 
31.8 
 
 
26.1 
37.5 
31.8 
18.2 
23.9 
 
 
 
11.4 
 
18.2 
17.0 
 
15.1 
 
 
10.2 
8.0 
3.4 
20.5 
8.0 
 
 
6.8 
10.2 
6.8 
6.8 
 
 
30.7³ 
13.6 
12.5 
23.9 
 
 
9.1 
9.1 
22.7 
40.9³ 
31.8 
 
 
 
21.6 
 
8.0 
12.5 
Abbreviations: α Cronbach’s alpha, CI confidence interval, N number 
¹ Reliability of Domain and Total scores were assessed with Inter Class correlations. Item-to-Scale 
correlations were performed with non parametric analyses. All Cronbach’s α’s were significant (p < 0.01), 
CI = confidence interval. 
² 0=Don’t know/Don’t have, 1=Not bad at all, 2=Not so bad, 3=Don’t really mind, 4=Bad, 5=Very bad. 
³ Floor or ceiling effect was detected (>25% of the children responded on extreme response categories) 
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Table 5: Change in Total score of the Pelican instrument between visit 1 
and 2 in children with steady and changed asthma control (independent 
samples t-test) 
 
Change in Quality of life score¹ 
 Steady asthma  
control (A)²    
Changed asthma  
control (B)    
Difference (AB) 
 N mean N Mean p-value 
All 
patients 
47 -0.31 23 -0.23 0.46 
6-8 years 20 -0.30 16 -0.23 0.71 
9-11 years 27 -0.33 7 -0.21 0.51 
Abbreviations: N number 
¹ Expressed as the change in mean score per item 
² Steady asthma control was defined as ≤3 points difference in C-ACT score between visits and changed 
asthma control was defined as >3 points difference in C-ACT score. 
 
 
Construct validity 
Since data of the PAQLQ was not normally distributed, we used Spearman 
rank correlations to assess convergent validity of the Pelican instrument. We 
observed a negative moderate correlation between the Pelican score and the 
PAQLQ total score (r= -0.59, p < 0.01). The Pelican instrument and PAQLQ 
have reversed scales, which explains the minus sign. Pelican domain scores 
showed weak to moderate significant correlations with the PAQLQ domains. 
Furthermore, significant moderate correlations were seen with the feeling 
thermometer that was administered by the child and the partly self-
administered C-ACT but not with the proxy-rated ACQ. We did not find 
correlations between the Pelican score and lung function (FEV1), FeNO or 
functional status. Hypothesised correlations and detailed results of construct 
validity can be found in Table 1. 
 
Discriminative validity 
The Pelican instrument discriminated well between subjects with well-
controlled and uncontrolled asthma according to the C-ACT (t = 3.20, p < 0.01; 
Δ0.64 Pelican score) and between children with and without asthma (t = 6.31, 
p < 0.01; Δ0.94 Pelican score). 
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Individualised part of the Pelican instrument 
Items selected by the children as most detrimental in the individualised part 
scored 0.95 points (SD = 0.95) higher in the standardised part of the Pelican 
instrument compared to unselected items. Furthermore, in 10 of 14 children 
the individual items corresponded with the most relevant problems related to 
asthma that children mentioned during the interviews (72.7%) (Table 3). 
Table 4 shows the most chosen items by children in the individual part of the 
Pelican instrument. 
 
DISCUSSION  
The Pelican instrument is an online asthma-specific HRQL instrument for 
children. This study, performed in a population of Dutch children between 6 
and 12 years old, assessed the psychometric properties of this instrument 
according the Classical Test Theory. After factor analysis, a theoretical model 
of 5 domains was set with 21 items. Internal consistency was good, although 
consistency for the domains ‘Social and emotional aspects’ and ‘Triggers’ was 
lower but still acceptable. Test-retest-reliability of the Pelican instrument in 
children with steady asthma control (C-ACT) was good. Convergent and 
divergent validity of the Pelican instrument with related (e.g. PAQLQ) and 
unrelated constructs was generally in concordance with our set of a priori 
hypotheses. Therefore, we can conclude that cross-sectional construct 
validity of the Pelican instrument was moderate to good. Furthermore, the 
instrument was able to discriminate between children with controlled or 
uncontrolled asthma and between children with or without asthma. It should, 
however, be taken into consideration that it is unsure if the healthy children 
in our study responded reliable to the Pelican instrument since several 
questions (for example about asthma management) do not apply to them. The 
validity of the individualised part was investigated and appeared to be good 
as well. 
The Pelican instrument differs from existing paediatric asthma-
specific HRQL instruments in several ways. Firstly, in the majority of existing 
instruments, items were predominantly selected by professionals and 
parents, whereas items for the Pelican instrument were based on children’s 
perspectives. (18) That might explain why the Pelican instrument showed 
proper correlations with self-administered instruments but not with proxy-
instruments. A previous study found that parents’ ratings do not correlate 
with children’s experienced quality of life and parents might not even be able 
to provide this kind of information about the child. (34) When HRQL 
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information is used to direct patient care, we suggest to use outcomes 
primarily derived from children themselves. The Pelican instrument gives 
children a voice in the physician’s office and might prevent that 
communication about the patient takes place between parents and physicians 
only. Previous research has shown that children in the age of 6-11 are capable 
of completing questionnaires themselves and children can be seen as good 
content experts. (23, 24) Naturally, parental reported-outcomes (when 
available) could be used to complement the results of self-administered HRQL 
questionnaires. Secondly, the Pelican instrument is a digital questionnaire 
that is supported with auditory and visual clues and children are able to 
choose to complete it with or without a computer animated movie. As far as 
we are aware, none of the existing paediatric asthma-specific HRQL 
instruments offers these advanced features. And finally, the most important 
feature of the Pelican instrument is its clinical applicability. Children are able 
to fill out the questionnaire online at home before a doctor of nurse visit. 
They select a personal top three of individual problems related to asthma and 
this outcome is readily available for the health care professional who can 
apply the patient’s outcome in treatment. The webcenter uploads the results 
of the patient and immediately calculates HRQL domain and total scores. 
Online assessment and computerised score calculation saves time and costs 
since it does not require personnel. At this moment, a randomised controlled 
trial takes place to evaluate the effectiveness of implementation of the Pelican 
instrument in Dutch primary and specialised paediatric asthma care 
(www.clinicaltrial.gov, NCT01109745).(35) 
Strengths and limitations 
Recruitment of participants for this study was difficult, leading to multiple 
recruitment procedures, a smaller number of subjects than aimed for (n=100) 
and lower statistical power. In addition to the reliability and validation of the 
Pelican instrument, we wanted to investigate responsiveness but this could 
not be assessed since not enough participants demonstrated a clinically 
relevant change in asthma control during the 2-month observation period. In 
the psychometric study of the PAQLQ, a higher proportion of the study 
population showed improved asthma control after starting to use inhaled 
corticosteroids since baseline. (36) In our study, all subjects already used 
inhaled corticosteroids and reported good asthma control at baseline, leaving 
less room for improvement. Another possibility would have been to follow-up 
participants until they experienced a change of asthma status or exacerbation, 
as was done in the psychometric study of the HAY (12), but limited resources 
did not allow us to organise this. The responsiveness of the Pelican 
instrument will be evaluated during a follow-up study on the Pelican 
instrument. (35) 
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 Another limitation was the use of a difference of <3 points on the C-
ACT score as a measure for ‘steady asthma control’. This cut-off point was 
based on the adult version of the ACT since the cut-off point for the C-ACT is 
not known. (31) Furthermore, we found a ceiling effect of the PAQLQ, as was 
also seen in a previous study (on the domain ‘Emotions’), which may have 
lead to lower correlations between the PAQLQ and the Pelican instrument 
than expected. (14) 
 A strength of this study was the qualitative part of the semi-structured 
interviews with a subgroup of 14 participants to determine user friendliness, 
comprehensibility and relevance of items. In general, children had little 
difficulty understanding the language and application of the Pelican 
instrument. We found lower concordance between the interview and 
responses on the Pelican instrument in three children, of which two children 
were from non-Western ethnic groups. Ethnic influence on concordance was 
not supported by a sub-group analyses of all non-Western children compared 
to Western children (ICC 0.83 and 0.91 respectively). To ensure construct 
validity of the Pelican instrument in ethnic minority groups, we would advise 
to perform future validation studies.  
 If the Pelican instrument would like to be used in other populations 
than in this study or in children with asthma from other countries, it is 
advised to follow translation and cultural adaption procedures and further 
validation of this instrument is required. (37) In case of using the Pelican 
instrument for scientific purpose to compare treatments, it is advised to 
perform administration of the Pelican in standardised trial situation with 
controlled conditions and not at home. 
Conclusion 
The Pelican instrument showed acceptable reliability and construct validity in 
Dutch children with asthma between 6 to from 6 until 11 years of age, but its 
responsiveness to changes in asthma-related health status still needs to be 
established. Evaluation of HRQL instruments is a continuous endeavor 
requiring studies in diverse clinical populations. The current results justify 
further studies to evaluate the effectiveness of implementation of the Pelican 
instrument in primary and specialised care settings in order to support 
patient-centred paediatric asthma care.  
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Asthma instrument in the Netherlands; (PedQL) Pediatric Quality of Life 
Inventory   
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ABSTRACT 
 
OBJECTIVE: Asthma is one of the major chronic health problems in children in 
the Netherlands. The Pelican is a paediatric asthma-related quality of life 
instrument for children with asthma from 6-11 ears old, which is suitable for 
clinical practice in primary and specialised care. Based on this instrument, we 
developed a self management treatment to improve asthma-related quality of 
life. The Pelican intervention will be investigated in different health care 
settings. Results of intervention studies are often extrapolated to other health 
care settings than originally investigated. Because of differences in 
organization, disease severity, patient characteristics and care provision 
between health care settings, extrapolating research results could lead to 
unnecessary health costs without the desired health care achievements. 
Therefore, interventions have to be investigated in different health care 
settings when possible. This study is an example of an intervention study in 
different health care settings. In this article, we will present the study 
protocol of the Pelican study in primary and specialised care. 
 
METHODS: This study consists of two randomised controlled trials to assess 
the effectiveness of the Pelican intervention in primary and specialised care. 
The trial in primary care is a multilevel design with 170 children with asthma 
in 16 family practices. All children in one family practice are allocated to the 
same treatment group. The trial in specialised care is a multicentre trial with 
100 children with asthma. Children in one outpatient clinic are randomly 
allocated to the intervention or usual care group. In both trials, children will 
visit the care provider four times during a follow-up of nine months. This 
study is registered and ethically approved.  
 
DISCUSSION: This article describes the study protocol of the Pelican study in 
different health care settings. If the Pelican intervention proves to be effective 
and efficient, implementation in primary and specialised care for paediatric 
asthma in the Netherlands will be recommended. 
 
KEYWORDS: Asthma, Quality of life, Children, Primary care, Specialised care, 
Self management, Randomised controlled trial (RCT) 
 
TRIAL REGISTRATION NUMBER: clinicaltrial.gov (NCT01109745). 
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INTRODUCTION 
 
Asthma is the most common chronic disease in childhood in the Netherlands. 
(1) Its prevalence ranges from 3% in children aged 5–9 years to 3.7% in 
children aged 10–14 years. (2, 3) Although the prevalence is leveling off, 
asthma remains a significant burden for the child, family and the society at 
large. (4, 5) In the Netherlands, children with intermittent and mild asthma 
are usually treated by a family physician, while patients with more severe or 
uncontrolled asthma are treated by specialised paediatric care. (6) This 
implies that children with asthma treated in primary and specialised care 
may differ in features like disease severity and complexity, level of symptom 
control, functional status and co-morbidity. (7) Recent reports point to 
substantial room for improvement in the management of childhood asthma. 
(8-11) Poor adherence to therapy and inadequately treatment are two 
important reasons why asthma is uncontrolled. (9) Poor adherence has been 
associated with discrepancies between the perceived relevance of treatment 
goals between patients and their health care providers. Usual care for 
children with asthma focuses on reducing morbidity and mortality by 
maintaining optimal asthma control, while asthmatic children want to live a 
normal life with as few limitations from their asthma as possible. (12) Taking 
the child’s perception into account in the management of its asthma could 
result in achieving treatment goals of patients and providers and contribute 
to patient centred care. However recent studies pointed out that input of 
children and their parents into asthma management is only taken into 
account by health care providers during a minority (6 to 10%) of medical 
visits. (13) 
One of the important treatment outcomes showing a patient’s 
perspective is health related quality of life (HRQL). HRQL is a complex of all 
aspects of an individual’s subjective experience that relate to health, disease, 
disability and impairment, which is usually measured in physical, emotional, 
cognitive and social dimensions. (14-16) An HRQL questionnaire adds 
significant information about the functional impairments of a patient to 
clinical and physiological characteristics. Previous studies have shown that 
the most important HRQL components for children are consequences of 
asthma on peer relationships, dependence on medication, shortness of 
breath, cough, limitations in activities and limitations due to tobacco smoke 
exposure. (17, 18) 
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We have previously developed a child friendly web based tool to assess 
asthma-related quality of life in paediatric patients with asthma, using the so-
called ‘Pelican instrument’. In this paper, we describe the rationale for, and 
the designs of two randomised controlled trials (RCTs) that are based on the 
implementation of the Pelican instrument. In these trials the effectiveness of 
its implementation will be evaluated in both primary and specialised care 
setting in the Netherlands. Both trials are optimally adjusted in 
methodological design to meet the needs of the concerned care setting. 
Because of the known differences in health care organization and patient 
characteristics, it is important to establish possible effects of the treatment in 
both health care settings separately. In the past, results from specialised care 
studies have often been extrapolated into primary care, and vice versa. (19, 
20) Knowing that several important differences exist between these care 
setting, it is likely that this might lead to ineffective, unnecessary or expensive 
health care without the desired health achievements. Therefore, it is crucial to 
evaluate such that interventions are evaluated in primary as well as in 
specialised care. 
 
Research questions 
 
The primary research question 
– Is the Pelican intervention in primary and specialised health care effective 
in improving HRQL of children with asthma? 
 
The secondary research questions 
– Is the Pelican intervention in primary and specialised health care effective 
in improving HRQL of the parents of children with asthma? 
– Is the Pelican intervention in primary and specialised health care effective 
in improving asthma control of children with asthma and their parents? 
– Does the Pelican intervention improve patient-doctor relationship and 
satisfaction with delivered care in primary and specialised health care? 
– Is the Pelican instrument able to detect psychosocial problems and is the 
patient centred care intervention based on this instrument able to improve 
such problems? 
– Is the Pelican intervention user friendly in regular medical care and cost-
effective in a primary and specialised care setting? 
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Hypothesis 
The primary hypothesis of the Pelican study is that a self management 
treatment based on HRQL information (Pelican instrument) is able to 
improve HRQL on the Paediatric Quality of Life Questionnaire with 
standardized activities (PAQLQ-s; Minimal clinical important 
difference/improvement or MCID of ≥0.5 points) in children with asthma 
from 6–11 years old in primary and specialised care with a proportional 
difference in favour of intervention relative to usual care of 25% of children. 
Furthermore, it is also hypothesised that the instrument could improve 
asthma control and satisfaction with care of parents. 
 
 
METHODS/DESIGN 
 
Study design 
This study consists of two RCTs: one in primary care and one in specialised 
care. Because the study design, sample size calculation and treatment 
allocation differ between the trials, these aspects are described separately. All 
other aspects apply to both trials. 
170 participants in primary care will be recruited from 16 family 
practice in the Netherlands. The primary care study is a multicentre parallel 
group study with a hierarchical or nested design. This means that all 
participating patients within a family practice will be allocated to the same 
treatment group (usual care or intervention group). During visits the usual 
care group receives care of the FP according NHG (Dutch FP Association) 
guidelines. (21) Besides usual care, the intervention group will receive 
recommendations based on the Pelican outcome by a practice nurse as well. 
The most optimal study design for intervention studies is a multilevel 
design to avoid contamination between usual care and the intervention, 
which is applied in the primary care trial. There are, however, not enough 
outpatient clinics in the Netherlands to be able to use a multilevel design in 
specialised care. This means that specialised nurses provide care for both 
patients of the intervention and those of the usual care group. 100 
participants in specialised care will be recruited in 5 outpatient clinics in the 
Netherlands. The usual care group receives care according to NVK (Dutch 
Association of Paediatrics) guidelines of paediatric asthma in the Netherlands 
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of a care provider (e.g. paediatrician or nurse). (22) The intervention group 
receives an intervention with the Pelican outcome by an asthma nurse 
complementary to usual care. 
 
Sample size calculation 
A multilevel power calculation was performed for the trial in primary care 
based on the percentage of children with an improvement of 0.5 points on the 
PAQLQ-s instrument score (Δ0.5 is the minimum clinically important 
difference (MCID) for the PAQLQ-s). (23,24) We consider a proportional 
difference in favour of intervention relative to usual care of 25% of children 
with a MCID to be clinically relevant. Based on the assumptions ICC = 0.04, α = 
0.05, 1-β = 0.80, 20% of usual care group with a 0.5 points increase in PAQLQ 
score, and dropout rate of 15%, a total of 170 children with asthma needs to 
be included from 16 FPs. 
A power calculation was performed for the trial in specialised care 
based on the percentage of children with an improvement of 0.5 points on the 
PAQLQ-s instrument score. We consider a proportional difference in favour of 
intervention relative to usual care of 25% of children with a MCID to be 
clinically relevant. Based on the assumptions α = 0.05, 1-β = 0.80, 10% of 
usual care group with a 0.5 points increase in PAQLQ-s score, and dropout 
rate = 15%, a total of 100 children with asthma needs to be included. 
 
Selection phase 
In both trials children aged 6 to 12 years with asthma diagnosed by a 
physician will be recruited. Moreover, children must have used their asthma 
medication (i.e., bronchodilators and / or inhaled corticosteroids) for at least 
six weeks during the previous year to confirm ‘active asthma’. Exclusion 
criteria for these studies are: 1) a comorbide condition that significantly 
influence the HRQL, 2) not being able to attend a regular school class and 3) 
insufficient skill of Dutch language. 
Parents of children are informed about the project by verbal 
explanation and an information brochure. For children, study information 
age-adjusted study information is provided on the website of the project. 
Written informed consent of both official caregivers will be obtained to 
ensure voluntary and anonymous participation. In accordance with the 
guidelines on scientific research with underage individuals, children may be 
withdrawn from the study at any time if they object. (25) 
   
CHAPTER 3 | STUDY PROTOCOL 
Page| 61 
 
 
 
 
 
 
 
 
 
 
 
Randomisation: treatment allocation 
Enrolment of participants and allocation to treatment will be performed by 
the family practices or outpatient clinics. Participants can be allocated to the 
usual care or intervention group. In both trials minimisation will be used. 
Minimisation is an advanced randomisation technique as described by 
Pocock. (26, 27) The balance between both groups will be kept with 
consideration of prognostic factors (categorical variables) as described below 
with a computer programme called Minim. 
In the primary care trial family practices will be allocated balanced on 
the following prognostic factors: 1) number of potential participants for study 
within FP (<18 or ≥18 patients with the diagnosis asthma between 6–11 
years old) and 2) usual asthma care (absence of structured asthma care, 
structured asthma care for adults or structured asthma care for children). 
In the specialised care trial the minimisation technique will be used to 
force treatment allocation of individual participants with consideration of the 
prognostic factors age (6–8 years old and 9–11 years old) and level of asthma 
control (ACQ6 score <1 and ACQ6 score ≥ 1). 
 
Pelican instrument 
The Paediatric Electronic quality of Life Instrument for Asthmatic children in 
the Netherlands or Pelican is a web based asthma-related quality of life 
questionnaire that is presented as a web based computer game. It is effortless 
to complete, easy to understand (questions are read aloud) and full of 
attractive sounds and pictures. While playing the game, the child answers 
questions about his or her experience of asthma. Item selection for the 
Pelican was based on children’s personal perspectives that were obtained 
using focus groups. (17) Items are concrete aspects of living with asthma 
what makes them an easy starting point for treatment and are scored in 
burden experience on a 5-point Likert scale ranging from ‘no burden at all’ (0 
points) to ‘very high burden’ (5 points). Scores are visually supported by 
emoticons. Besides overall quality of life, the instrument has the ability to 
priorities issues of asthma bothering the patient most. 
 
Intervention 
The intervention is a self management treatment based on the patient’s reply 
to the Pelican questionnaire. Treatment is provided by a specialised nurse 
with the objective to improve the patient’s asthma-related quality of life. The 
 
 
Page| 62 
 
nurse is trained during a 2-hour meeting in this intervention with theoretic 
background, video instructions and role playing exercises. Supplementary to 
the training, a minimum of five evaluation moments are included during the 
trial. 
The child fills out the Pelican before the scheduled visit and the 
outcome is forwarded to the nurse. The intervention is based on the theory of 
behaviour change and shared decision making. (28) The health care provider 
supports the parent and child to explore their needs and treatment goals 
(according SMART principles (29)) and think about solutions for disease 
related problems and challenges. Together, the parent, child and nurse work 
on a treatment plan to improve disease management resulting in better 
disease outcomes. The treatment plan is a mutual agreement that is specific, 
acceptable and realistic. During the next visit, the nurse will evaluate the 
effectiveness of the treatment plan: why was it successful or unsuccessful to 
achieve treatment goals. If not successful, the care provider will explore the 
causes (lack of knowledge/skills, motivational, practical or social barriers) 
and evaluates whether they can be resolved. 
 
Study parameters 
The primary outcome of the study is HRQL as measured with the PAQLQ-s 
(standardised activities). The Dutch version of the PAQLQ-s was validated in 
children ≥ 6 years and has psychometric properties similar to those reported 
for the original PAQLQ-s (24). Also the HRQL of the main caregiver is assessed 
with the PACQLQ (Paediatric asthma caregiver quality of life questionnaire). 
(30) 
Secondary outcomes are asthma control, psychosocial problems and 
satisfaction with care. Asthma control is measured by questionnaires such as 
the Asthma Control Questionnaire (ACQ6; 31), the Childhood Asthma Control 
Test (C-ACT; 32) and the Asthma Therapy Assessment Questionnaire (ATAQ; 
33, 34). Psychometric properties of all asthma control instruments were 
found to be good. Lung function with reversibility (pre- en post- FVC, pre- and 
post- FEV1) and Fraction of exhaled NO1 (FeNO) will be assessed according 
international guidelines. (35, 36) Psychosocial problems will be measured 
with the Dutch version of Strengths and Difficulties Questionnaire (SDQ) that 
shows good psychometric properties. (37) An adapted version of the Patient-
Doctor relationship Questionnaire (PDRQ-9) will be used to measure parent’s 
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satisfaction with provided care to their child by a care provider and other 
patient-doctor relationship aspects. (38) 
 
Data collection 
In the recruitment phase, the parents receive a questionnaire on family 
characteristics (e.g., socio-economic status, family history of respiratory 
diseases, composition of family, smoking habits), child asthmatic symptoms, 
medication use, attitude towards asthma. All participants visit the family 
practice or outpatient clinic four times during a follow-up period of 9 months. 
The parents as well as the children fill out a questionnaire at the start and end 
of the study to measure HRQL, asthma control, psychosocial problems and 
satisfaction with care. During the first visit, lung function will be measured of 
subjects in the primary care trial. In specialised care, both lung function and 
fraction exhaled NO will be measured during the first and last visit. Next, the 
parents fill out monthly calendars on asthma control, symptoms and 
medication use of their child. Finally, health care providers, parents and 
children will be inquired about the satisfaction and user friendliness of 
implementation of the Pelican using structured questionnaires. Since the 
Pelican study is a complex intervention, data will be collected for process 
evaluation. (39) 
 
Data analysis 
The primary analysis is an intention-to-treat analysis, however both 
explanatory and intention-to-treat analyses will be performed. The effect of 
the Pelican in primary care will be analysed using multi-level analyses 
techniques. The effect of the Pelican in specialised care will be assessed using 
multivariate regression models. A correction for baseline value of the 
outcome of interest (e.g., HRQL, asthma control) will be added to the model. 
 
Process evaluation and cost-effectiveness analysis 
The implementation of the Pelican in health care is an complex intervention. 
(39) A detailed process evaluation is crucial to evaluate what the active 
ingredients are and how they are exerting their effect. Potential barriers and 
facilitators of implementation are screened in every phase of the study, 
starting at the completion of the Pelican instrument by the child at home, the 
use of the Pelican instrument during the medical visit by the health care 
professional and finally the influence on asthma specific HRQL. (40) A cost-
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effectiveness analysis (CEA) from a societal perspective will be performed 
and reported according to national and international guidelines. (41, 42) The 
costs included will be programme costs, direct medical costs and indirect 
costs measured in their natural units and transformed to costs using real 
prices and standard reimbursement of expense tariffs. An effect is defined as 
a relevant change in HRQL (i.e., ∆PAQLQ-s ≥0.5 point) in the denominator and 
the total of all relevant costs in the nominator. 
 
Ethics 
Ethical approval is obtained from the Medical Ethics Committee of the 
Arnhem-Nijmegen region in the Netherlands. This Trial Is registered by 
clinicaltrial.gov (NCT01109745). 
 
 
DISCUSSION 
 
Patient centred care, especially in chronic diseases, has a growing need to 
implement information on health related quality of life (HRQL) next to clinical 
and physiological measures. Although several quality of life instruments for 
childhood asthma already exist, the Pelican instrument distinguishes itself 
because of its applicability in regular medical care. In this article, we 
presented the methodological design of the Pelican study. Our primary 
research question is whether the use of the Pelican will improve the asthma-
related quality of life in children with asthma from 6–11 years old. The 
secondary research questions are whether the use of the Pelican intervention 
will improve asthma control, satisfaction with care and HRQL of the parent. 
Furthermore, it will be evaluated whether the Pelican is able to detect and 
reduce psychosocial problems. The study consists of two RCTs with a follow-
up of nine months performed in primary and specialised care respectively. 
Although the study design, sample size and treatment allocation of 
participants differ between both trials, the research questions and data 
collection will be identical. The trial in primary care will be a multilevel 
design, while participants within outpatient clinics of specialised care will be 
randomly allocated to the usual care and intervention group. 
The Pelican study has a couple of strong characteristics. In this study, 
we choose to add another HRQL instrument to the data collection besides the 
   
CHAPTER 3 | STUDY PROTOCOL 
Page| 65 
 
 
 
 
 
 
 
 
 
 
 
Pelican instrument as an independent HRQL measurement to answer our 
primary research question. Another strong characteristic of this study is that 
the intervention will be investigated in both principal health care settings for 
childhood asthma, doing justice to the differences that exist in organization 
and patient characteristic between primary and specialised care. For 
example, paediatric patients with asthma in primary care show lower disease 
severity compared to patients in specialised care. (7) This could imply 
different levels in room for improvement in HRQL and thus could lead to 
different effect results. Performing two trials which are methodologically 
optimised to the health care setting leads to better validity and reliable 
results of treatment effect and cost effectiveness analyses. Furthermore, a 
detailed process evaluation will be done to map barriers and facilitators of 
the treatment. 
However, some drawbacks must be mentioned. It is impossible to 
perform a double-blind RCT because patients will be aware of the treatment 
group allocation. In addition, being a subject in an intervention study will 
cause the Hawthorne effect, easily leading to a favourable response. (43, 44) 
A specific limitation of the primary care trial is the frequency of medical visits. 
To keep up scientific comparability between the two trials and actively work 
on a treatment plan with the patient, the frequency of four medical visits 
during a period of nine months was set. This frequency of medical visits is 
usual in specialised care but doubled the frequency of visits in primary care 
compared to the recommendations in national guidelines. Usual care in the 
primary care study is, therefore, best described as ‘enhanced usual care’. (45) 
Increasing contact time between child and care provider may give more 
favourable results. This effect is expected to be equal in both study arms in 
the primary care trial. Ideally, a usual care group without any protocol 
enhancements would have been added to the RCTs. Furthermore, we choose 
to let the Pelican intervention be performed by a practice nurse. Nurses play 
an increasing important role in health care for chronic patients, such as 
diabetes and COPD patients. Involvement of paediatric nurses is already part 
of usual care in most paediatric outpatient clinics while paediatric asthma 
management in primary care is usually provided by family physicians without 
involvement of nurses. A recent study of Kuethe et al. (46) suggested that the 
level of asthma control in children managed by an asthma nurse is not 
inferior to traditional management by primary or specialised care physicians. 
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(46) Our choice of practice nurse involvement was made with the eye on 
expected future changes in paediatric asthma care in family practices. 
A limitation in the specialised care trial is the risk on contamination 
bias. The specialised nurses in outpatient clinics provide care for patients of 
the intervention and usual care group. Although nurses were instructed not to 
use intervention techniques in the usual care group, contamination bias is 
unavoidable. The trained nurse in outpatient clinics might unintentionally 
apply training aspects (such as shared decision-making) during treatment of 
patients in the usual care group and may potentially minimize the difference 
in outcomes between the two treatment groups. 
In conclusion, the aim of this study is to assess the effectiveness of the 
Pelican in primary and specialised care through a self management treatment 
with the aim of improving asthma-related quality of life in children with 
asthma from 6–11 years old. If the Pelican proves to be effective and efficient, 
implementation of this instrument in usual care for paediatric asthma will be 
recommended. Although the implementation of the Pelican intervention will 
be evaluated in two almost equal RCTs, it was necessary to adjust the design 
of both trials to fit the concerning settings. Although, different study design 
characteristics lead to less comparability between the two trials, the unique 
feature of this project is that we do not need to extrapolate study outcomes to 
another care settings based on numerous assumptions, as the intervention is 
evaluated simultaneously in both major care settings. 
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ABSTRACT 
 
OBJECTIVE: Insufficient asthma management leads to impaired health-related 
quality of life (HRQL). The aim of this study is to assess whether 
individualised self management (ISM) support will improve HRQL in children 
with asthma compared to enhanced usual care (EUC) in Dutch family 
practices.  
 
METHODS: A cluster-randomised controlled trial with 9-months follow-up. 
ISM is a nurse-led intervention that is optimised to the needs of children, 
leading to a written action plan. Power calculation demanded inclusion of 170 
children (aged 6-11 year) diagnosed with asthma and active medication use.  
 
RESULTS: Outcomes were HRQL of the child (Paediatric Asthma Quality of 
Life Questionnaire, PAQLQ-s) and several secondary outcomes. Data of 29 
children (mean age 8.6, SD 1.7) was analysed; ISM (n=15) or EUC (n=14). 
Logistic regression analysis (minimal clinical important 
difference/improvement; MCID ≥0.5) and descriptive analyses were 
performed. Despite high PAQLQ-s score at baseline (median ISM 6.35, EUC 
6.02), a substantial number of subjects from both groups showed MCID of 
HRQL (ISM 33%, EUC 57%). Treatment differences on HRQL were not 
significant (OR 0.38, 95%CI 0.08, 1.69). Secondary outcomes did not show 
significant differences either, with exception of PAQLQ-s symptoms domain 
score in favour of EUC. 
 
CONCLUSION: Due to recruitment problems and underpowered analyses, no 
firm conclusions on the effectiveness of ISM support for childhood asthma in 
primary care could be drawn. Still, this study can be considered a valuable 
pilot study and in the future, there might be better capacity in family practices 
to commit to such treatment. 
 
KEY WORDS: Randomised controlled trial RCT, primary care, paediatrics, self 
management. 
 
TRIAL REGISTRATION NUMBER: clinicaltrial.gov NCT01109745. 
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INTRODUCTION 
 
Asthma is a chronic inflammatory pulmonary disease, characterised by 
variable and recurring symptoms such as breathlessness and wheezing. (1) 
Poor disease management leads to increased symptoms, exacerbations and 
impaired health-related quality of life (HRQL) and is responsible for three-
quarters of the total health care costs for asthma. (2, 3) Training patients how 
to self manage their illness properly, may lead to better asthma control 
against lower costs. Self management refers to an individual’s own actions 
which contribute to maintaining, improving or restoring health and treating 
or preventing exacerbations. (4) 
  Self management programmes for childhood asthma have been widely 
studied. A Cochrane review with 32 studies assessed the effectiveness of such 
programmes in childhood asthma. (5) These programmes were rather 
diverse, usually nurse-led in a clinic or school and given individually or in 
groups. This review shows that self management was effective in improving 
lung function measures, functional status, quality of life and reducing school 
absence, restricted activity, emergency room visits, and nights disturbed by 
asthma. Programmes were most effective in children with moderate-severe 
asthma. More recent papers and reviews show potential in improving 
objective and subjective asthma outcomes as well, but their results were 
inconsistent. (6-9) Also internet-based monitoring and self management 
programmes are emerging for youths and adult asthma patients, but for the 
time being their effectiveness is inconclusive. (10-14) 
 An important difference between individualised self management 
(ISM) support and previously studied self management programmes is that 
other programmes often provided standard training with fixed educational 
topics and were not investigated in family practice settings. The ISM 
programme we developed consists of a nurse-led intervention in which the 
precise elements are adjusted to the needs of the individual child. These 
needs are the starting point for ISM and are measured by a self-administered 
online HRQL questionnaire (called ‘Pelican instrument’), in which the child 
selects concrete asthma-related problems before the scheduled visit to the 
practice nurse.  
 The ISM programme is in line with the current advice of the Lung 
Alliance Netherlands (LAN) to regularly monitor children with asthma, use 
individualised action plans, educate patients, and facilitate self management. 
   
   
Page| 76 
(15) The aim of this study was to assess the effectiveness individualised self 
management (ISM) support on improving HRQL in children with asthma 
compared to enhanced usual care (EUC) in Dutch family practices. Due to 
considerable recruitment problems, the findings reported in this manuscript 
should be considered to result from a pilot study. 
 
 
METHODS 
 
Design  
The study design was a cluster-randomised controlled trial (RCT) in Dutch 
family practices. Practices were randomly allocated to enhanced usual care 
(EUC) alone or individualised self management (ISM) care supplementary to 
EUC. All participants were followed for nine months, in which four visits to 
the family practice were scheduled. The study protocol has been approved by 
the Medical Ethics Committee of the Arnhem-Nijmegen region in the 
Netherlands. Other specific details with regard to the study methods can be 
found elsewhere. (16) 
 
Pelican instrument 
The Pelican instrument is a self-administered online HRQL instrument 
developed for primary school aged children with asthma (6-11 years). This 
instrument can be applied for scientific purposes and for individual patient 
care. The instrument exists of a general part with 22 questions that can be 
answered on a five-point Likert scale and an individual part that allows a 
child to select concrete asthma-related problems that bother him or her in 
daily life. Details on the development and validation process of the Pelican 
instrument can be found elsewhere. (17, 18) 
 
Self management support  
Children allocated to ISM received self management support on top of usual 
care. Before each scheduled visit, children completed the online Pelican 
instrument. The child’s selection of asthma-related problems was the starting 
point for a six-step ISM intervention based on shared decision-making. 
Together with the patient and parent(s), a practice nurse discussed which 
selected problem would be subject of treatment (Step 1). When needed, 
details around a problem were discussed (Step 2), a treatment goal was 
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formulated (Step 3), a brainstorm session on solutions was held (Step 4) and 
solutions that all involved agreed on were documented in a written action 
plan (Step 5). Solutions could focus on education, inhalation technique, 
medication adjustments, therapy adherence, exercise, environment, social 
impact, self-efficacy, and many other individual aspects. During the next visit, 
the results of the written action plan were evaluated (Step 6) and if the 
treatment goal was not achieved, the six-step intervention was repeated. (16) 
Nurses were trained before the start of the study. During the study, nurses 
were monitored with a fixed number of feedback/observation moments. 
Telephone support for specific questions was provided as well. 
 
Enhanced usual care 
Enhanced usual care consisted of an assessment of symptoms, medication use 
and exposure to triggers according the guidelines of the Dutch College of 
Family practitioners every three months. (19) Usual care was provided by the 
family practitioner (FP) or practice nurse. Usual care visits would last 
approximately ten minutes – the standard length of a consultation in Dutch 
family practice. 
 
Family practices 
From February 2011 to July 2013 family practices with a practice nurse 
employed, were recruited using different recruitment methods. FP care 
networks were approached and if the study was in scope with their care 
priorities, mailings, telephone calls and personal requests were send to 
individual practices that were affiliated to the network. 
 
Participants 
Parents of children with ICPC code R96 were invited by their FPs through 
written information and were sent a reminder after two weeks. Additional 
information was given by e-mail or telephone. Age-appropriate information 
on the project was available on the website of the Pelican Project for children 
(http://koplopers.org/pelikaan; in Dutch). Both legal caregivers had to sign a 
written informed consent (if applicable). After consent, in- and exclusion 
criteria were assessed. 
Children aged 6 until 11 years with physician-diagnosed asthma, who 
had used asthma medication (i.e., bronchodilators and/or inhaled 
corticosteroids) for at least six weeks during the previous year, were 
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included. Exclusion criteria were comorbid conditions that significantly 
influence HRQL (such as diabetes or congenital heart defects), not being able 
to attend a regular school class, and insufficient skill in speaking and/or 
reading the Dutch language. 
 
Practice allocation 
Participating family practices were allocated to the treatment groups by a 
computerised minimisation procedure. Prognostic factors used to stratify 
minimisation were the number of potential participants for the study in a 
practice (n<18 or n≥18 paediatric asthma patients) and presence of 
structured usual care for patients with asthma (yes or no).  
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a. Exclusion could be due to more than one reason 
 
Figure 1: Flowchart of recruitment of childhood asthma patients (6-
11yr) treated in Dutch family practices for the Pelican study (a study 
with the aim to assess effectiveness of nurse-led individualised self 
management) 
A
n
al
ys
e
s 
En
ro
llm
en
t 
No response (n=53), Response (n=57) 
 
Rejection to participateª (n=39): no asthma (5), 
no complaints (15), no time (3), not interested 
(1), burdensome (2), No/not enough asthma 
medication (3), age (2), other research projects 
(1), don’t want focus on asthma (1) other (8), 
not mentioned (4)  
 
Children invited by general practice (FP) (n=224) 
Intervention Group (n=110)     Usual care Group (n=113) 
 
Children excluded  (n=3) 
- In-/exclusion criteria (0) 
- One practice withdrew (2) 
- Unattainable (1) 
Lost to follow-up (n=0) 
No response (n=72), Response (n=41) 
 
Rejection to participate* (n=21): no asthma (1), 
no complaints (6), no time (2), not interested 
(2), burdensome (2), No/not enough asthma 
medication (5), age (1), other research projects 
(1), other (1), not mentioned (2)  
Children excluded*  (n=2) 
- No diagnosis asthma (1) 
- No regular school class (1) 
- One practice withdrew (1) 
 
 
Excluded from analyses (n=0) 
 
Lost-to-follow-up (n=1) 
- Unknown (1) 
Excluded from analyses (n=3)  
- Too much missing (>7%) (3) 
 
Children started at baseline visit (n=33) 
Intervention Group (n=15)            Usual care Group (n=18) 
Intention-to-treat analyses (n=29) 
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Measurements 
Demographic characteristics were inquired using a questionnaire filled out by 
the parents. At baseline, lung function measures with reversibility testing 
were performed according to international guidelines. (20) 
 All primary and secondary outcomes were assessed at baseline and 
after nine months. The primary outcome of this study was HRQL of the child 
(measured by the self-administered Paediatric Asthma-related Quality of Life 
Questionnaire – standardised; PAQLQ-s (21, 22)). Secondary outcomes were 
HRQL domain scores of the PAQLQ-s (activities, symptoms and emotions), 
HRQL of the child measured by the Pelican instrument (17), asthma control 
(measured by the partly self-administered Child-Asthma Control Test; C-ACT 
(23, 24), and proxy-rated Asthma Control Questionnaire 6; ACQ6 (25, 26)), 
psychosocial problems (measured by the proxy-rated Strengths and 
Difficulties Questionnaire; SDQ (27)), and HRQL of the parents (Paediatric 
Asthma Caregiver Quality of Life Questionnaire; PACQLQ (28)). Subjective 
asthma experience was assessed by two questions: ‘Do you worry about 
having asthma?’ (Q1), ‘To what extent is your life affected by your asthma?’ 
(Q2). Children scored these questions on two visual analogue scales (VAS) 
ranging from 0 (‘not at all’) to 10 (‘a lot). Finally, asthma control (ACQ6), 
number of exacerbations and school/work absenteeism due to asthma were 
recorded monthly by the parents in a study diary. Dutch versions of 
questionnaires were used and psychometric properties of the instruments 
used (with exception of study diary) appeared to be good. 
 Questionnaires for parents were completed on paper or digitally 
(through www.SurveyMonkey.com). Children completed their questionnaires 
on paper, with exception of the web based Pelican instrument. Parents were 
reminded twice when questionnaires were not completed within two weeks. 
 
Hypotheses and sample size 
The primary hypothesis was that supplementary ISM would be able to 
significantly improve HRQL (PAQLQ-s, ≥0.5 points) in 25% of children with 
asthma compared to (enhanced) usual care alone. Secondary hypotheses 
were that ISM would be able to significantly improve HRQL on the Pelican 
instrument, asthma control (C-ACT, ≥2 points; ACQ6, ≥0.5 points), VAS scores 
on subjective asthma experience, psychosocial problems (SDQ) and HRQL of 
the parents (PACQLQ, ≥0.5). 
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According to a multi-level power calculation based on the percentage 
of children with relevant improvement (≥0.5) on the PAQLQ-s, a total of 170 
study subjects for the study was required. (16) 
 
Blinding 
This was a single-blinded study. The analyses presented in this manuscript 
were based on blinded data. The study code was broken after the analyses 
were concluded. 
 
Statistical Analyses 
First, the quality of the dataset was investigated (frequencies, normality 
distributions, missing values, outliers). Missing values were imputed 
according recommendations of questionnaire developers. If a pre-defined 
maximum of missing values was exceeded, domain and total scores were not 
calculated and excluded from further analyses. Only outliers due to input 
errors were corrected. 
Initially, multi-level analysis techniques (as recommended for cluster-
RCTs) were planned. When the number of subjects per cluster is limited (1-5 
participants per cluster), however, the ‘design effect’ is negligible. The design 
effect of this study after recruitment was 1.1 (based on ICC=0.04 and 3.4 
participants per practice) as recruitment of study participants was not as 
successful as planned. Therefore, regular regression analyses were 
performed, without taking clustering of participants within practices into 
account.  
For the primary outcome, an uncorrected logistic regression analysis 
was done on the proportion of children with a minimal clinical important 
difference (MCID; ≥0.5) in PAQLQ-s score between the baseline and follow-up 
measurement. For most secondary outcomes (i.e., the Pelican instrument, 
ACQ6, C-ACT, SDQ, VAS of Q1 and Q2, PACQLQ, exacerbations, school/work 
absenteeism), explorative analyses were performed. Uncorrected logistic 
regression analyses were used on the PAQLQ-s domains (activities, symptoms 
and emotions; MCID ≥0.5). Group mean values of study diary outcomes over 
nine months were calculated and visualised in a line graph. 
Participants were included in intention-to-treat analyses if the 
primary outcome was known at baseline as well as at the end of the nine 
months follow-up. All data were analysed using SPSS (version 20; SPSS Inc., 
Chicago, IL, USA). 
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RESULTS 
 
Family practices 
FP care networks usually refused participation because of other care 
priorities than childhood asthma (e.g. COPD, diabetes, cardiovascular risk 
management). A total of 112 family practices was invited to participate of 
which 28 practices did not respond and 73 other practices refused 
participation for reasons such as lack of time, participation in other research 
projects, too few children with asthma, or no affinity. Of the eleven practices 
that decided on participation, two practices were withdrawn due to lack of 
sufficient participants, leaving nine practices participating in the study. 
aFigure 1 and aTable 1 in the Appendix show details regarding recruitment 
and practice characteristics.  
 
Study participants 
224 Children with asthma from the electronic patient record systems of the 
participating practices were invited (figure 1). Parents rejected participation 
mostly because they were convinced that their child no longer had asthma or 
asthma complaints. Parents of 38 children with asthma gave informed 
consent, however, five children were excluded from the study because they 
did not meet in- or exclusion criteria. A total of 33 children started with the 
study, 15 in the ISM group and 18 in the EUC group. One child was lost to 
follow-up during the study and three children had too many missing data of 
the primary outcome, leaving 29 children for the analysis. Table 1 shows 
demographic and clinical characteristics of the study population. 
 
Effects on the primary outcome  
The median PAQLQ-s score at baseline was 6.35 (IQR 5.61-6.78) for ISM and 
6.02 for EUC alone (IQR 5.05-6.34). 33% (n=5) of ISM children and 57% (n=8) 
of EUC children showed a relevant improvement in HRQL (PAQLQ-s MCID 
≥0.5), logistic regression analyses did not show statistically significant 
differences between groups (Table 2). 
 
Effects on secondary outcomes 
Results on uncorrected logistic regression analyses of PAQLQ-s domains 
between ISM and EUC can be found in Table 2. Due to small numbers of 
subjects within groups, data was mainly described and not analysed. Children 
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and parents already scored favourable on secondary outcomes such as 
health-related quality of life (Pelican, PACQLQ), asthma control (ACQ6, C-
ACT), psychosocial problems (SDQ) and number of exacerbations at baseline. 
Although both groups show improvement on secondary outcomes, it cannot 
be concluded that there are clinically important differences between ISM and 
EUC (see Table 1). aFigure 2 in the Appendix shows line graphs for asthma 
control (ACQ6), number of exacerbations (as reported by parents) and 
school/work absenteeism in the ISM and EUC groups over a 9-month follow-
up period. No trends could be detected. 
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Table 1: Demographic and clinical outcomes of children with asthma 
participating in the primary care trial of the Pelican study at baseline 
and after 9 months follow-up (supplementary individualised self 
management group (ISM) and enhanced usual care alone (EUC)) 
 
 ISM (n 15) EUC (n 14) 
 Baseline End Baseline End 
Outcome (questionnaire) 
Median 
(IQR) 
Median 
(IQR) 
Median 
(IQR) 
Median 
(IQR) 
Gender (male) 10 (66.7)  8 (57.1)  
Age at baseline (e.g. first visit) 
(Mean,SD) 
6-8yrs 
9-11yrs 
8.4 (1.7) 
10 (66.7) 
5 (33.3)  
8.7 (1.7) 
9 (64.3) 
5 (35.7) 
 
Ethnicity 
Caucasian 
African 
 
14 (93.3) 
1 (6.7)  
 
14 (100) 
0 ( 0.0) 
 
Socioeconomic status (education) 
Low 
Middle 
High 
 
0 ( 0.0) 
2 (13.3) 
13 (86.7)  
 
1 (  7.1) 
4 (28.6) 
9 (64.3) 
 
Lung function (a) 
FEV1%pred (Mean, SD) 
Reversibility 
 
111 (13.5) 
2 (13.3)  
 
101 (12.7) 
3 (21.4) 
 
Medication use number (%) 
Inhaled corticosteroids 
Short-acting beta-adrenoceptor agonist 
Long-acting beta-adrenoceptor agonist 
 
12 (80.0) 
9 (60.0) 
1 (  6.7)  
 
8 (57.1) 
8 (57.1) 
2 (14.3) 
 
Health-related quality of life (PAQLQ-s) 
Activities 
Emotions 
Symptoms 
6.35 (1.17) 
5.80 (1.60) 
6.75 (0.75) 
6.30 (1.30) 
6.78 (0.96) 
7.00 (1.00) 
7.00 (0.25) 
6.70 (1.20) 
6.02 (0.89) 
5.70 (2.15) 
6.69 (0.75) 
5.55 (1.10) 
6.50 (0.72) 
6.30 (1.45) 
7.00 (0.38) 
6.45 (0.75) 
Health-related quality of life (Pelican) 
(b) 
Activities 
Triggers 
Symptoms 
Asthma management 
Social/emotional 
2.43 (0.81) 
1.33 (1.00) 
2.40 (2.00) 
2.50 (1.00) 
2.40 (1.25) 
2.00 (1.00) 
 
1.81 (1.40) 
1.17 (0.92) 
1.90 (1.85) 
2.10 (1.05) 
2.00 (1.81) 
1.00 (0.50) 
2.43 (1.78) 
2.00 (2.17) 
2.90 (2.40) 
3.20 (1.75) 
2.75 (2.43) 
1.50 (2.00) 
 
1.95 (1.62) 
1.83 (1.67) 
2.20 (1.85) 
2.10 (2.70) 
2.13 (2.31) 
1.25 (1.19) 
Health-related quality of life of the 
parent (PACQLQ) (b) 
Activities 
Emotions 
 
6.85 (0.54) 
7.00 (0.50) 
6.78 (0.56) 
 
6.96 (0.31) 
7.00 (0.00) 
6.94 (0.19) 
 
6.62 (0.87) 
7.00 (1.12) 
6.56 (1.28) 
 
6.85 (0.54) 
7.00 (0.25) 
6.78 (0.78) 
Asthma control (ACQ) (b) 
Well controlled <1 (n, %) 
Uncontrolled ≥1 (n, %) 
0.5 (0.6) 
12 (80.0) 
3 (20.0) 
0.1 (0.5) 
12 (85.7) 
2 (14.3) 
0.8 (1.4) 
8 (57.1) 
6 (42.9) 
0.3 (1.0) 
8 (72.7) 
3 (27.3) 
Asthma control (C-ACT) (b) 
Well controlled >22 (n, %) 
Uncontrolled ≤ 22 (n, %) 
22.0 (6.0) 
7 (50.0) 
7 (50.0) 
26.0 (4.5) 
11 (84.6) 
2 (15.4) 
25.5 (3.5) 
5 (35.7) 
9 (64.3) 
29.0 (2.0) 
9 (81.8) 
2 (18.2) 
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Psychosocial problems (SDQ) (b) 
Normal (n, %) 
Minor (n, %) 
Major (n, %) 
Missing (n, %) 
 
6.0 (11.0) 
12 (80.0) 
  0 (00.0) 
  3 (20.0) 
  0 (00.0) 
 
4.5 (8.3) 
12 (80.0) 
  2 (13.3) 
  0 (00.0) 
  1 (  6.7) 
 
8.0 (7.3) 
11 (78.6) 
  2 (14.3) 
  1 (  7.1) 
  0 (00.0) 
 
7.0 (5.0) 
10 (71.4) 
  0 (00.0) 
  1 (  7.1) 
  3 (21.4) 
 
VAS1: Do you worry about asthma? (b) 
 
1.65 (3.80) 
 
0.10 (0.25) 
 
2.65 (3.86) 
 
0.88 (1.37) 
VAS2: Do you feel different because of 
asthma? (b) 
 
1.44 (3.25) 
 
0.38 (3.88) 
 
1.27 (4.81) 
 
0.52 (0.17) 
 
Abbreviations: Asthma Control Questionnaire (ACQ), Child Asthma Control Test (C-ACT), Enhanced Usual 
Care (EUC), Percentage predicted of Forced Expiratory Volume in 1 second (FEV1%pred), Individualised 
Self Management (ISM), Interquartile Range (IQR), Paediatric Asthma Quality of Life Questionnaire with 
standardised activities (PAQLQ-s), Paediatric Asthma Caregiver  Quality of Life Questionnaire (PACQLQ), 
Standard Deviation (SD), Strenghts and Difficulties Questionnaire (SDQ), Visual Analogue Scale (VAS). SDQ 
Question 13 was missing among 90 of 92 subjects due to organizational problems and was imputed with 
individual mean of scale. 
a. Reference values used of Global Lung Initiative 2012 for FEV1%predicted of FEV1post to salbutamol 400 
µg, Reversibility of 12% compared to pre-bronchodilator FEV1. 
b. number of cases: ACQ end (ISM 14, EUC12), C-ACT baseline (ISM 14, EUC 14), C-ACT end (ISM 13, EUC 
11), Pelican end (ISM 14, EUC 12), PACQLQ end (ISM 14, EUC 11), SDQ end (ISM 14, EUC 11), VAS1&2 end 
(ISM 14, EUC 1 
 
 
 
 
 
Table 2: Results of uncorrected logistic regression analyses on quality of 
life in children with asthma (6-11 year) treated in Dutch family 
practices according supplementary Individualised Self Management 
(ISM) support and Enhanced Usual Care alone (EUC) 
 
Outcome ISM EUC OR  (a) 95% 
Confidence 
Interval 
n n   
PAQLQ-s 15 14 0.38 0.08 to 1.69 
    PAQLQ-s Activities 15 14 0.50 0.11 to 2.19 
    PAQLQ-s Emotions 15 14 0.90  0.19 to 4.17 
    PAQLQ-s Symptoms 15 14 0.20 (b) 0.04 to 0.97 
Abbreviation: Paediatric Asthma Quality of Life Questionnaire with standardised activities (PAQLQ-s; 
Minimal Clinical Important Difference ≥0.5). 
a. Logistic regression analyses with Odds Ratio (OR, based on MCID; yes or no) and confidence interval 
presented in table. 
b. Significant at p < 0.05 
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DISCUSSION 
 
Main findings 
A cluster-RCT was performed in a Dutch population of 33 children (6-11 yr) 
in nine family practices that was, unfortunately, statistically underpowered. 
The aim was to assess the effectiveness of a nurse-led ISM support 
supplementary to usual care to improve HRQL in childhood asthma. At 
baseline, both treatment groups showed high PAQLQ-s score and favourable 
results on secondary outcomes as well, leaving little room for improvement. 
Nonetheless, in both groups a substantial proportion showed a clinically 
relevant change on HRQL after 9 months (ISM 33% and EUC 57%, 
respectively). Analyses of 29 participants did not show differences on either 
the primary or the secondary outcomes with exception of PAQLQ-s symptoms 
domain score in favour of EUC.  
 
Strengths and limitations of this study 
The most important limitation of this study was the lack of recruiting enough 
family practices and asthma patients and, therefore, interpretation of results 
should be done carefully. FPs mainly mentioned to have other care priorities 
and lack of time. RCTs are often considered as time-consuming studies 
besides patient care. (29) Parents rejected participation mostly because they 
believed that the asthma diagnosis was invalid or their child did not have 
current asthma symptoms (figure 1). Also, parents of children with mild 
asthma or good asthma control might consider regular monitoring and 
supplementary guidance in self management as too intensive care. (30) 
Another limitation was that the number of visits according to the 
study protocol (once every three months) was higher than what is usually 
seen in primary care asthma management. In daily practice these children 
were only seen when parents initiated a visit because of their child’s asthma 
symptoms. (19) Therefore, ‘usual care’ in this study must be considered as 
‘enhanced usual care’. (31) Because the ISM programme required frequent 
visits for the practice nurse to be able to work actively on an action plan with 
the patient, this visit frequency was chosen to attain comparability between 
the two treatment arms (i.e. so the number of visits would not cause the 
difference between groups). The improvement seen on HRQL in the EUC 
group might therefore also be a result of introducing frequent monitoring 
    
CHAPTER 4 | RCT IN PRIMARY CARE 
Page | 87  
 
 
 
 
 
 
 
 
 
 
 
visits, next to the additional attention that is paid to the child because of study 
participation (called Hawthorne effect). 
Despite of being underpowered, this study still has a couple of 
strengths, and can thus be considered as a valuable pilot study for further 
research. First of all, a new ISM support intervention that fits very well in the 
new scope of recent asthma management was investigated in family practices. 
(15) Another strength is that ISM support was implemented by a practice 
nurse. In outpatient clinics, it is seen that involvement of nurses is already 
part of usual paediatric asthma care and it is suggested that the level of 
asthma control in children managed by nurses is not inferior to traditional 
management by primary or specialised care physicians (against lower health 
care costs). (32, 33) Since self management takes considerable time and 
effort, it is expected that nurses will gain a more prominent role in asthma 
care in family practices as well. (30, 34) Finally, it is important to mention 
that the primary outcome in the study was measured with another HRQL 
questionnaire (PAQLQ-s) than the HRQL questionnaire that was used as a 
part of the intervention (i.e., the Pelican instrument). Therefore, 
‘entanglement’ of intervention and outcome was prevented. 
 
Interpretation of findings in relation to previously published work 
To the best of our knowledge, this was the first time that individualised self 
management support was investigated in family practices for primary school-
aged asthma patients. Therefore, it was difficult to compare these results with 
previous studies. Although the insignificant results on the effectiveness of ISM 
support on improving health-related quality of life in this study could be 
explained by underpowered analyses, previous papers on individualised 
paediatric asthma care in other health care settings show promising results 
on improving health-related quality of life and several other outcomes. (8, 9) 
Furthermore, there is no plausible explanation why the usual care group 
shows significant improvement on symptoms (measured by PAQLQ-s) 
compared to usual care + individualised self management group. It would be 
likely that this is an incidental finding. 
 
Implications for future research, policy and practice 
The current study did not show differences between supplementary ISM and 
usual care alone for childhood asthma in Dutch family practices. However, the 
analyses were underpowered and both groups showed high HRQL scores at 
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baseline, leaving little room for improvement. Whether or not ISM should be 
implemented in primary care, can therefore not be concluded from this study. 
A similar RCT in children with asthma recruited from hospitals in the 
Netherlands has recently been finished as well. Recruitment in that study was 
successful and further evidence regarding the effectiveness of the Pelican-
based ISM support intervention will be provided. 
 The study reported in this paper and the hospital study will be 
followed by an in-depth analysis of the content and process of the ISM 
intervention. ISM is a complex intervention existing of several phases and 
aiming at patients with different individual treatment goals. (35) These 
aspects may influence the effectiveness of the intervention and therefore a 
detailed evaluation is crucial to understand how and why the intervention 
works or fails.  
Finally, further research is necessary to assess (cost-) effectiveness of 
individualised self management programmes for childhood asthma in Dutch 
primary care. Suggestions are to compare three treatment arms: 
‘unenhanced’ usual care (seeing patients on indication), with routine care 
(seeing patients on a regular base with a minimum of once a year), and 
individualised self management support care (as suggested by new national 
asthma guidelines).  
 
Conclusion 
The current, underpowered study (which should be considered a pilot study) 
does not provide sufficient evidence to conclude that the studied ISM support 
programme is effective in improving HRQL in paediatric asthma patients 
treated in Dutch primary care. Further research into the effectiveness of 
individualised self management in primary care is needed but will not be easy 
considering the recruitment problems in this study. It is questionable 
whether current preconditions are favourable for an individualised self 
management support programme such as evaluated in this study. In the 
future, there might be better capacity in family practices to commit to such a 
program. 
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ABSTRACT 
 
IMPORTANCE: Patient-centred care is advocated for all patients. An online 
tool could help to assess the treatment goals of children with asthma and 
facilitate patient-centredness in paediatric asthma management. 
 
OBJECTIVE: To determine whether integrating children’s individual 
treatment goals in the outpatient management of paediatric asthma results in 
relevant health benefits. A priori we considered a difference of 25% in 
proportion of children with a health-related quality of life improvement 
between study arms relevant. 
 
DESIGN: A randomised controlled multicenter trial with 9 months follow-up. 
Enhanced outpatient asthma care served as the comparator. Group allocation 
could not be blinded for children, parents and health care providers, but 
analyses were blinded. 
 
SETTING: Outpatient asthma clinics in 5 Dutch hospitals.  
 
PARTICIPANTS: One hundred and one (101) children aged 6 to 12 years old 
that were treated for asthma in the participating hospitals (31% of all 
subjects invited) were enrolled, 97 started in the study. All subjects 
completed the study, but data on the primary outcome was valid for 93 
children only (i.e., too many missing questionnaire responses in 4 children). 
 
INTERVENTION: A personal action plan on childhood asthma management 
based on the asthma-related problems of children that were reported in a 
previously validated online tool (‘Pelican instrument’).  
 
MAIN OUTCOME AND MEASUREMENTS: Health-related quality of life as 
measured with the Paediatric Asthma Quality of Life Questionnaire with 
standardised activities (PAQLQ-s). An increase of 0.5 points was considered 
to be the minimal clinically important improvement in PAQLQ score. 
 
RESULTS: In both groups, a substantial proportion showed a relevant 
improvement in quality of life (patient-centred care 52.4%, enhanced usual 
care 25.5%). Uncorrected and corrected intention-to-treat analyses showed 
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differences in favour of patient-centred care: Odds Ratio 3.22 (95%CI 1.34-
7.74 p<0.01) and 2.55 (95%CI 0.95-6.87, p=0.06), respectively. 
 
CONCLUSIONS AND RELEVANCE: Patient-centred care for childhood asthma 
resulted in relevant more children that experienced a relevant quality of life 
improvement, though not statistically significant after correction for baseline 
quality of life values.  
 
KEYWORDS: Randomised controlled trial RCT, primary care, paediatrics, self 
management. 
 
TRIAL REGISTRATION NUMBER: Clinicaltrial.gov NCT01109745 
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INTRODUCTION 
 
Asthma is the most common chronic disease in childhood with a prevalence 
of 9.5% in the US. (1) The most important stakeholder in the management of 
childhood asthma is the child itself. Therefore, it is remarkable that 
information exchange on health problems, diagnosis and treatment is usually 
a rather exclusive interaction between the parent(s) and the physician, 
without the child taking part in it. (2) Clearly parents are important 
stakeholders as well and - depending on the age of the child – usually more 
reliable conversation partners for care providers. Nevertheless, they may not 
be able to truly reflect their child’s needs and individual preferences. (3-5) 
Acceptable and effective ways to implement patient-centred care (PCC) are 
currently missing for paediatric asthma management. 
Previous childhood and adolescent asthma management programmes 
were not tailored to childrens’ individual needs. These programmes mainly 
focused on patient education, while some programmes also included home 
monitoring of clinical disease parameters like symptoms and peak flow. (6-
12) Still, these interventions were found to have positive effects in terms of 
health status, knowledge about asthma, and satisfaction with care. The use of 
a personalised programme that focuses on the goals and needs of the child 
has the potential to be more effective in terms of improving health related 
quality of life (HRQL) and increasing the level of asthma control. 
We have previously developed an online tool for school-aged children 
with asthma that can be used to (a) identify their asthma-related problems 
and, based on that, (b) support formulation of personalised disease 
management goals. (13) In this so-called ‘Pelican-instrument’ the child selects 
asthma-related items that it dislikes the most (like not being able to run as 
fast as peers or have to think about taking asthma medication all the time), 
without involvement of the parents. The Pelican instrument was found to be a 
valid tool, which is acceptable and enjoyable for children. (14) The selected 
items are forwarded to the care provider, who is trained in engaging a triadic 
interaction with the child and parent(s) based on the Pelican output and who 
sets up a personalised action plan. The aim of the study that we report in this 
paper was to assess whether integrating children’s individual treatment goals 
using the Pelican instrument in the outpatient management of paediatric 
asthma results in improved HRQL and other relevant health benefits.  
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METHODS 
 
We carried out a nine-month, multicenter, randomised controlled trial (RCT) 
to assess the effectiveness of integrating children’s individual treatment goals 
in the outpatient management of paediatric asthma in the Netherlands. Full 
details of the protocol have been published elsewhere. (15) Ethics approval 
was obtained from the Medical Ethics Committee (file number 2009/292). 
 
Population 
This study took place between August 2011 and March 2014. Children with 
physician-diagnosed asthma were recruited from five general hospitals in the 
Netherlands. Children could participate if they were 6 to 12 years old; had 
used bronchodilators and/or inhaled corticosteroids for at least six weeks 
during the previous year; and were treated for asthma by the recruiting 
paediatrician on a regular basis. Exclusion criteria were: comorbidity that 
significantly influences HRQL; insufficient Dutch language skills; and/or 
unable to attend a regular school (to exclude children with learning 
disabilities). Both official caregivers (if applicable) gave written informed 
consent before any study procedure took place.  
 
Randomisation 
We assigned children to patient-centred care (PCC) or enhanced usual care 
(EUC) in a 1:1 ratio using minimisation software (Minim) that forced a 
balance between study arms for age (6-8 versus 9-11 years old) and asthma 
control (Asthma Control Questionnaire 6 (ACQ6) score <1 versus ≥1). (16,17) 
Participating siblings were assigned to the same treatment arm based on the 
minimisation code of the first recruited child. The minimisation code of the 
participant was generated and held by the Department of Primary and 
Community Care of the Radboud university medical center. 
 
Enhanced usual care and patient-centred care 
Children in the EUC group visited the hospital with one or both parents every 
three months during follow-up (i.e., a total of four visits of approximately 15-
20 minutes each). Care was provided by a paediatrician or paediatric nurse 
according to the current Dutch guideline for paediatric asthma, which 
includes evaluation of symptoms and medication use, and making 
adjustments to asthma management if applicable. (18) 
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Children in the PCC group received attention to their personal 
treatment goals by paediatric nurses on top of EUC. As a part of the study the 
nurses were trained to (a) facilitate shared decision making with parent(s) 
and child to select a goal based on problems that were recorded by the child 
in the Pelican instrument, (b) formulate treatment goals according to the 
SMART principle (i.e., Specific, Measurable, Acceptable, Realistic, Time-
related) (19), and (c) set-up an individualised (self-)management plan that 
includes unanimously selected actions to achieve the formulated goals. 
Execution of the action plan was evaluated during the next visit. If a goal was 
achieved, a new goal could be selected. Additional actions to achieve the 
previously set treatment goal(s) could also be formulated. 
 
Outcomes and measurements 
Primary outcome was disease-specific HRQL as measured with the Paediatric 
Asthma Quality of Life Questionnaire with standardised activities (PAQLQ-s) 
that consists of 23 questions in three domains (symptoms, emotions and 
activities). (20,21) An increase of 0.5 points is considered to be the minimal 
clinically important improvement (MCII) in PAQLQ score. Secondary 
outcomes were asthma control as assessed with the Childhood Asthma 
Control Test (C-ACT, MCII: 2 points); and the proxy-rated ACQ6 (MCII: -0.5 
points). (22-24) In addition, quality of life of parents was assessed with the 
Paediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ, MCII: 0.5 
points). (25) The Strengths and Difficulties Questionnaire (SDQ) was used to 
assess psychosocial problems. (26,27) The SDQ categorises subjects as having 
major problems, borderline problems and no problems. Next to total scores, 
domain scores of the mentioned above instruments were calculated as well (if 
applicable). Pre- and post-bronchodilator (BD) spirometry (i.e., 15 minutes 
after administration of 400 μg salbutamol by spacer) was carried out 
according to European Respiratory Society/American Thoracic Society 
(ERS/ATS) recommendations by lung function technicians who had 
experience in measuring children. (28) The Global Lung Initiative (GLI) 
reference equations were used to calculate predicted values. (29) For 
analyses we used the pre-BD forced expiratory volume in one second (FEV1) 
% of predicted. Fractional exhaled Nitric Oxide (FeNO) level was assessed 
using a NIOX Mino device. (30) Finally, parents were asked to report 
exacerbations. All outcomes were assessed at the start and end (i.e., after nine 
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months) of the trial, except for ACQ6 score and exacerbations, which were 
collected on a monthly basis using a digital study calendar.  
 
Analyses 
We considered a difference of 25% of children with a clinically important 
improvement in HRQL between study arms as a relevant difference. Sample 
size calculation showed that 100 participants were needed – with 85 
remaining for intention to treat analysis – to evaluate the primary outcome. 
Details of the sample size calculation are provided elsewhere. (15) A priori, 
we planned a per-protocol analysis as well, but this analysis was not 
performed as only one subject violated study protocol procedures. 
The analysis plan was agreed in advance by the investigators and the 
analyses were blinded for study allocation. Subjects were included in the 
analyses if baseline and 9-month follow-up PAQLQ-s scores could be 
calculated (i.e., missing responses on ≤ 2 items after imputation of missing 
values according to authors guideline). (31) The primary analysis was based 
on the proportion of subjects with a MCII on the outcomes. Using logistic 
regression analysis an uncorrected odds ratio (OR) and an OR corrected for 
baseline values (with corresponding 95% Confidence Intervals) were 
calculated. A priori, we drafted a list of potential confounders, which included 
study centre, socioeconomic status, season at start date, and gender. 
However, only baseline values had a relevant and consistent impact on the 
logit of group allocation in the multivariate logistic regression models. If the 
MCII cut-off value was unknown for a particular secondary outcome, we used 
multivariate linear regression to test the differences between the groups for 
9-months observations (i.e., again with correction for baseline values). 
Difference in FeNO values between PCC and EUC were tested as the 9-months 
change from baseline in parts per billion (ppb), as absolute FeNO values were 
not normally distributed and only arbitrary cut-off values have been 
published. To enable comparison with other studies we provide data on 
absolute differences between groups for outcomes with a MCII in aTable 2. 
Also, details on SDQ scores (aTable 3) and visualised changes in monthly 
reported ACQ6 scores (aFigure 3 and 4) and exacerbations (aFigure 5) are 
provided online.  
All analyses were done on an intention-to-treat basis with SPSS 
statistics (version 20.0; IBM SPSS inc., Chicago, IL, USA) and significance was 
defined as p < 0.05. 
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RESULTS 
 
Subjects 
We enrolled 101 eligible subjects (31% of all subjects invited) and 97 started 
with the study. Figure 1 provides details on subject recruitment and 
participation. Data of 93 children (mean age 9.0 yr, 57 boys) were analysed 
(PCC n=42; EUC n=51). Baseline characteristics of study groups were 
comparable, with the exception of the number of children with uncontrolled 
asthma based on the C-ACT, which was higher in the PCC group (72% versus 
50%, Table 1).  
 
Health related quality of life and asthma control 
In both groups, a substantial proportion of children showed a ≥0.5 point 
improvement in PAQLQ-s scores (PCC 52.4%, EUC 25.5%). Uncorrected and 
corrected analyses showed differences in favour of PCC: OR 3.22 (95%CI 
1.34-7.74, p<0.01) and OR 2.55 (95%CI 0.95-6.87, p=0.06), respectively 
(Table 2). Clinically relevant improvements in the separate PAQLQ-s domains, 
asthma control (proxy-rated ACQ and C-ACT) and parents’ HRQL (PACQLQ 
score) were all more prevalent in the PCC group, but none of these differences 
reached statistical significance.  
 
Other clinical and psychosocial outcomes 
Change in FeNO level (p=0.37) and pre-BD FEV1 % predicted (p=0.04) were 
both in favour of PCC. Changes in psychosocial problems (SDQ score) were 
relative small and slightly more prevalent in PCC, but not statistically 
significant. Monthly ACQ score and exacerbations did not showed a trend in 
time between groups (aFigure3, aFigure4, aFigure5). 
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Table 1. Characteristics of children with asthma in the patient-centred 
care group and enhanced usual care group at baseline. Values are 
numbers (percentage) of patients unless stated otherwise.  
Variables Enhanced 
usual care  
(n=51) 
Patient-
centred care 
(n=42) 
Mean (SD) age, years   9.2 (1.6)  8.7 (1.5)  
Boys 32 (63) 25 (60) 
Ethnicity  
   Dutch 
   Western immigrants 
   Non-Western Immigrants 
 
42 (82) 
  3 (6) 
  6 (12) 
 
33 (79) 
  2 (5) 
  7 (17) 
Education level of highest educated parent 
   low 
   middle 
   high  
   unclear 
 
  3 (6) 
17 (34) 
29 (58) 
  1 (2)  
 
  5 (12) † 
12 (29) 
24 (57) 
  1 (2) 
Parental smoking 10 (20) 10 (24) 
Respiratory medication use in the month prior 
to baseline 
   Inhaled corticosteroids 
   Inhaled short-acting β2-agonist 
   Inhaled long-acting β2-agonist 
   Leukotriene antagonist 
   Anticholinergic drugs 
 
 
46 (90) 
38 (75) 
14 (28) 
  3 (6) 
  2 (4) 
 
 
34 (83)* 
27 (66)* 
  9 (22)* 
  3 (7)* 
  0 (0) 
Asthma control 
   ACQ6 ≤ 1 (controlled) 
   ACQ6 > 1 (uncontrolled) 
 
33 (65) 
18 (35) 
 
23 (56) † 
18 (44)  
Asthma control† 
   C-ACT ≥ 22 (controlled) 
   C-ACT < 22 (uncontrolled) 
 
22 (50)‡ 
22 (50)  
 
11 (28)¶ 
28 (72)  
Mean (SD) pre-bronchodilator (bd) FEV1 (L) 
Mean (SD) pre-bd FEV1 (% of predicted) 
1.84 (0.4)  
101.0 (12.7) 
1.75 (0.4)*  
102.2 (13.2)* 
Reversibility (≥ 12% improvement of FEV1 
after bronchodilation).  
10 (20) 11 (27) † 
ACQ6 Asthma control questionnaire with 6 items, C-ACT Child Asthma Control Questionnaire,  
* 1 missing, ‡ 7 missings, ¶ 3 missings, † p < 0.05. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Siblings were ‘forced’ into the same treatment arm (two sibling pairs participated in the study, one in 
each treatment group), † Children were excluded from the analyses if too many missing values in the 
primary outcome (i.e., Paediatric Asthma Quality of Life PAQLQ Questionnaire) existed at baseline or nine 
months follow-up.   
Figure 1. Flow chart of participant recruitment and study 
participation. 
Invitation of Dutch outpatient clinics (n = 8) 
Invitation of caregivers of paediatric asthma patients by 5 outpatient 
clinics 
(n=324) 
 
Received EUC (n = 51) 
 
Received PCC (n = 46) 
 
Drop out before t0 (n=4) (lack of time 
(3), other (1)) 
  
Analysed EUC (n = 51) 
 
Analysed PCC (n = 42) 
 
Lost to follow-up (n=0) 
Excluded from analyses 
(n=4)† 
  
Lost to follow-up (n=0) 
Excluded from analyses 
(n=0) 
  
Not willing to participate (n =3)                                
(other priorities (1), not enough time and/or staff (2)) 
No response (n = 146), Not willing to participate (n = 70) (no 
symptoms (13), no time (11), participation to demanding (6), no asthma (3),  
participation in other research project (5), not interested (4), don’t want to 
put focus on asthma (3) , transport/travel time (3),  age (1), other (12), not 
mentioned (11))  
 
Drop out before t0 (n=0)  
  
Informed consent by caregivers of paediatric asthma patients 
(n = 108) 
 
Children randomized (n = 101)* 
 
Allocated to enhanced usual 
care (EUC) 
(n = 51) 
 
Allocated to patient-centred 
care (PCC) 
(n = 50) 
 
Children excluded (n = 7) 
(too old (1), not master the Dutch language ( 1), comorbidity (1), no 
regular school class (2), other reasons ( 2)) 
  
Table 2a. Health-related quality of life (HRQL), asthma control, and clinical outcomes of participants 
receiving enhanced usual care and patient-centred care at baseline and 9 months. Values are means 
(95% confidence interval) and percentage of participants with a minimal clinical important 
improvement in 9 months compared to baseline unless stated otherwise. 
PAQLQ(s) Paediatric Asthma Quality of Life Questionnaire (standardised), PACQLQ Paediatric Asthma Caregiver Quality of Life Questionnaire, C-ACT Childhood 
Asthma Control Test, ACQ6 asthma control questionnaire with six items, Pre-BD FEV1 % of predicted pre-bronchodilator Forced Expiratory Volume in one 
second as % of predicted, FENO ppb Fraction Exhaled Nitric Oxide in parts per billion.  
a. statistically significant difference between groups (p-value < 0.05);  b. median and 25th-75th percentile; c. based on the difference between first and second 
FENO measure as the FENO value after 9 months did not fulfil the criteria of a normal distribution, while the FENO change variable did. 
 Enhanced usual care (EUC) Patient-centred care (PCC) 
Outcome  
(range in score) 
 
 
n 
Baseline 
 
 
 
n 
% clinical 
relevant 
improvement  
in 9 months 
 
 
n 
Baseline 
 
 
 
n 
% clin. relevant 
improvement in 
9 months 
Asthma-specific Health-related quality of life of children (primary outcome) 
PAQLQ(s) (1-7) 51 5.9 (5.7 – 6.2) 51 25.5 42 5.6 (5.3 – 5.8) 42 52.4 
     Emotions (1-7) 50 6.4 (6.1 – 6.6) 47 21.3 42 6.2 (5.9 – 6.4) 41 39.0 
     Symptoms (1-7) 51 5.8a (5.5 – 6.1) 51 31.3 42 5.2 (4.9 – 5.6) 42 57.1 
     Activities (1-7) 47 5.6 (5.4 – 5.9) 45 35.6 39 5.4 (5.1 – 5.7) 38 60.5 
Health-related quality of life of parent / caregiver 
PACQLQ (1-7)b 51 6.5 (6.2 – 6.9)  50 18.0 40 6.5  (5.8 – 6.8) 38 26.3 
Asthma control 
C-ACT (0-27) 44 21.0 a (19.9 – 22.1) 40 40.0 39 18.8 (17.2 – 20.3) 36 55.6 
ACQ6 (0-6) 51 0.9 (0.7 – 1.1) 50 36.0 41 1.2 (0.9 - 1.6) 39 41.0 
Clinical outcomes 
  
 
n 
Baseline 
 
n 
Absolute  
change 
 
n 
Baseline 
 
n 
Absolute  
change 
Pre-BD FEV1% of 
predicted 
51 101.0 (97.4 – 104.6) 50 -5.0 (-7.3 - -2.6) 41 102.2  (98.1 – 106.4) 41 -1.2 (-4.2 – 1.7) 
FENO in ppb 48 11b (9.3 – 18)b 47  0.7 (-3.2 – 4.7) 40 14.5b (8.3 – 46.3)b 38 -3.7 (-13.8 – 6.4) 
   
Table 2b. Health-related quality of life (HRQL), asthma control, and clinical outcomes of 
participants receiving enhanced usual care and patient-centred care at baseline and 9 months. 
Values are means (95% confidence interval) and percentage of participants with a minimal clinical 
important improvement in 9 months compared to baseline unless stated otherwise. 
PAQLQ(s) Paediatric Asthma Quality of Life Questionnaire (standardised), PACQLQ Paediatric Asthma Caregiver Quality of Life Questionnaire, C-ACT 
Childhood Asthma Control Test, ACQ6 asthma control questionnaire with six items, Pre-BD FEV1 % of predicted pre-bronchodilator Forced Expiratory Volume 
in one second as % of predicted, FENO ppb Fraction Exhaled Nitric Oxide in parts per billion.  
a. statistically significant difference between groups (P-value < 0.05); b. median and 25th-75th percentile; c. based on the difference between first and second 
FENO measure as the FENO value after 9 months did not fulfil the criteria of a normal distribution, while the FENO change variable did.  
 Difference between groups at 9 months 
Outcome  
(range in score) 
Difference  
in % improvement 
PCC versus EUC 
Unadjusted OR P-value 
OR adjusted for 
baseline values 
P-value 
Number 
needed to 
treat 
Asthma-specific Health-related quality of life of children (primary outcome) 
PAQLQ(s) (1-7) 26.9a  3.2 (1.3 - 7.7) 0.01 2.6 (0.9 – 6.9) 0.06   4 
     Emotions (1-7) 17.7  2.4 (0.9 – 6.1) 0.07 1.3 (0.4 – 4.6) 0.70   6 
     Symptoms (1-7) 25.1a  2.9 (1.2 – 6.8) 0.01 2.0 (0.7 – 5.3) 0.18   4 
     Activities (1-7) 24.9a  2.8 (1.1 - 6.8) 0.03 2.5 (1.0 – 6.4) 0.06   4 
Health-related quality of life of parent / caregiver 
PACQLQ (1-7)b   8.3  1.6 (0.6 – 4.5) 0.35 1.4 (0.4 – 5.0) 0.63 12 
Asthma control 
C-ACT (0-27) 15.6  1.9 (0.8 – 4.7) 0.18 1.3 (0.5 – 3.5) 0.63   6 
ACQ6 (0-6)   5.0  1.2 (0.5 – 2.9) 0.63 0.9 (0.3 – 2.4) 0.82 20 
Clinical outcomes 
  
∆ change 
PCC versus EUC 
B  
B adjusted for 
baseline values 
  
Pre-BD FEV1% of predicted 3.7a  5.0 (-1.3 – 11.3) 0.12 3.8 (0.1 – 7.5) 0.04  
FENO in ppb -4.4 -4.5c (-14.3– 5.4) 0.37 NA   
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DISCUSSION 
 
We assessed the effectiveness of patient-centred paediatric asthma 
management based on the Pelican instrument in outpatient clinics in the 
Netherlands. More children in the PCC group than in the EUC group 
experienced a clinically relevant HRQL improvement (52.4% and 25.5%, 
respectively). After correction for baseline values this difference remained 
close to being statistically significant (i.e., p=0.06). On average, one in four 
children would benefit within nine months from PCC on top of EUC (i.e., the 
number needed to treat (NNT) was 4). Secondary outcomes (asthma control, 
psychosocial problems, lung function and parents’ HRQL) improved more in 
the PPC group as well, though FEV1 % predicted was the only outcome that 
showed a statistically significant difference between the study arms in the 
corrected analyses, in favour of PCC.  
 
Only two previous studies used an interactive programme in which 
the children had to answer questions about their asthma symptoms, quality 
of life and/or medication use, which was used to direct asthma disease 
management. (11,12) These studies reported improvement on self 
management skills, asthma symptoms, asthma control, lung function and 
other outcomes. However, in contrast to our program, the feedback to the 
children consisted of predefined responses based on the child’s entry in these 
programmes and did not result in a personalised action plan.  
 
Individualised asthma management plans cannot be concealed for 
participants and care providers, and therefore children were aware of 
treatment allocation. This may have biased their responses, especially for 
subjective outcomes like quality of life and asthma control. Moreover, con-
tamination of the EUC condition may have occurred, as in some hospitals one 
nurse provided care for children in both study arms. Randomisation of 
hospitals instead of participants could have prevented this unwanted effect, 
but the number of participating hospitals needed for a study with such a 
multilevel design was not feasible in a small country like the Netherlands. 
According to the sample size calculation the number of participants was 
sufficient to answer our primary research question, but we did not anticipate 
on a baseline HRQL difference that needed to be corrected for. A strength of 
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our study was the use of a contemporary, validated e-health programme that 
was enjoyable according to children. (13) Moreover, we used another HRQL 
instrument than our Pelican instrument as the primary outcome for the study, 
in order to prevent entanglement of intervention and outcome measurement. 
Finally, we assessed the effect of patient-centred care on top of optimised 
asthma management. Therefore, the differences between the groups reflect 
the extra effect that can be achieved when a patient-centred approach is 
added to high-quality paediatric asthma outpatient care .  
 
In this study, only one in four children in the enhanced usual care 
group showed a clinically relevant improvement in HRQL, whereas more than 
half of the children in the Pelican-based intervention group experienced such 
an improvement. These results need to be confirmed by other studies, 
especially because the differences were no longer statistically significant after 
correction for baseline values. However, a clinically relevant improvement in 
more than half of the children suggests that patient-centred care for children 
with asthma using the Pelican instrument is feasible and effective in 
improving HRQL in paediatric outpatient clinics. There are other non-
communicable diseases in childhood, for which a similar patient-centred 
approach could be beneficial too, such as diabetes mellitus and juvenile 
cancers. This option warrants further investigation. Moreover, we need to get 
a better understanding of the specific actions that were effective in solving 
the asthma-related problems in the PPC group and other actions that were 
not. 
 
 
CONCLUSION 
Patient-centred paediatric asthma outpatient management based on the 
Pelican instrument seemed to result in a substantially larger proportion of 
children that experienced a clinically relevant asthma-specific quality of life 
gain after nine months of follow-up. Our findings need to be confirmed in 
other, larger studies.  
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ABSTRACT 
 
BACKGROUND: We assessed the process of care of a Patient-centred Care 
programme that integrated individual goals in asthma management (based on 
self management principles) of children 6 to 12 yrs of age treated in 
outpatient care. 
 
METHODS: Information on children’s individual problems (as indicated by 
the Pelican instrument), level of impairment, asthma management goals and 
actions was collected. Facilitators/barriers of implementation and 
satisfaction of parents, children and nurses were assessed with 
questionnaires and analysed with descriptive statistics. 
 
RESULTS: Most frequently identified problems by children (n=42) were 
‘cough’, ‘cigarette smoke’ and ‘shortness of breath’. 82% of selected items 
showed room for improvement. About 2 to 7 actions were formulated and 
children had an active role in more than 76% of the actions. ‘Using rescue 
medication prior to activities/triggers’, and ‘talk to others about your asthma’ 
were most frequently recommended. Children thought the Pelican instrument 
was easy (95%) and fun (65%) and both parents and nurses were positive 
about the incorporation of the programme in the treatment. Following 
potential barriers were found: (1) only 25% of goals was formulated 
according to SMART principles; (2) traditional management aspects 
(medication use) are treated instead of individual problems of children. 
 
CONCLUSION: Implementation of patient-centred care based on the Pelican 
instrument shows potential in specialised care, although modifications in 
patient-centred probem selection and goal setting still need to be improved in 
the execution of the evaluated treatment. 
 
KEYWORDS: Process evaluation, children, asthma, quality of life 
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INTRODUCTION 
Asthma is one of the most common chronic illnesses among children in 
Western countries. (1, 2) It is an inflammatory pulmonary disease with 
variable and recurrent symptoms such as wheezing and shortness of breath. 
(3) Treatment consists primarily of avoiding triggers (e.g. exposure to 
allergens), improving physical condition and controlling symptoms with 
medications. Since patients plays an important role in managing asthma, 
taking their perception into account and stimulating self management is 
recommended. (4, 5)   
Although previous research has already shown favourable results of 
self management and educational interventions on reducing childhood 
asthma morbidity, there have been no previous studies - to the best of our 
knowledge - to integrate children’s personal goals in self management for 
asthma. (6-9) We have developed an asthma-specific health-related quality of 
life instrument (HRQL; Pelican instrument) that enables children to register 
asthma-related problems that bother them mostly in daily life. (10-14) The 
selected problems are the starting point of a nurse-guided patient-centred 
care (PCC) programme based on self management principles. The nurse 
supports children and parents in specifying their needs, formulating 
treatment goals and deciding on appropriate actions that are written down in 
an action plan.  
We performed a randomised controlled study to assess whether 
nurse-guided PCC was effective in improving children’s HRQL in nine months. 
Results of this study in paediatric outpatient clinics, indicate beneficial effects 
on asthma-specific HRQL in a relevant proportion of primary school aged 
children with asthma. In a second study, the effectiveness of PCC in family 
practices could not be evaluated because the analyses were underpowered 
due to recruitment problems. (15) Since PCC programmes are complex 
interventions that are adjusted to individuals and often consist of several 
treatment phases, a detailed evaluation of the intervention and its execution 
is crucial to understand how and why a PCC programme works or fails. (16) 
Successful implementation depends on agreement and active engagement of 
children, parents and health care professionals. In this paper we analyze four 
implementation elements of our nurse-guided PCC programme: (a) 
preparedness of health care providers and families to execute the PCC 
program, (b) children’s’ selection of asthma-specific problems using the 
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Pelican instrument and the way these were integrated in written action plans, 
(c) implementation of the PCC programme according to the selected 
intervention methods, and (d) supportiveness or barriers of children, parents 
and nurses to participate in the PCC program. 
 
 
METHODS 
 
Design, study samples and ethics approval 
We used the data of two randomised controlled trials (RCTs) that looked at 
the effectiveness of our PCC intervention on improving HRQL in primary 
school-aged children with asthma. (17) A RCT was performed in specialised 
care in five hospitals, and another clustered RCT was performed in primary 
care in nine family practices in the Netherlands (15). In both trials children 
with asthma were allocated to a control group receiving usual care or an 
intervention group receiving PCC complementary to usual care. Subjects were 
followed for nine months with four scheduled visits. During the study, 
process of care was evaluated among children, parents and nurses allocated 
to the intervention group to assess feasibility and acceptability of this 
particular PCC intervention. The studies were approved by the Medical Ethics 
Committee of the Arnhem-Nijmegen region in the Netherlands (CMO 
2009/292). Details on design, treatment allocation and sample size 
calculation can be found in the study protocol (17) and on clinicaltrial.gov 
(NCT01109745). 
 
Subjects 
Study subjects for the process of care evaluation were children, parents and 
nurses that participated in the two RCTs and were allocated to the 
intervention group. Children with physician-diagnosed asthma, 6 to 12 years 
of age, who had used asthma medication (i.e., bronchodilators and/or inhaled 
corticosteroids) for at least six weeks during the previous year were 
recruited. Both official caregivers signed informed consent for participation. 
Exclusion criteria were comorbid conditions that significantly influence HRQL 
(such as diabetes or congenital heart defects), not being able to attend a 
regular school class, and insufficient skill in speaking and/or reading the 
Dutch language.  
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Pelican instrument and PCC treatment 
The Paediatric Electronic quality of Life Instrument for Childhood Asthma in 
the Netherlands (Pelican) is an online self-administered asthma-specific 
HRQL questionnaire for primary school-aged children. (10) The child is asked 
to select a minimum of one and a maximum of three items from a pre-selected 
list of personal asthma-related problems (such as wheezing, medication use, 
not allowed to caress pets). This list is based on results of a focus group study 
on aspects considered essential according to Dutch primary school-aged 
children with asthma. (10, 18) Furthermore, the child can add one extra 
individual problem that is not present in the pre-selected list. The selection of 
the child’s asthma-related problems is the starting point for PCC according to 
a six-step procedure. Together with the child and parent(s), a nurse discussed 
which selected problem would be prioritised for treatment (Step 1). Details 
around a problem were discussed (Step 2) and a treatment goal was 
formulated according to SMART principles (Step 3). (19) Next, possible 
solutions were discussed (Step 4) and solutions on which mutual agreement 
was achieved, were documented in a written action plan (WAP) (Step 5). 
During the next visit, the results of the written action plan were evaluated 
(Step 6) and if the treatment goal is not achieved, the six-step intervention 
was repeated. Figure 1 shows a model of the entire complex intervention with 
its components. 
During a two-hour meeting before the start of the study, nurses were 
trained in interpretation of the Pelican outcome, the six-step PCC program, 
motivational communication and self management support. In addition, five 
scheduled personal consultation moments and continuous support for 
specific questions that nurses might have, were provided on request at all 
times by one of the investigators (SB).  
 
Data collection 
Demographic data of the participants were collected at the start of the study 
by means of a proxy questionnaire. PCC intervention content was recorded in 
the WAPs. Whether PCC was implemented according to methods and what 
barriers and facilitators were perceived, was assessed through evaluation 
forms that were completed by all involved nurses and a ±35% random 
sample of parents three months after visits. General satisfaction with PCC was 
investigated among all stakeholders one month after a child had finished the 
study. 
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Data analyses 
Data were analysed by means of descriptive statistics. Goals and actions as 
documented in the WAPs were categorised by two investigators 
independently (SB, RC). In case of a difference in agreement between two 
investigators, a third reviewer (LB) categorised data. Categorised data that 
showed agreement between two of three reviewers was used, otherwise 
consensus was reached through discussion. 
 
 
RESULTS 
 
Study population in primary and specialised health care 
In specialised care, 324 children from five hospitals were invited from August 
2011 until March 2013. 101 children were randomised and 97 started in the 
study (46 in the PCC group and 51 in the usual care group). Finally, 42 
children in the intervention group were included in the analyses (four 
children had too many missing values ).  
In primary care, we recruited 11 out of 112 invited family practices 
from February 2011 to July 2013. Five practices were allocated to the 
intervention group and six practices to the usual care group. Two practices 
withdrew from the study due to lack of willing participants. In total, 33 of 224 
invited children started in the study. Eventually, 15 children from four 
practices were treated according the PCC programme and were included in 
the analyses. (15) Table 1 shows baseline demographic and clinical 
characteristics of participants from both studies. 
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Table 1: Demographic and clinical characteristics of subjects receiving 
individualised self-management treatment in specialised and primary 
care 
       Specialised care (n=42)       Primary care (n 15) 
 n Median (IQR) n Median (IQR) 
Gender (n male, %) 42 25 (59.5) 15 10 (66.7) 
Age (Mean, SD) 42 8.7 (1.5) 15 8.4 (1.7) 
Ethnicity (n, %)  
Dutch 
Western immigrant 
Non-Western immigrant 
42  
33 (78.6) 
  2 (  4.8) 
  7 (16.6) 
15  
14 (93.3) 
0 (  0.0) 
1 (  6.7) 
Education level of parents 
(n,%)   
Low 
Mid 
High 
42  
6 (14.3) 
12 (28.6) 
24 (57.1) 
15  
0 (  0.0) 
2 (13.3) 
13 (86.7) 
Asthma control (C-ACT) 
Well controlled >22 (n, %) 
Uncontrolled ≤ 22 (n, %) 
39 18.8 (17.2-20.3) 
11 (28.2) 
28 (71.8) 
14 22.0 (19.0-25.0) 
10 (86.6) 
  4 (  6.7) 
Lung function 
FEV1% predª (L) (Mean, SD) 
Reversibility (n,%) 
41  
1.75 (0.4)  
  11 (26.8) 
14  
1.11 ( 0.1) 
    2 (13.3) 
Medication use (n, %) 
Inhaled corticosteroids 
Short-acting β-adrenoceptor 
agonist 
Long-acting β -adrenoceptor 
agonist 
41  
34 (82.9) 
27 (65.9) 
  9 (22.0) 
15  
12 (80.0) 
  9 (60.0) 
  1 (  6.7) 
HRQL  (PAQLQ-s) 
Activities 
Emotions 
Symptoms 
42 5.64 (4.90-6.24) 
5.55 (4.75-6.00) 
6.87 (6.34-7.00) 
5.20 (4.38-6.30) 
15 6.35 (5.61-6.78) 
5.80 (5.40-7.00) 
6.75 (6.13-6.88) 
6.30 (5.40-6.70) 
HRQL  (Pelican) 
(Mean, SD) 
Activities  
Triggers 
Symptoms 
Asthma management 
Social/emotional 
42 2.52 (0.76) 
 
1.67 (1.00-2.31) 
2.80 (2.00-3.20) 
2.80 (2.20-3.85) 
2.63 (1.94-3.75) 
1.75 (1.00-2.31) 
15 2.38 (0.84) 
 
1.33 (1.00-2.00) 
2.40 (1.80-3.80) 
2.40 (1.80-2.80) 
2.50 (2.00-3.25) 
2.00 (1.75-2.50) 
Selected asthma-problems by 
children (problem, n) in 
Pelican instrument at baseline 
125 Cough (14) 
Shortness of breath (14) c 
Cigarette smoke (13) 
44 Dust (7) 
Medication use (5) 
Cigarette smoke (5)c 
Psychosocial problems (SDQ)ᵇ  
(Mean, SD) 
Normal (n, %) 
Minor (n, %) 
Major (n, %) 
40  
10.30 (5.82) 
28 (66.7) 
  6 (14.3) 
  8 (19.1) 
15  
9.75 (5.54) 
10 (66.7) 
  4 (26.7) 
  1 (  6.7) 
 
Abbreviations: Asthma Control Questionnaire (ACQ), Child-Asthma Control Test (C-ACT), Inter Quartile Range 
(IQR), Health related Quality of Life (HRQL), Paediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ), 
Paediatric Asthma Quality of Life Questionnaire with standardised activities (PAQLQ-s), Paediatric Electronic 
quality of Life Instrument for Children with Asthma in the Netherlands (Pelican), SD (Standard Deviation), 
Strenghts and Difficulties Questionnaire (SDQ)  
a Reference values used of Global Lung Initiative 2012 (GLI) 
b SDQ Question 13 was missing among 90 of 92 subjects due to organizational problems and was imputed with 
individual mean of scale 
c Ex aequo ranking 
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Preparedness to participate in a study towards PCC for paediatric asthma 
In the specialised care study, the main reason for parents to refuse 
participation was ‘child has no complaints of asthma’. Response rate was 
33%. In primary care, we experienced considerable recruitment problems of 
patients and their parents and also of family practices. The overall response 
rate of invited families in primary care was 17%. One third of rejecting 
families, indicated they did not agree with the asthma diagnosis and/or that 
their child did not have asthma symptoms. Main reasons for family practices 
to reject participation were ‘other care priorities’ (such as diabetes, Chronic 
Obstructive Pulmonary Disease and cardiovascular risk management) and 
‘lack of time’. Furthermore, reasons such as ‘participation in other research 
projects’, ‘lack of sufficient number of paediatric asthma patients in the 
practice’ and ‘lack of interest or affinity with paediatric asthma care’ were 
often mentioned. Due to the small number of participants in primary care, 
further results on process evaluation of the PCC intervention will only be 
described for subjects treated in specialised care. (15) 
 
PCC intervention content in specialised care 
Pelican instrument 
Parents were instructed to let children complete the Pelican instrument at 
home before visits. In case this was impossible or forgotten, the child was 
allowed to complete the Pelican instrument at the outpatient clinic. Four 
children could not complete the Pelican instrument at home before the visit 
to the nurse because they did not have an available computer at home (n=1) 
or the online Pelican instrument did not run on their computer (n=3). Two of 
five outpatient clinics (40%) had computers available to provide the 
possibility to complete the Pelican instrument on location before the 
scheduled visit. For study purposes, the other three clinics were offered 
notebooks. 
In total, children selected 352 asthma-related problems in the Pelican 
instrument with a median of 3 problems per child per visit. The most 
frequently selected asthma-related problems during the first three visits were 
‘cough’, ‘cigarette smoke’ and ‘shortness of breath’ (Table 2). Children used the 
opportunity to add an individual problem (n=34, 9.7% of 352 selected 
problems) besides those on the pre-selected list. In 18 of these cases, the child 
used this option to add a fourth item from the preselected list, leaving 16 
distinct individual problems (4.6%), such as ‘hay fever’. Although, the Pelican 
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instrument is self-administered, nurses mentioned during personal 
consultation that some parents thought their child was unable to oversee 
his/her asthma-related problems and to provide reliable answers without 
parental help. 
 
PCC intervention during visits 
Compliance to attending scheduled visits at the outpatient clinic was 97.6% 
(n=123 out of 126 scheduled visits). Reason for noncompliance was ‘no 
current asthma complaints’. A total of 113 problems were addressed during 
visits and a maximum of two problems could defined per WAP (n=101). The 
most frequent chosen problems selected in WAPs were ‘medication use’, 
‘running’ and ‘cigarette smoke’ (Table 2). Reasons why no problems were 
discussed (according to nurse) were: the child did not complete the Pelican 
instrument (8), the problems selected by the child were not severe enough to 
treat (14), the child did not answer reliably on Pelican instrument (4), a lack 
of time (2), lack of motivation of the child (2), other problems were more 
important (2), problems unlikely to be susceptible to change (1), parent(s) 
and children lacked capacity to manage problems (1) (overlap in reasons was 
possible). 
Two to seven actions per problem were defined in the WAPs. ‘Using 
rescue medication prior to activities/triggers’, and ‘talk to others about your 
asthma’ were the most frequently defined actions (Table 3). Actions that 
showed most improvement on problem scores (i.e., percentage of children 
showing improvement ≥50% and mean change ≥ 0.70) were ‘improve 
physical condition’, ‘improve medication inhalation technique’, ‘optimize 
availability of inhaler’, and ‘monitor asthma symptoms’. In 224 out of 294 
actions (76.2%) an active contribution of the child was required, in 99 actions 
(33.7%) of the parent(s), in 31 actions (10.5%) of the nurse, and in 14 actions 
(4.8%) of another/unspecified party (overlap in active contribution was 
possible). 
  
  
Table 2: Overview of selected asthma-related problems in the Pelican instrument that was completed 
(n=115) by 42 children and the integration of these problems in patient-centred care during three visits in 
outpatient clinics in the Netherlands 
 
a Individual asthma-related problems other than the selection of a fourth problem from the preselected list by the child in the 
individual question: limitations due to being ill or having a cold (n=3), often easily tired (n=4), not being able to hurry and having to 
act calm (n=1), cycle (n=1), allergies or hay fever (n=4), forget medication (n=1), stomach hurts (n=1), smoking/gymnastics/playing 
outside (n=1).  b Other problem: Individual problem mentioned by child that was not on the predefined list.   c Other problem: Problem 
selected for treatment was not based on child response on the Pelican instrument.  d score ≥3 on Pelican instrument 
Asthma-related problem/item 
(Pelican) 
No. of times 
selected by 
children  
No. of problems with 
room for improvement 
d 
No. of times selected 
problem was 
prioritised for PCC 
Actual 
problems 
discussed 
during PCC 
N n1 % (n1/N) n2 % (n2/n1) n 
Cough 48 38 79.2 8 21.1 10 
Cigarette smoke 36 27 75.0 9 30.9 10 
Shortness of breath 33 24 72.7 6 25.0 8 
Not allowed to caress pet 30 30 100.0 8 26.7 9 
Season 29 24 82.8 3 12.5 3 
Sore Throat 28 22 78.6 7 31.8 8 
Dust 25 17 68.0 3 17.7 3 
Medication 23 16 69.6 12 75.0 19 
Running 22 21 95.5 7 33.3 12 
Wheeze 18 15 83.3 7 46.7 7 
Individual problema 16 16 100.0 5 31.3 5 
Missing school 12 11 91.7 2 18.2 2 
Sports/games 10 9 90.0 3 33.3 6 
Hospital/doctor 10 7 70.0 0 00.0 0 
Being bullied 6 5 83.3 3 60.0 5 
Forget task 5 5 100.0 1 20.0 1 
Gymnastics 1 1 100.0 0 00.0 0 
Other problem    29b  5c 
TOTAL 352 288 81.8   113 
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Implementation of PCC according prescribed methods in specialised care 
Figure 1 shows whether PCC was delivered according to selected methods 
during all treatment phases. Results show that the majority (>70%) of the 
PCC intervention was generally well implemented according to protocol, with 
exception of formulating treatment goals according to SMART principles.  
 
Satisfaction with PCC in specialised care 
Table 4 shows results on satisfaction with PCC after each visit by a subset of 
parents (±35%; n=16) and nurses (n=5). General satisfaction was 
investigated one month after the study among children and parents as well. 
Eleven parents did not complete the last survey.  
During personal consultation with researchers, nurses mentioned 
some doubts and barriers. Nurses thought that children were often unable to 
distinguish between ‘current’ and ‘recent’ problems and often relied on old 
memories, especially when asthma-related problems, such as exacerbations, 
had had a substantial emotional impact. Furthermore, two nurses felt that 
there were hardly any acceptable solutions when children were not allowed 
to keep a pet. Also, the nurses concluded that implementing PCC was more 
difficult for young children (6 to 8 years) and children with comorbidity, 
especially ADHD. 
 
   
    
 
Table 3: Actions in written action plans (Actions n=290; WAP n=101) during three visits leading to change in 
asthma-related problems (improved/unchanged/deteriorated/missinga) in specialised health care 
 
Action No. of times 
action was 
used 
Problem 
score 
change 
known 
Problem 
score change 
Problem 
improved 
Problem 
unchanged 
Problem 
deteriorated 
 n % n Mean (SD) n % n % n % 
Use asthma medication before activity or trigger  37 12.6 31 0.10 (1.35) 10 32.3 14 45.2 7 22.6 
Talk to others concerning asthma-related problems 31 10.5 26 0.00 (1.90) 10 38.5 9 34.6 7 26.9 
Adjust dose/frequency of asthma medication 17 5.8 13 0.00 (1.00) 3 23.1 7 53.8 3 23.1 
Rinse mouth/drinking water 17 5.8 15 0.13 (1.13) 7 46.7 3 20.0 5 33.3 
Receive information/education on asthma 14 4.8 11 0.45 (1.37) 4 36.4 5 45.5 2 18.2 
Warming up 13 4.4 11 -0.36 (1.36) 3 27.3 5 45.5 3 27.3 
Improve asthma medication inhalation technique 11 3.7 10 0.80 (0.92) 7 70.0 2 20.0 1 10.0 
House sanitation/ventilation 11 3.7 7 0.29 (0.76) 3 27.3 3 27.3 1 9.1 
Optimize availability/repository of inhaler  9 3.1 9 0.78 (1.64) 5 55.6 3 33.3 1 11.1 
Improve physical condition 8 2.7 6 0.83 (1.17) 3 50.0 3 50.0 0 00.0 
Avoid trigger/walk away from trigger  8 2.7 7 0.57 (0.79) 3 42.9 4 57.1 0 00.0 
Pet animals somewhere else (when not allowed at 
home)  
8 2.7 8 0.25 (0.46) 2 25.0 6 75.0 0 00.0 
Adjust timing of asthma medication intake  7 2.4 7 0.57 (0.79) 3 42.9 4 57.1 0 00.0 
Educate class mates or others 7 2.4 7 0.71 (2.76) 3 42.9 3 42.9 1 14.2 
Reminder system for asthma medication use 7 2.4 6 0.33 (1.63) 3 50.0 1 16.7 2 33.3 
Parent/other does not smoke in presence of child 7 2.4 6 0.67 (0.82) 3 50.0 3 50.0 0 00.0 
Gradual temperature transition 6 2.0 5 0.00 (1.23) 2 40.0 2 40.0 1 20.0 
Reward system for child in agreement with caregivers 6 2.0 6 -0.17 (2.14) 3 40.0 1 16.7 2 33.3 
Use throat emollients 6 2.0 4 0.50 (1.29) 2 50.0 1 25.0 1 25.0 
Acting calm/taking rest (in general) 4 1.4 2 0.50 (0.71) 1 50.0 1 50.0 0 00.0 
Change medication agent 4 1.4 4 0.75 (1.50) 1 25.0 3 75.0 0 00.0 
Monitor asthma symptoms 4 1.4 4 0.75 (1.26) 3 75.0 0 00.0 1 25.0 
Making doctor’s appointment on time/frequently 3 1.0 2 1.50 (3.54) 1 50.0 0 00.0 1 50.0 
Referral to specialist 3 1.0 1 1.00 (    /  ) 1 100.0 0 00.0 0 00.0 
Wash hands after contact with animal 3 1.0 3 0.33 (0.58) 1 33.3 2 66.7 0 00.0 
Regulate breathing 2 0.7 2 0.00 (0.00) 0 00.0 2 100.0 0 00.0 
Other action 41 14.0 36 0.58 (1.23) 15 41.7 18 50.0 3 8.3 
Total actions 294 100.0 249  102 41.0 105 42.1 42 16.9 
a Better item score on Pelican instrument was a change of ≤-1, equal was the same score and worse was ≥1. Missing data were caused by incompletion of the Pelican instrument by 
the child before one of the four scheduled visits or individual problems treated. Note: The formulated action can apply to several problems. The mean change on item score is based 
on all selected problems for which this action was formulated in the written action plan. 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: n, number; PCC Patient-centred care;  
WAP, written action plan 
 
 
Figure 1: The family’s process of care during Patient-centred care (PCC) in the Pelican study during the first 
three visits (n=123) of 42 children treated in specialised care 
(if needed) 
AT HOME: The child completes the Pelican 
instrument before hospital visit (Total 
population n=42) 
- Completed n=115 (91.3%) 
- Number of problems selected (n=352) 
- 288 of 352 of selected problems (81.9%) 
show room for improvement (median score 
4.0, IQR 4.0-5.0) 
- Most frequently selected problems: cough, 
cigarette smoke and shortness of breath 
 
AT THE HOSPITAL: 
The family receives the PCC intervention during their 
visit at the hospital (step 1-5 of PCC) 
 
- 97.6% compliance to visits (n=123) 
- 82.9% of visits with WAPs (n=101) 
- Number of problems discussed: n=113 
- Most frequently discussed: medication, running and 
exposure to cigarette smoke 
- 24.8% of the problems had a SMART treatment goal 
(n=28 of 113), 62.0% partly SMART (n=70) and 12.4% 
not SMART (n=14) 
- Actions formulated (n=294; median 2, range 2-7 per 
problem) 
- A PCC visit had a duration of ± 40 minutes according to 
the nurse 
AT HOME: The family implements the written 
action plan at home (according to a subset of 
16 parents) 
- 38 of 46 evaluated WAPs (82.6%, n=2 missing) 
were executed 
NEXT VISIT AT THE HOSPITAL: 
The effects of the written action plan will be evaluated and when 
necessary the PCC intervention will be repeated (step 6 of PCC) 
 
- Nurses evaluated 60 out of 101 WAPs (84.5%; n=30 evaluations missing) 
during the next visit. Reasons for unevaluated WAPs were unknown. 
- 38 of 113 treated problems (41.8%; n=22 missing) was improved during 
next visit (measured by the Pelican instrument). 
- In 41 out of 60 evaluated WAPs (69.5%; n=1 missing) the treatment goal 
was achieved according to the nurse. 
- Reasons (multiple reasons possible) why the goal was not achieved 
according nurse: The problem is unsusceptible to change (5), other 
problems had priority (1), actions were not implemented at home (2), 
parent(s) and child had not enough motivation (2), other reasons (10) 
 
  
Table 4: Satisfaction with PCC management of asthma in specialised care in the Netherland by children (n= 40), one 
of their parents (n=31) and nurses (n=5) 
 
 
Satisfaction items Criterion Unit N      n (%) 
Do children with asthma think it is fun to complete the Pelican 
instrument? 
(Note: n=2 missing) 
(Very) fun 
Neutral 
Not fun (at all) 
Children 40 
 
 26 (65.0) 
  6 (15.0) 
  8 (20.0) 
Do children think it is difficult/easy to complete the Pelican 
instrument? 
  
Remarked by children that instrument is somewhat childish 
Not difficult (at all) 
Neutral 
(Very) difficult 
Children 
 
 
Children 
40 
 
 
40 
38 (95.0) 
  1 (  2.5) 
      1 (  2.5)  
  5 (12.5) 
 Is ISM support better adjusted to the needs of your child than 
usual care, according parents? 
     
     
   
Is the WAP useful according parents? 
 
 
Generally improved 
More or less the same 
Generally deteriorated 
Otherwise 
 
(Very) useful 
Not useful/not useless 
(Very) useless 
Otherwise 
Parents 
 
 
 
 
Parents 
 
 
 
31 
 
 
 
 
31 
 
    10 (32.3) 
  16 (51.6) 
1 (  3.2) 
    4 (12.9) 
 
  19 (61.3) 
    6 (19.4) 
    3 (  9.7) 
    3 (  9.7) 
Were management strategies appropriate/beneficial to solve the 
problem according to a subset of parents (n=16) with in-depth 
process information? 
     
    Parents opinion on appropriateness 
 
 
    Parents opinion on the helpfulness  
 
 
 
(Very) appropriate 
Neutral 
(Very) inappropriate 
 
(Very) helpful 
Neutral 
Not helpful 
Otherwise 
 
 
 
3 evaluations (8 missing) in 
a subset of parents 
 
 
3 evaluations (8 missing) in 
a subset of parents 
 
 
 
 
38 
 
 
 
38 
 
 
 
 
 
 
32 (84.3) 
4 (10.5) 
  2 (  5.2) 
  
20 (64.5) 
  5 (16.1) 
  3 (  9.7) 
3 (  9.7) 
  
Table 4 (continuation): Satisfaction with PCC management of asthma in specialised care in the Netherland by 
children (n= 40), one of their parents (n=31) and nurses (n=5) 
 
Would parents like to continue with ISM support after the study? Absolutely/Probably 
I don’t mind 
Absolutely/Probably not 
Otherwise 
Parents 31 
 
    16 (51.6) 
      7 (22.6) 
      6 (19.4) 
      2 (  6.5) 
Is the child’s outcome of the Pelican instrument comprehensible 
according to the nurses? 
 
Most of the times 
Sometimes 
Nurses 5 
 
    3 (60.0) 
    2 (40.0) 
the outcome of the Pelican instrument susceptible to change 
according to the nurses? 
 
Most of the times 
Sometimes 
Nurses 5 
 
    2 (40.0) 
    3 (60.0) 
Did nurses think the PCC consult was useful for children? 
 
 
 
Would nurses advise ISM support to their colleges? 
  
Mean grade of Pelican instrument and ISM support, given by nurses 
(between 0-10) 
(Very) useful 
Not useful/not useless 
(Very) useless 
 
Yes 
Evaluations of visits  
(11 missing)  
 
 
Nurses 
 
Points 
112 
 
 
 
5 
 
    7.4 
(0.89) 
97 (86.6) 
   12 (10.7) 
     3 (  2.7) 
 
5 ( 100) 
    
6;7;8;8;8 
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DISCUSSION 
 
To the best of our knowledge, this is the first time that individual child-
reported outcome measures are integrated in asthma management, enabling 
personalised health-care for the patient population. The aim of this study was 
to describe the content of the PCC intervention, whether the intervention was 
executed according to protocol, the supportiveness or barriers of respective 
stakeholders to integrate PCC in paediatric asthma management. We used 
information from children, parents and nurses that were allocated to the PCC 
treatment arms of two randomised controlled trials in specialised and 
primary care. We observed considerable differences between both health 
care settings in preparedness for patient participation with a response rate of 
33% and 17% respectively. Due to a small number of subjects in primary care 
(n=15), analyses of the process of care of PCC were performed for the 
specialised care setting only.  
Almost all children, completed the Pelican instrument before the 
scheduled visit (91,3%). Children thought that completing the Pelican 
instrument was fun and not difficult. In general, the PCC intervention during 
visits was performed according protocol (>70%). However, one in four WAPs 
show a discrepancy between problems selected by children and the 
problem(s) treated during PCC (e.g. ‘medication use’ was addressed in seven 
cases while it had not been selected by children and/or a priori did not show 
room for improvement). Also, formulation of treatment goals was in 
accordance to SMART principles in only 25 percent of the WAPs. Two to 
seven actions per problem and children were actively involved in the 
execution of them (76.2%). Three quarters of the families implemented the 
actions as formulated on the WAP at home. Parents and nurses felt that 
treatment was improved and that the WAP was a (very) useful instrument. 
Three in four parents were willing or not reluctant to continue with  PCC after 
the end of the study, if this was offered. 
 
The response rate for our trials was rather low, compared to another 
Dutch RCT among children with asthma treated in specialised care that 
assessed regular monitoring of asthma symptoms and environmental tobacco 
smoke exposure (66%) (20, 21), and compared to another Dutch RCT looking 
at an internet self management intervention in adolescents with asthma 
treated in primary and specialised care (54%). (20, 21) This might be caused 
   
CHAPTER 6 | PROCESS EVALUATION 
Pagina| 129 
 
 
 
 
 
 
 
 
 
 
by the larger time investment of the Pelican-based PCC intervention with 
personalised care during face-to-face consultations, compared to monitoring 
only or an internet-based intervention. In addition, not all asthma patients 
might experience asthma-related problems or reduced HRQL (as could be 
seen in baseline clinical characteristics), which could be motivators to 
participate in studies. Especially in primary care, children showed good 
asthma control and HRQL scores and this may be a reason of why patients 
and their parents did decline the invitation to take part in the program. In the 
Netherlands, children with a more complex asthma presentation and severe 
lack of asthma control are treated in specialised care. Our results emphasize 
the importance of investigating (the needs for) interventions in different care 
settings, even within one and the same country. Early engagement of 
stakeholders in the development and execution of implementation research 
could prevent unnecessary research and save costs. (22-25).  
In general, all components of the PCC programme were executed quite 
well according to the intervention methods. This is comparable to other 
intervention studies, such as a nurse-led telemonitoring programme in 
paediatric asthma patients and a smoking cessation intervention for 
caregivers of children with asthma. (26, 27) An important observation, 
however, was the mismatch between the problems selected by children and 
those that were addressed during PCC, despite patient-centred training of the 
nurses at the start of the study. This observation might be explained by the 
‘habit’ of health care providers to direct communication and transfer their 
own treatment goals instead of facilitating treatment responsibility in 
patients and parents or informal caregivers. (28)  
 
Strengths and Limitations 
The current study describes the process of care of PCC for childhood asthma, 
as an important addition to effectiveness studies that were performed in 
specialised and primary care. (17) A process evaluation is an important 
aspect of complex interventions and provides insight into the ‘black box’ of 
why interventions work or fail. This evaluation focused on the description of 
the disease management cycle and information about barriers, possibilities 
and opinions of health care professionals, parents and - most importantly - 
children themselves. The data we collected was mainly quantitative. 
Collecting additional qualitative information on the process, for example by 
interviews, would have enriched our evaluation but was considered an extra 
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burden for participants as study participation was already rather demanding. 
Despite quite a bit of missing data, relevant information on barriers and 
facilitators was collected during this study. 
 
Recommendations for future research  
Implementation of the PCC programme in this study was executed in the 
context of a randomised controlled trial. Ideally, further investigation in real 
life conditions should be performed. Self management requires enough 
capacity and skills of patients to gain insight into their chronic illness and 
treatment decisions. Some parents and nurses suggested that young aged 
children (6 to 8 years of age) were not always capable to provide reliable 
answers on the Pelican instrument or to actively participate in conversation 
about asthma management. This also applied to children with ADHD. Further 
research on specific subgroups is recommended. Furthermore, it would be 
interesting to investigate a programme that is individualised on visit 
frequency and severity of asthma problems as well. Assessing the cost-
effectiveness of the Pelican-based PCC will be the topic of further research by 
our research group. 
 
Advice for clinical implementation 
PCC in specialised health care for paediatric asthma seems to be feasible, 
acceptable and effective (Chapter 5). Therefore, implementation of PCC in 
outpatient clinics in the Netherlands is recommended. Since implementation 
of personalised disease management takes considerable time and effort, 
nurse-involvement in PCC seems inevitable. According to a recent Cochrane 
review and a study in the Netherlands, nurse-led care for patients with 
asthma is equally effective compared to physician-led care for the outcomes 
assessed. (29, 30) This process evaluation shows that a couple of aspects of 
PCC treatment need improvement; nurses require extensive and continuous 
training to keep paying attention to children’s individual asthma-related 
problems and to formulate goals according SMART principles. Finally, it is 
important that the Pelican instrument is suitable for any personal computer 
or tablet to enhance implementation. Ideally, the application should also be 
integrated in the electronic patient record systems of health care providers. 
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Conclusion 
We concluded that PCC is currently not advised in primary care. However, the 
programme has shown potential to be feasible and, acceptable in specialised 
care, and can be recommended for use in this setting. During the study all 
phases of PCC were generally well implemented, but despite training, there 
still seems to be room for improvement with regard to patient-centredness 
and ‘SMART’ goal setting by nurses. Further research needs to be done for 
specific patient groups, for example children with comorbidity (such as 
Attention Deficit and Hyperactivity Disorder). Future investigation towards 
implementation in real life and cost-effectiveness is warranted as well. 
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In this chapter, I will present a case and summarize the main findings of this 
thesis. Additionally, I will reflect on the implications of our findings for 
(clinical) practice and future research. 
 
 
CASE 
 
Benjamin, aged 10, was suffering from asthma symptoms during physical 
activities, disabling him to finish a complete soccer game. During the 
consultation described in the introduction of this thesis, the mother acts as a 
spokesperson about Benjamin’s asthma. This fictional sketch will be 
recognisable to many physicians and nurses involved in asthma care. Getting 
‘second hand’ information (e.g. from the parent) can, however, provide a 
distorted or incomplete image of Benjamin’s complaints and limitations as 
discussed earlier in this thesis.  
There are several arguments in favour of paying direct attention to 
the child in medical consultation. According to developmental research, 
children understand more medical issues than is often assumed and, if 
addressed with regard to their own level, are able to adequately contribute to 
discussions with adults. (1) Furthermore, it is important that children learn to 
participate in medical interviews in order for them to develop a (shared) 
responsibility in their own health and disease management. This preparation 
might be crucial to become an adolescent and adult who is able and willing to 
(self) manage asthma properly. Open and direct communication between 
health care providers and children is desired since involved children are 
better informed, less anxious, might adhere better to agreements and recover 
faster. (1) It is, however, important to realize that both parent(s) and child 
need time to adjust to such role changes. (1) 
Returning to Benjamin; a couple of months later, he and his mother 
visit the nurse, who is trained in patient-centred care, at the outpatient clinic. 
Benjamin has completed the Pelican instrument at home before visiting the 
nurse. The outcome indicates that Benjamin suffers from being bullied during 
school gymnastics. This gives the nurse the opportunity to ask directed 
questions. When the nurse refers to these results and explains the importance 
of hearing Benjamin’s story from himself, he finally tells: “It happens during 
gymnastics, you have to run in circles and halfway round I have to cough a lot 
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so I usually have to sit aside because then…, otherwise it’s annoying for the 
others. I try to run as fast as possible at the beginning and then I try to keep up. 
But I fall further and further behind. And everyone says like: ‘Come on, go faster, 
you slow snail!.” Mother reacts surprised: ‘I did not know of this bullying. He 
never told me so, and of course I never see what happens at school.’ After thirty 
minutes, Benjamin and his mum leave the consultation room with a written 
action plan, which they decided on together with the nurse. Mother arranges 
a conversation with the teacher to create awareness of the bullying during 
gymnastics and to discuss possible solutions. Benjamin will give an oral 
presentation on asthma to his class mates and explains why he needs to take 
medications. From now on, Benjamin takes his bronchodilator before gym 
class. In four weeks, the nurse will contact Benjamin. If the situation at school 
has not improved by then, she will inquire on possible solutions to deal with 
the situations and, when necessary, support the family in making 
arrangements with the school. 
 
 
SHORT REFLECTION 
 
Asthma is one of the most common chronic illnesses in children in the 
Netherlands. (2-5) The chronic respiratory inflammation is associated with 
hyper-responsiveness of the airways, leading to symptoms such as wheezing, 
breathlessness, chest tightness, and coughing. (2-3) As asthma cannot be 
cured, disease management strategies aim to optimize clinical presentation, 
minimize exacerbations and diminish the burden on patients, families and 
health care systems. (3, 6) 
The chapters included in this thesis address the discrepancy between 
treatment goals of patients and their health care providers as an important 
factor of ineffective asthma management strategies. Taking the child’s and 
families perception into account, could result in more effective treatment, 
possibly leading to lower health care costs. In the current project, integrating 
the child’s perspective was achieved in two ways: (a) by the Pelican 
instrument, an e-health application that enabled children to select individual 
asthma-related aspects bothering them mostly in daily life and (b) by actively 
involving children and parents in decision making during self management 
support, leading to an individualised written action plan. 
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This thesis contains: a general introduction, a validation study of the 
Pelican instrument, a primary and a specialised care study to assess the 
effectiveness of a patient-centred care (PCC) programme based on the Pelican 
instrument with the objective to improve health-related quality of life (HRQL) 
in children with asthma and an evaluation of the process of care during those 
studies. 
 
 
MAIN INTERPRETATIONS AND CONCLUSIONS 
 
In Chapter 2, we assessed the validity and reliability of the Pelican instrument, 
a self-administered HRQL instrument for children with asthma aged 6 to 11 
years old in the Netherlands. Factor analysis resulted in a questionnaire with 
21 items, five domains (Triggers, Symptoms, Activity limitations, Asthma 
management and Social/emotional impact) and a good Internal Consistency. 
We concluded that the instrument was sufficiently valid and reliable to allow 
implementation of the instrument in clinical practice.  
Chapter 3 presents the study protocol of two randomised controlled 
trials to assess the effectiveness of a PCC support programme on improving 
HRQL in children with asthma treated in primary and specialised care. The 
nurse-led PCC is a six-step complex self management support intervention 
with the child’s outcome on the Pelican instrument as a starting point:  
1. Choose a problem from the child’s Top 3-selection in the Pelican 
instrument; 
2. Exploration of this problem; 
3. Formulating treatment goals; 
4. Proposing and voting for solutions to achieve the set treatment  
goal; 
5. Design a personal written action plan; 
6. Evaluate the effectiveness of this plan during the next visit. 
Communication in this intervention was based on principles of shared 
decision making and motivational interviewing. (7-10) Moreover, 
professional expertise in individualised and asthma-specific care of the 
involved nurse is required.  
Chapter 4 shows the results of a cluster-randomised controlled trial to 
assess PCC in family practices in the Netherlands. Due to recruitment 
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problems, this underpowered study (which should be considered a pilot 
study) did not provide sufficient evidence to conclude that the evaluated PCC 
programme is effective in improving HRQL in children with asthma. Further 
research into the effectiveness of individualised self management in primary 
care is needed but it is questionable whether current preconditions are 
favourable for programmes that are in line with set national guidelines of the 
Lung Alliance in the Netherlands, such as evaluated in this chapter.  
Chapter 5 presents the results of a study that looked at the 
effectiveness of the same PCC intervention in a population of children with 
asthma treated in specialised care. One out of two children in the PCC group 
experienced a clinical relevant improvement on HRQL, compared to one out 
of four children in the usual care group. PCC based on the Pelican instrument 
seems to improve HRQL, although not confirmed with statistical significance 
after correction for confounders (p=0.06). Secondary outcomes such as 
asthma control, lung function, psychosocial problems, HRQL of the caregiver 
improved as well, however, only lung function (FEV% predicted prior to 
bronchodilator) showed a statistically significant difference in improvement 
in favour of the PCC group. 
Finally, chapter 6 describes the possibilities and bottlenecks of the 
implementation of PCC in primary and specialised health care. We concluded 
that the evaluated PCC programme is currently not feasible in primary care. 
However, the programme shows potential in specialised care, and can be 
recommended for use in this setting. During the study all phases of PCC were 
generally well implemented, but despite training, there still seems to be room 
for improvement with regard to patient-centredness and ‘SMART’ goal setting 
by nurses.  
 
 
 
 
Page| 142 
INFLUENCE OF HEALTH CARE SETTING 
 
As described in Chapter 4, we experienced considerable recruitment 
problems of available and willing family practices and patients. There are 
several considerations on why recruitment for the primary care study was 
difficult. First of all, we approached family practitioner care networks to 
explore whether our research project was in scope with their vision and 
goals. In most cases, these care networks mentioned that asthma care for 
children and adolescents was not a care priority and that they were focussing 
on implementation of structured disease management programmes for adult 
patients with chronic illnesses such as diabetes, COPD and/or cardiovascular 
risks. Implementing asthma guidelines for adults (and children) was planned 
for future years. Even when a care network was willing to invite member 
practices to participate in our study, we received a lot of rejections from 
practices for reasons such as ‘lack of time’, ‘too few children with asthma 
(ICPC code R96) in the medical record system’, ‘participating in other 
research projects’ and ‘not interested’. Participating in a RCT and in a self 
management support programme, requires a substantial time investment of 
practices. (11-13) In our case, this resulted in an increased number of patient 
visits, and additionally demanded sufficient training and time of the nurse. In 
the Netherlands, nurses play an increasing important role in health care for 
chronic patients, however, usually not yet in paediatric patients. Therefore, 
we assumed that only nurses who have affinity with the patient population 
(i.e. children with asthma) and confidence in the intervention were likely to 
participate in our study. Our choice to make practice nurses responsible for 
the execution of the intervention was made with the anticipated nurse 
involvement in paediatric asthma care in primary care (as is already the case 
in specialised care) in the near future. (14) Practices made a list of patients 
from 6 until 11 years old that were diagnosed with asthma and used asthma 
medication in the previous year. Quite often, it turned out that there were too 
few children (n<18) compared to the time investment that is required from 
practices. Even when children were invited after all, the main reasons for 
parents to reject participation were ‘disagreement with asthma diagnosis’ or 
‘no asthma symptoms’. Based on these findings, our research group 
performed a study towards the diagnosis of children treated in primary care 
(results of this study are soon to appear in the August 2015 edition of the 
Dutch journal of Family Practitioner & Science; Huisarts & Wetenschap). 
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The experienced recruitment problems in combination with quite 
good baseline scores of HRQL and asthma control (although still with some 
room for improvement), might indicate that children with asthma under 
treatment of a family practitioner have a mild asthma profile with few 
complaints. It should be discussed whether it is desirable to perform frequent 
assessment and visits in patients with stable mild to moderate asthma. There 
might not even be a need for PCC among this group of patients.  
 
In specialised health care, on the other hand, recruitment was 
successful and paediatricians, nurses and families were interested in an 
interactive support programme that takes the child’s perspective in 
consideration in asthma management. Furthermore, an asthma visit every 
three months was more common in specialised care, making less of a 
difference in time investment for participating care providers and families. 
Children that were recruited for the study in Dutch paediatric outpatient 
clinics showed more room for improvement on several outcomes at baseline 
than children in primary care. Additionally, a notable proportion of children 
showed clinical relevant improvement on HRQL after nine months in favour 
of the PCC group compared to usual care (although not statistically 
significant). Implementation of PCC by specialised nurses during the current 
study was performed according to prescribed guidelines in the study 
protocol, however, patient-centredness and SMARTness of treatment goals 
still showed room for improvement. 
 
In the past, results from specialised care studies have often been 
extrapolated into primary care, and vice versa. (15, 16) Knowing that several 
important differences exist between these care settings, it is likely that this 
might lead to ineffective, unnecessary or expensive health care without the 
desired health improvements. (17-19) Examples of what can be expected to 
be different between primary and specialised health care settings are 
organisational, financial and cultural aspects. Furthermore, due to the 
gatekeeper function of family practitioners in the Netherlands, it is expected 
that patients treated in primary care have, on average, a less complex or 
severe clinical presentations of chronic illnesses (such as asthma) than 
patients treated in specialised health care. The strength of the studies 
reported in this thesis is the fact that effectiveness of the same intervention 
was assessed in different health care settings with almost identical research 
 
 
Page| 144 
designs (Chapter 4 and 5). This would allow us to compare results for both 
primary are and specialised care and draw separate conclusions. 
Unfortunately, we were unable to compare the results of both studies since 
the study in primary care was underpowered, and did not lead to firm 
conclusions on effectiveness. The current project shows the importance of 
taking health care setting and individual severity and complexity of disease in 
consideration when implementing new health interventions. A difference in 
need, acceptability and preconditions, for paediatric asthma-related PCC 
programmes between primary and specialised health care was found. This 
difference should be taken into account when formulating implications for 
future research and clinical practice. 
 
 
THE USE OF HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS 
IN RESEARCH AND CLINICAL PRACTICE 
 
The primary outcome of the Pelican effectiveness studies in primary and 
specialised care was HRQL. Although the use of quality of life as a patient-
reported outcome has become widespread in the last two decades, there is no 
consensus on a universally accepted definition of the concept. The precise 
interpretation of quality of life is subject to philosophical, ethical and social-
cultural discussions. Should it be considered from a subjective perspective in 
which the meaning of this concept is dependent on the judgment of the 
individual subject? Or should quality of life be considered from a more 
objective perspective in which the meaning is defined by objective factors 
(e.g. predetermined items and domains)? (20-22) Obviously, the perspective 
chosen on this concept has consequences for the measurement methods used 
for quality of life. An example of an instrument based on the subjective 
approach is the Schedule for the Evaluation of Individual Quality of Life 
(SEIQoL). (23) This is a semi-structured interview-based instrument to assess 
quality of life of the individual in healthy or ill adults. First, individuals choose 
the areas of their lives that they consider being of the greatest importance. 
Then, they quantify the extent to which reality matches expectation in the 
areas. Lastly, individuals assess the relative importance of their chosen areas. 
Individuals require cognitive capacities such as a good attention span 
(completion takes 10-20 minutes), insight into factors which determine one’s 
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quality of life, the ability to think abstractly and the ability to make judgments 
based on information presented in diagrammatic form, to complete the 
SEIQoL instrument reliably. Whether children have enough cognitive 
capacities to complete such instruments is unknown and requires further 
investigation. An example of an instrument developed from the objective 
approach of quality of life for children with asthma, is the Paediatric Asthma 
Quality of Life Questionnaire with standardised activities (PAQLQ-s; primary 
outcome measure in the Pelican project). (24) This is a self-administered 
questionnaire that exists of 23 questions that have been assigned an equal 
weight and allows calculation of domain scores (symptoms, activity 
limitations and emotional functioning) and a total score. The time frame of 
the PAQLQ-s is one week. 
 
Whether instruments are based on a subjective or objective approach 
of quality of life, should be seen on a gradual scale. It is an interesting 
question whether HRQL in the Pelican instrument is approached from a 
subjective or objective perspective. The Pelican instrument is somewhere in 
between those two perspectives. The standardised part of 21 questions is 
based on an objective perspective of quality of life with a fixed number of 
domains and equal weight acknowledged to different domains. Based on this 
part of the instrument, domain and total scores can be calculated. The 
individual part of the Pelican instrument includes a personal Top 3 (+ an 
individual item) of the child and represents a subjective perspective of quality 
of life. Although weight is not taken into account in domain and total scores, 
the Top 3 items are given more clinical weight. The individual outcome 
represents specific asthma-related aspects that bother the child most and can 
be used as a starting point for patient-centred care. In general, this implies 
that children with the same total and domain scores on the Pelican 
instrument could have selected a completely different Top 3 in the 
individualised part. 
 
Although there is still debate about whether to use an objective or 
subjective approach of quality of life, it seems appropriate to use an objective 
approach for HRQL when applying it in research (to compare effectiveness for 
different interventions) and a subjective approach for use in clinical practice. 
Therefore, we conclude in agreement with the results in Chapter 2, 4 & 5, that 
the individual part of the Pelican instrument can be considered appropriate 
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for use in clinical practice. Whether the Pelican instrument is useful for 
research implications still needs to be investigated (e.g. responsiveness to 
change). Currently, the most appropriate instruments to assess HRQL in 
children and adolescents with asthma in medical research seem to be the self-
administered Pediatric Quality of Life Inventory (PedsQL; 25-29) and PAQLQ-
s (24, 30). Although there are some disadvantages to those questionnaires, as 
described in Chapter 2, psychometric properties of both instruments are 
good. 
 
 
THE USE OF ASTHMA CONTROL OUTCOME MEASURES IN 
RESEARCH AND CLINICAL PRACTICE 
 
Asthma control is one of the secondary outcomes used in the Pelican project 
and achieving well-controlled asthma is the main treatment goals according 
to GINA guidelines. To assess asthma control several measures are available 
and customary in current clinical practice. Physiological substitute measures 
for asthma control are various lung function parameters (Forced Expiratory 
Volume in 1 second (FEV), Forced Vital Capacity (FVC), percentage of 
predicted FEV1 and reversibility of obstruction) and Fraction of exhaled 
Nitric Oxide (FeNO) to assess airway inflammation. Even young children (>4 
years) are capable of producing reliable results on these measurements when 
applied by well-trained personnel. (31, 32) Subjective measures of asthma 
control are the Asthma Control Questionnaire (ACQ) and the partially self-
administered Child-Asthma Control Test (C-ACT). (33-36) The ACQ consists of 
6 questions and a seventh item that expresses FEV1 as % predicted. The 
questionnaire assesses asthma control over one week. There are two 
validated versions; one version for children aged 6-10 years old that are 
helped with responding by a parent or guardian and one self-administered 
version for adolescents aged 11-17 years old. (33) The 7-item ACQ with lung 
function indices FEV1% of predicted normal does not seem to correlate well 
with asthma control as defined by GINA guidelines. (37) The parent-
administered shortened version with 6-items (ACQ6), as used in the Pelican 
studies, has not yet been validated appropriately which can be considered as 
a methodological limitation of the current study. (38) The C-ACT, also used in 
the Pelican project, is a seven-item questionnaire which is designed and 
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validated for children from 4–11 yrs of age. Four items are answered by 
children through visually supported answer categories (no specific time-
frame was set). The other three items are answered by parents and addresses 
the previous 4 weeks. C-ACT correlates well with GINA criteria in predicting 
uncontrolled asthma, but commonly used cut-off points (e.g. 19) for C-ACT 
seem to underestimate the proportion of children with uncontrolled asthma 
as defined by GINA. (39) Currently, the C-ACT appears to be useful for both 
research and clinical purposes. The advantage of this questionnaire is that the 
instrument is partly completed by children themselves and is therefore 
preferred as a screening tool in PCC.  
 
 
PSYCHOSOCIAL AND PSYCHIATRIC FACTORS IN CHILDHOOD 
ASTHMA 
 
Previous research has indicated that psychosocial and psychiatric factors are 
not uncommon in chronic illnesses (such as asthma) and could have a major 
impact on many other aspects of treatment and health outcomes, such as 
quality of life. (40-45) In general, quality of life of patients with psychiatric 
disorders is worse than in healthy individuals and similar, or even lower, than 
in patient with chronic physical conditions. (46-50) Although a biological 
pathway of stress is suggested through the effect of cortisol on asthma and 
asthma development, this was not confirmed by a recent Dutch study (51). A 
behavioural pathway would be very likely as well. Earlier studies, for 
example, have shown that asthmatic children or caregivers with psychosocial 
problems experience more difficulties in general and specifically in asthma 
management and therapy adherence, which contributes to an undesirable 
course of HRQL and asthma of the child over time. (52-55) Also, absence from 
school due to asthma has been associated with problems in educational 
achievements and social skills (e.g. social isolation, low self-esteem, 
depression). Especially female asthma patients, patients from ethnic minority 
groups and low income families are likely to have poorer asthma control and 
more psychosocial problems. (56) 
Previous studies show inconsistent results on whether children with 
asthma have generally more psychosocial problems than healthy peers. 
Although our study (Chapter 5) found less clear associations, two studies in 
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Belgium and the Netherlands have shown that such problems occur quite 
often in this patient population. (56, 57) The Belgium study reported 
significantly more internalizing problem behaviours in children with asthma 
(aged 6-18, mean age 11.4) compared to healthy children according to 
parent-completed Child Behaviour Check Lists (CBCL). The Dutch study in 
specialised care by Tibosch et al. (2010) found that parents reported a 
moderate to high prevalence of minor or major psychosocial problems; 42.5% 
of children aged 6-10 years (n=77 out of 181; minor 14.9%, major 27.6%) and 
39.7% in adolescents aged 11-16 years (n=60 out of 151; minor 13.9%, major 
25.8%) using the Strengths and Difficulties Questionnaire (SDQ). (56) In the 
Pelican study, prevalence of psychosocial problems in children with asthma 
aged between 6 and 11 years was 20.7% (n=6 out of 29; minor 7.5%, major 
13.8%) in primary care and 31.7% (n=29 out of 91; minor 12.1%, major 
19.8%) in specialised care as reported by a parent-completed SDQ. 
 
Besides psychosocial problems, it is not uncommon that children with 
asthma have psychiatric comorbidity as well. One of the most common 
psychiatric disorders in childhood is attention deficit and hyperactivity 
disorder (ADHD). It is suggested that children who are diagnosed with 
asthma and ADHD, have a threatened course of both conditions. (50) While 
ADHD is thought to be associated with difficulties in patient-physician 
communication and therapy adherence, the nature of asthma and its 
medications are suggested to increase the frequency of ADHD symptoms. 
Studies that have attempted to examine these mechanisms are still 
inconclusive. (58-60) In general, quality of life of children with ADHD is lower 
than in children with asthma. (61) Comorbid conditions, such as ADHD, that 
influence quality of life significantly more than asthma usually gain priority in 
treatment of patients. (62) Mutual influences of comorbid conditions need to 
be taken into account. In the Pelican study, parents of 3.5% (n=1 out of 29) of 
children with asthma treated in primary care and 6.5% (n=6 out of 93) of 
children treated in specialised care reported comorbidity of ADHD. During 
evaluation and monitoring of the Patient-Centred Care programme, nurses 
anecdotally mentioned that ADHD in children did lead to some 
communicative difficulties during consultation. Children with ADHD showed 
less active participation during communication and were more easily 
distracted. According to nurses, children seemed to struggle with their ability 
to overview their problems in daily life and to think of concrete aspects that 
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could help them to solve these problems. Of course, these are important 
aspects of the evaluated six-step PCC programme in which children’s own 
goals and ideas are involved in a written action plan. Whether ADHD 
comorbidity significantly interferes with PCC, could not be examined in this 
study due to small subgroups and therefore requires systematical 
investigation with qualitative and/or quantitative research. 
 
In conclusion, it might be relevant to assess psychosocial problems in 
children from ethnic minority groups, low income families and with 
psychiatric comorbidity. Although it was not confirmed by our own study 
(Chapter 5), interference of these problems with disease management need to 
be taken into account when treating individual patients. A previous study by 
Kazak et al. (2011) showed that a psychosocial screening tool was feasible in 
health care for children with cancer. Moreover, use of such a tool was 
associated with increased documentation of psychosocial risks in patient 
record systems. (63) Although quality of life is the most commonly used 
patient-reported outcome and includes mental well-being, a previous study 
showed that HRQL instruments are not always able to sufficiently identify 
children with major psychosocial problems. (57) In 15.9% of caregivers (of 
children with asthma) with optimal HRQL, parents reported major 
psychosocial problems. Therefore, other instruments should be used for 
monitoring psychosocial problems in clinical practice. Frequently used 
measurements on psychosocial and psychiatric problems in research and 
clinical care are the Strengths and Difficulties Questionnaire (SDQ) and the 
Child Behavior Checklist (CBCL). (64-68) The SDQ that was also used in the 
Pelican project, has a parent-reported version for children aged 2-17 years 
and a self-administered version for adolescents aged 11-17 years. This 
questionnaire consists of 25 items with five subscales and does not indicate a 
time frame. The CBCL consists of two versions, one for children aged 1.5-5 
years and one for children and adults from 6 to 18 years old. The questions 
concern internalizing and externalizing psychiatric problems with six-month 
time frame. Psychometric properties of both instruments are comparably 
good. Since SDQ measures psychosocial strengths and difficulties in a non-
psychiatric population, the use of this questionnaire in childhood asthma care 
seems most obvious. How results of this instrument should be interpreted 
and used in asthma management for individual patients, needs more 
exploration. (69) 
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IMPLEMTATION OF PATIENT-REPORTED OUTCOME MEASURES IN 
CHILDHOOD ASTHMA CARE 
 
Using patient-reported outcome measures (PROMs) for health assessment has 
gained importance in health care. Factors contributing to this development 
are governments and third party payers who are increasingly asking for 
evidence of treatment effectiveness. In addition, self-monitoring is essential if 
patients are involved in disease management. Regarding the work field of 
PROMs, there is ongoing debate on how to interpret and implement the 
individual outcomes. In this section, I will highlight and discuss these issues. 
 
Since the use of PROMs as evaluative and monitoring tools seems to 
be desirable, more research should be done towards the applicability of such 
instruments in daily practice. A recent systematic review by Worth and 
colleagues (2014) identified asthma-related PROMs that offer the greatest 
potential for use in clinical settings. However, further work is needed to 
assess whether these are fit-for-purpose for use in clinical practice with 
individual patients and to ensure that these are validated for use in clinical 
settings, acceptable to patients, caregivers and clinicians, and yield 
meaningful outcomes. (70) To our knowledge, the Pelican study is the first 
project that developed an individual HRQL measure for children with asthma 
with the specific purpose to apply the results in patient-centred care. 
There is a need for clear guidelines that help care providers to choose 
PROMs that are valid, reliable and relevant. It is not desirable to ask patients 
or caregivers to fill out a large battery of questionnaires. Therefore, it is 
important to explore the utility of health outcomes to physicians in terms of 
information and the relevance to patients. In addition, since many 
questionnaires show overlap in items (e.g. the Pelican instrument and Child 
Asthma Control Test (C-ACT) both include items on asthma symptoms), 
research should focus on developing screening tools in which overlap is 
avoided. One example of such a tool developed for patients with severe 
Chronic Obstructive Pulmonary Disease (COPD), is the Nijmegen Clinical 
Screening Instrument (NCSI). Through this concise survey the entire health 
status (e.g. anxiety, depression, lung function, exacerbation, quality of life) of 
adults with COPD are measured. (71) Another example is the world-wide 
growing Patient-Reported Outcomes Measurements Information System 
(PROMIS) initiative of the National Institutes of Health (NIH) that generates 
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item banks (using Item Response Theory methodology) for patients with 
chronic illnesses that enable computerised adaptive testing (CAT) tools for 
tailored individual assessment. (72, 73) Item banks usually contain 
information on physical, mental and social health and consist of main items 
and additional items. When developing such a tool for childhood asthma, 
interesting outcomes to be considered are medication use and adverse effects 
from medicines, exposure to relevant triggers, asthma control (measured by 
the C-ACT), exacerbations, HRQL (measured by the Pelican instrument), 
physical condition, school/work absence and co-morbidity (e.g. allergies, 
allergic rhinitis, eczema, obesity and psychiatric disorders). When indicated 
for individual patients, psychosocial outcome measures (SDQ) can be 
included into the screening tool. The relevance of these health outcomes is in 
accordance with the recent guidelines for asthma care for children and 
adolescents from Lung Alliance in the Netherlands. (74) Involving all 
stakeholders in developing such tools and in questionnaire selection is, 
however, crucial for feasibility and success of implementation. They can give 
feedback on content, saturation and clarity of items. (75-76)  
 
If a particular PROM has been proven to be feasible as evaluative and 
monitoring tools in clinical practice, it needs clarification on the methods and 
frequency of monitoring patients. It is expected that feasibility of screening 
tools is improved when instruments are web based. Advantages of online 
screenings tools for health care providers are that sending questionnaires 
and reminders can be done largely automatically. It is easy to set the 
frequency of monitoring and to adapt the selection of instruments of interest. 
Benefits for patients are that they can complete questionnaires at home, 
which reduces pressure and socially desirable responding. Outcome scores 
are automatically calculated and can be visualised in graphs. In addition, 
results can be uploaded in the electronic medical record system for health 
care providers and in an online patient profile. The earlier mentioned NCSI 
tool is an example of a computerised system in which the patient’s results are 
visible in a Patient Profile Card. Positive experiences have been found and 
both lung nurses and pulmonologists were able to motivate patients more to 
change their behaviour with the aid of this tool. (77, 78) A disadvantage of 
online tools is that the health care provider can never be sure that 
instruments will be completed and whether the patient or someone else has 
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answered the questions. It is, however, expected that the advantages 
outweigh these points both in costs and feasibility.  
With regard to the frequency of monitoring health outcomes in a 
chronic disease such as asthma, it is expected that some outcomes are more 
likely to fluctuate in a period of time than others. While asthma symptom 
levels can change weekly or even daily, effects of asthma treatment on HRQL 
are more likely to become visible on the long term. Therefore, it is 
undesirable to perform screening of all outcomes at the same frequency. In 
the two trials reported in Chapter 4 and 5, we choose to monitor HRQL 
(measured by the Pelican instrument) once every three months according to 
the optimised asthma care guidelines for paediatricians (79). However, it is 
unclear whether it is necessary to monitor patients with well-controlled 
asthma equally frequent as patients with uncontrolled asthma. Therefore, 
more research should be done to the optimal frequency of monitoring. From a 
clinical point of view, it would be likely that in patients with mild to moderate 
asthma, one screening moments per year will do. This is in agreement with 
the current Dutch guideline for paediatric asthma care (74). On the other 
hand, patients with intermittent to severe asthma may require more 
screening moments, based on individual needs. A minimum of once per 
season seems likely be advised since clinical presentation of asthma 
symptoms often varies over seasons. (80) 
 
The last issue concerning the use of PROMs, is the method of 
implementation during consultation visits. Previous studies and reviews 
showed that PROMs can serve as the link between the health care provider 
and patient to foster collaborative and personalised medicine. This improves 
quality of care, promotes greater patient responsibility, facilitates 
communication with providers, encourages shared decision-making, and 
enhances adherence. (81-85) Further research has to provide more insight 
into methods from which both patients and health care providers benefit 
most of using PROMs. Especially in case of paediatric patients, methods of 
implementation are complex due to developmental factors and the 
involvement of parents as a co-responsible party. Therefore, it should be 
discussed whether health care providers should implement PROMs according 
to an established protocol or whether they should be given the freedom to 
implement PROMs according own interpretation. In the Pelican project, we 
have trained the participating nurses especially in shared decision making 
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according to a six-step model during a two-hour meeting before the start of 
the study and during five evaluation moments. Most nurses already had some 
experience with shared decision making, while others had some difficulties 
with giving patients and parents more responsibility over asthma 
management. 
 
 
FUTURE IMPLICATIONS FOR PRACTICE AND RESEARCH 
 
I believe that the intervention of the Pelican project is in line with the recent 
guideline for paediatric asthma care of the Lung Alliance in the Netherlands 
(LAN). (74) The LAN advices health care providers to regularly monitor 
asthma patients, use an individual action plan, educate the patient and 
stimulate self management of symptoms and exacerbations. Although the 
studies described in Chapter 4 and Chapter 5 were unable to show significant 
(adjusted) effectiveness of PCC on health-related quality of life in primary 
school aged children with asthma treated in primary and specialised care in 
the Netherlands, this section contains nuanced advice for practice 
implications. With regard to practice implications of PCC in primary care, I 
advise that implementation of such a programme should not be executed 
under the current conditions. This advice is based on the experienced 
problems in recruitment and the assumption that this might be caused by 
other care priorities of practices and patients. Nonetheless, increasing the 
number of scheduled visits, instead of exacerbation-induced care, might 
improve health outcomes, as was seen in the usual care group of our study 
(Chapter 4). In addition, the Pelican instrument can still be used as a 
screening tool in primary care without implementation of the entire six-step 
PCC intervention.  
In case there is a transition of patients from specialised to primary 
health care in the future (as is already seen for many other groups of patients 
with chronic diseases in the Netherlands, for example in mental health care 
for children and adolescents (86)), implementation of PCC as studied in this 
manuscript, could be beneficial. In these circumstances, future research 
towards PCC is recommended. 
For specialised care, on the other hand, implementation of PCC is 
recommended and currently in progress. Although the results reported in 
Chapter 5 did not show statistical significance for HRQL and some of the 
 
 
Page| 154 
secondary outcomes after adjustment for confounders, still a relevant 
proportion of patients showed a clinically important improvement in favour 
of PCC. In addition, lung function showed significant improvement in PCC 
compared to usual care as well. Preconditions and usability (Chapter 6) for 
the evaluated PCC programme show potential for paediatric outpatient clinics 
in the Netherlands, although there is still room for improvement in patient-
centredness regarding problem selection and goal setting. With regard to 
implementation of PCC in children with comorbid ADHD, the Pelican study 
could not draw firm conclusions. 
 
Future studies using the Pelican instrument and intervention are on the 
agenda. In the first place, responsiveness to change of an instrument is an 
important part of the validation process and is required to make statements 
concerning clinical important changes of patients. At this point, 
responsiveness of the Pelican instrument (in terms of clinical improvement as 
well as worsening) is not yet established and is, therefore, one of the next 
objectives for research. With regard to cost-effectiveness, further 
investigation will be needed in specialised care, as well as real life studies 
with large numbers of subjects to confirm the effectiveness of PCC on HRQL 
(Chapter 5).  
It should be mentioned that the Pelican instrument has two versions, 
one with and one without a story-line, and that these version were not 
validated separately. Although, the questions and responses were equal in 
both versions and it is not expected that the story-line would influence the 
validity and reliability of the questionnaire, further validation of both 
versions is recommended. Validation of instruments and proving 
effectiveness of interventions, is a continuous process. This is why it would be 
advisable to pursue investigation in similar and different populations, for 
instance in different age groups, other cultures/countries and specific patient 
groups such as patients from ethnic minority groups or patients with 
comorbid conditions (ADHD or otherwise). When using the Pelican 
instrument in such studies, we suggest to perform administration under 
controlled conditions, as we have done during the validation process. Only 
under controlled conditions, one can be sure that the questionnaire was filled 
out by no one else but the study participant and thus warrant reliable 
responses (instead of randomly selected answers). And finally, if more studies 
confirm the results of effective and feasible implementation of individualised 
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instruments, such as the Pelican instrument, it would be interesting for future 
research whether it could be applied to other chronic childhood conditions as 
well, such as constipation or diabetes. However, early engagement of 
stakeholders (patients and professionals) in the development and execution 
of such research, could prevent unnecessary scientific and medical initiatives 
and save costs. (87-91) 
 
 
CONCLUDING REMARKS 
  
In conclusion, the psychometric properties of the Pelican instrument were 
acceptable in Dutch paediatric asthma patients from 6 to 11 years old. 
Therefore, the Pelican instrument can be considered a valid and reliable 
instrument. Validation of instruments is a continuous process and is 
recommended to be continued. Any relevant alteration to questions or 
responses as well as different versions of questionnaires, need to be 
evaluated. Before the Pelican instrument can be used in other countries, 
cultures or patient populations, psychometric properties need to be 
determined again, in the given context.  
 Implementation of PCC based on the validated Pelican instrument 
could not be assessed for effectiveness on HRQL of children with asthma 
treated in family practices due to recruitment problems. At this point, 
conditions do not appear to be favourable for implementation of PCC 
programmes such as investigated in the current study. In specialised care, a 
relevant proportion of children in the intervention group showed clinical 
improvement compared to usual care in specialised care after 9 months, 
although no firm conclusions on the effectiveness of the studied patient-
centred care programme could be drawn. In addition, this PCC programme 
shows potential to be an acceptable and feasible for nurses and parents of 
children treated in specialised care. However, training and attitudes of nurses 
need to continue in patient-centredness and formulation of treatment goals 
according SMART principles shows room for improvement as well.  
Future studies towards the responsiveness of the Pelican instrument, 
long-term real-life effectiveness, effectiveness of PCC in specific patient 
groups (e.g. childhood asthma with comorbidity such as ADHD), as well as a 
cost-effectiveness need to be carried out in specialised care.  
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Summary 
 
This thesis describes the importance of including children’s own treatment 
goals in paediatric asthma care. Children’s goals are measured by a health-
related quality of life questionnaire, called the Pelican instrument. This self-
administered online instrument allows children to select concrete asthma 
problems that children face in day-to-day life. Implementation of this 
instrument in clinical practice was performed according a six-step 
programme of patient-centred care based on self management principles. 
This six-step programme is guided by a nurse and includes investigation of 
the child’s selection of problems in the Pelican instrument, choosing one or 
two problems to work with during hospital visit, brainstorm on solutions for 
these problems, design a written action plan en evaluate the results of this 
action plan and, if necessary, repeat this programme. 
 
Chapter 1 introduces the background and main objectives of this 
thesis. The current prevalence of paediatric asthma and uncontrolled asthma 
symptoms cast a heavy burden on patients, families and the health care 
system. One of the main reasons for uncontrolled asthma is non-adherence to 
treatment. It is expected that including the individual goals of patient 
increases adherence. Consequently, there is a need for asthma management 
that is continuously tailored to the individual child’s needs at any moment in 
the disease progress. Interventions that improve self management of patients 
seem to show promising results and are advised in asthma management 
guidelines. 
 
This thesis addresses the following objectives: 
 Present information on the validation of the Pelican instrument in 6-
11 year old children with asthma in the Netherlands  
 Report on the effects of applying the Pelican instrument by means of a 
patient-centred care programme in primary and specialised health 
care in the Netherlands 
 Explore the possibilities and bottlenecks of a patient-centred 
intervention based on the Pelican instrument 
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 Discuss whether and, if so, how the Pelican instrument should be 
implemented in daily medical care of childhood asthma 
 
Chapter 2 describes the validation of the Pelican instrument. The 
Pelican instrument is an online asthma-specific Health-related Quality of Life 
(HRQL) instrument for children, that could be used for research purposes 
(standardised part) to compare effectiveness of treatments and for clinical 
purpose in daily health care (individual Top 3). The study described in 
Chapter 2 was performed in a population of Dutch children from 6 until 11 
years old with the objective to assess the psychometric properties of this 
instrument according the Classical Test Theory. After factor analysis, a 
theoretical model of the standardised part of the Pelican instrument was set 
with 5 domains (Activities, Symptoms, Triggers, Asthma management and 
Social/emotional impact) and 21 questions/items (e.g. How do you feel about 
not being allowed to keep or caress pets/animals?) that are answered on a 5-
point Likert scale ranging from score 1 ‘not bad at all’ to score 5 ‘very bad’. 
Internal consistency was good (Cronbach’s α 0.89, 95%-Confidence Interval 
CI 0.85-0.92), although consistency for the domains ‘Social and emotional 
aspects’ and ‘Triggers’ was lower but still acceptable (ranging from 0.64-0.76, 
p<0.05). Test-retest-reliability of the Pelican instrument in children with 
steady asthma control was good (InterClassCorrelation ICC=0.88, 95%-CI 
0.79-0.93, p<0.01). Convergent and divergent validity of the Pelican 
instrument was generally in concordance with our set of a priori hypotheses. 
We observed a negative moderate correlation between the Pelican score and 
the Paediateric Asthma Quality of Life Questionnaire (PAQLQ) (r=-0.59, 
p<0.01). The Pelican instrument and PAQLQ have reversed scales, which 
explain the minus sign. Therefore, we concluded that cross-sectional 
construct validity of the Pelican instrument was moderate to good. 
Furthermore, the instrument was able to discriminate between children with 
controlled or uncontrolled asthma (t=3.20, p<0.01; ∆ 0.64 Pelican score) and 
between children with or without asthma (t=6.31, p<0.01; ∆ 0.94 Pelican 
score). The validity of the individualised part was investigated and appeared 
to be good as well. Items selected by children in the personal Top 3, scored 
0.95 points (SD 0.95) higher in the questionnaire than unselected items. In 
general, the Pelican instrument showed acceptable reliability and validity in 
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Dutch primary school-aged children with asthma, but its responsiveness to 
changes in asthma-related health status still needs to be established. 
Evaluation of HRQL instruments is a continuous endeavor requiring studies 
in diverse clinical populations. These results justified further studies to 
evaluate the effectiveness of implementation of the Pelican instrument in 
primary and specialised care settings in order to support patient-centred 
paediatric asthma care.  
 
Chapter 3 continues with a protocol for a follow-up study after the 
Pelican instrument appears to be a valid and reliable HRQL outcome measure 
in a Dutch population of primary school aged children with asthma (as 
presented in Chapter 2). The protocol suggests two Randomised Controlled 
Trials (RCT) towards the effectiveness of implementation of the Pelican 
instrument in clinical practice. One RCT will be performed in primary care 
and one in outpatient clinics in the Netherlands and both trials have similar 
designs with the objective to obtain comparability. The study in primary care 
is a multilevel design with 170 children with asthma in 16 family practices. 
All children in one family practice are allocated to the same treatment group. 
The study in specialised care is a multicentre trial with 100 children with 
asthma. Children in one outpatient clinic are randomly allocated to the 
intervention or usual care group. In both studies, children will visit the care 
provider four times during a follow-up of nine months. The intervention is a 
nurse-guided patient-centred care (PCC) programme with the aim to improve 
HRQL. The programme is a six-step process leading towards a written action 
plan through shared decision making. This study is registered and ethically 
approved.  
It is considered a strong characteristic of this study that the Pelican 
individualised self management support programme in investigated in 
different health care setting. In daily practice, it is often seen that results of 
intervention studies are extrapolated to other health care settings than 
originally investigated. Because of differences in organization, disease 
severity, patient characteristics and care provision between health care 
settings, extrapolating research results could lead to unnecessary health costs 
without the desired health care achievements.  
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Chapter 4 presents a cluster-RCT in a Dutch population of 33 children 
in nine family practices with the objective to assess effectiveness of a nurse-
guided PCC programme (based on the child’s outcome on the Pelican 
instrument) in improving HRQL. The primary hypothesis was that 
supplementary PCC would be able to significantly improve HRQL (measured 
by the Paediatric Asthma Quality of Life Questionnaire with standardised 
activities, PAQLQ-s; ≥0.5 points) in 25% of children with asthma compared to 
enhanced usual care (EUC) alone. Family practices, rather than individual 
subjects, were allocated to the treatment groups. All children within one 
practice received the same treatment (EUC+PCC n=15; EUC alone n=14). At 
baseline, both treatment groups showed high PAQLQ-s score and favourable 
results on secondary outcomes (such as asthma control) as well, leaving little 
room for improvement. Nonetheless, in both groups a substantial proportion 
showed a clinically relevant change on HRQL after 9 months (EUC+PCC 33% 
and EUC 57%, respectively). Logistic regression analyses of 29 participants 
(mean age 8.6 with SD 1.7; 18 boys) did not show differences on either the 
primary (Odds Ratio OR 0.38, 95%CI 0.08, 1.69) or the secondary outcomes 
with exception of PAQLQ-s symptoms domain score in favour of EUC (OR 
0.20, 95%CI 0.04-0.97), which is likely to be an incidental finding. 
Unfortunately this study was underpowered due to considerable recruitment 
problems and should therefore be considered a pilot study. We could not 
provide sufficient evidence to conclude that the studied PCC programme is 
effective in improving HRQL in paediatric asthma patients treated in Dutch 
primary care. Further research into the effectiveness of individualised self 
management in primary care is needed, however, it is questionable whether 
current preconditions in the Dutch primary care system are favourable for a 
PCC programme such as evaluated in this study. 
 
Chapter 5 in this thesis reports on the results of a RCT in a Dutch 
population of children with asthma treated in specialised health care. The 
objective and hypothesis of this study were equal to the primary care trial. 
Subjects were paediatric asthma patients from 5 Dutch hospitals (EUC+PCC 
n=42; EUC alone n=51). In both groups, a substantial proportion showed ≥0.5 
points improvement in PAQLQ-s scores (EUC+PCC 52.4% and EUC 25.5% 
respectively). Logistic regression analyses of 93 children (mean age 9.0 yr 
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with SD 1.6; 57 boys) showed PCC was effective in improving asthma-specific 
HRQL in a relevant proportion of primary school aged children with asthma 
in paediatric outpatient clinics (OR 3.2, 95%CI 1.3-7.7), although not 
statistical significant after correction for covariates (OR 2.6, 95%CI 0.9-6.9). 
Most secondary outcomes did not show significant differences between 
treatment with corrected logistic and linear regression analyses either 
(asthma control with C-ACT OR 1.3, 95%CI 0.5 – 3.5; HRQL of the parents 
with PACQLQ OR 1.4, 95%CI 0.4 – 5.0), with exception of lung function 
measured with the pre-FEV1 as percentage of the predicted value (B 3.8, 95% 
CI 0.1 – 7.5). Finally, we concluded that although no statistically significant 
improvement of health-related quality of life in children with asthma was 
observed in specialised care by PCC, a relevant proportion of children in the 
intervention group showed clinical improvement compared to usual care. 
Therefore, implementation of this programme would be recommended in 
paediatric outpatient clinics in the Netherlands. 
 
In Chapter 6, we described the process of content of PCC in specialised 
health care. Almost all children, completed the Pelican instrument before the 
scheduled visit (91,3%). In general, the PCC intervention during visits was 
performed according to protocol (>70%). Despite training of nurses, there 
still seems to be room for improvement with regard to patient-centredness: 
one in four WAPs show a discrepancy between problems selected by children 
and the problem(s) treated during PCC (e.g. ‘medication use’ was addressed 
in seven cases while it had not been selected by children and/or a priori did 
not show room for improvement). Also, formulation of treatment goals was in 
accordance to SMART principles in only 25% of the WAPs. Two to seven 
actions per problem and children were actively involved in the execution of 
them (76.2%). Three quarters of the families implemented the actions as 
formulated on the WAP at home. Parents and nurses felt that treatment was 
improved and that the WAP was a (very) useful instrument. We concluded 
that the programme has shown to be feasible and, acceptable in specialised 
care. Further research needs to be done for specific patient groups, for 
example children with comorbidity (such as Attention Deficit and 
Hyperactivity Disorder). Future investigation towards implementation in real 
life and cost-effectiveness is warranted as well. 
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 Chapter 7 contains the general discussion. In this final chapter the 
main conclusions of previous chapters and their relations have been reviewed 
and the use of patient-reported outcomes in daily practice has been 
discussed. In addition, the relevance of the results are described with regard 
to future research and their implications for clinical practice. The main 
recommendation for clinical practice is to provide personalised care based on 
a screening tool that contains important asthma-related themes, such as 
asthma control, quality of life, drug use, etc. For each individual issues can be 
added, such as psychosocial problems, when necessary. If this tool is a digital 
instrument, application in health care can be made time and cost efficient. 
Further studies and guidelines on the use of such tools are important to 
effective and user person-centred care. 
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Samenvatting (Dutch Translation of Summary) 
 
Dit proefschrift beschrijft het belang van het opnemen van individuele 
behandeldoelen in de zorg voor kinderen met astma. Behandeldoelen van 
kinderen worden gemeten door een gezondheidsgerelateerde kwaliteit van 
leven vragenlijst, genaamd het Pelikaan instrument. Dit online instrument 
kunnen kinderen thuis zelfstandig invullen voordat zij op consult gaan bij een 
huisartsenpraktijk of ziekenhuis en geeft hen de mogelijkheid om concrete 
astmaproblemen te selecteren die kinderen in het dagelijks leven 
tegenkomen. Dit manuscript beschrijft twee wetenschappelijke studies naar 
de effectiviteit van een patiënt-gerichte behandeling waarbij de uitkomst van 
het kind op het Pelikaan instrument als startpunt werd genomen. De 
behandeling bestaat uit zes stappen; 1. het bevragen van de door het kind 
geselecteerde problemen in het Pelikaan instrument, 2. het kiezen van één of 
twee problemen om mee te werken tijdens het bezoek aan het ziekenhuis of 
de huisartsenpraktijk, 3. brainstormen over mogelijke oplossingen, 4. het 
stemmen over geschikte oplossingen, 5. Het vastleggen van concrete 
afspraken in een schriftelijk actieplan van oplossingen, 6. het evalueren de 
resultaten van dit actieplan tijdens een vervolgbezoek en, indien nodig, kan 
de behandeling herhaald worden wanneer er onvoldoende resultaat blijkt te 
zijn behaald. Deze zes stappen worden begeleid door een gespecialiseerde en 
getrainde (astma-) verpleegkundige. 
 
Hoofdstuk 1 introduceert de achtergrond van astma bij kinderen en de 
belangrijkste doelstellingen van dit proefschrift. Astma is één van de meest 
voorkomende chronische aandoeningen bij kinderen. De mate van 
ongecontroleerde astmasymptomen vormen een zware belasting voor 
patiënten zelf, families en het zorgstelsel. Eén van de belangrijkste redenen 
voor ongecontroleerd astma is het gebrek aan therapietrouw van de 
behandeling. Het is te verwachten dat de betreffende therapietrouw zal 
verhogen wanneer er beter rekening gehouden wordt met de individuele 
behandeldoelen en wensen van de patiënt. Bijgevolg is er behoefte aan een 
astmabehandeling die op het individuele kind is afgestemd. Persoonsgerichte 
interventies die zelfmanagement van patiënten bevorderen, lijken 
veelbelovend in het verhogen van therapietrouw en worden dan ook in 
recente richtlijnen voor astmazorg gepromoot. 
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Dit proefschrift richt zich op de volgende doelstellingen: 
- Het validatieproces van de Pelikaan instrument onder 6-11 jarige 
kinderen met astma in Nederland presenteren; 
- Een overzicht bieden van de effecten van een persoonsgerichte 
interventie (gebaseerd op het Pelikaan instrument) bij kinderen met 
astma die behandeld worden in eerstelijns- en specialistische zorg in 
Nederland geven; 
- Meer inzicht verschaffen in de mogelijkheden en knelpunten van een 
zalfmanagement ondersteunende interventie bij kinderen met astma; 
- Bespreken óf, en zo ja, hóe een zelfmanagement ondersteunende 
interventie (gebaseerd op het Pelikaan instrument) in de dagelijkse 
medische zorg moet worden uitgevoerd voor astma bij kinderen. 
 
Hoofdstuk 2 beschrijft de validatie van het Pelikaan instrument. Het 
Pelikaan instrument is een online gezondheidsgerelateerd kwaliteit van leven 
(KvL) instrument voor kinderen met astma, dat kan worden gebruikt voor 
onderzoeksdoeleinden om de effectiviteit van behandelingen te vergelijken 
(gestandaardiseerde deel) èn voor klinische doeleinden in de dagelijkse 
gezondheidszorg (bepalen van de drie belangrijkste problemen van een kind 
met astma). Het onderzoek werd uitgevoerd in een populatie van 
Nederlandse kinderen van 6 tot en met 11 jaar met als doel om de 
psychometrische eigenschappen van dit instrument beoordelen op grond van 
de Klassieke Test Theorie. Op basis van een factoranalyse via een statistisch 
software programma (SPSS), werd het theoretisch model van de 
gestandaardiseerde deel van de Pelikaan instrument getoetst en vastgesteld 
op 5 domeinen (Activiteiten, Symptomen, Prikkels, Astmabeleid en Sociale / 
Emotionele aspecten) en 21 vragen (zoals ‘Hoe vind je het dat je geen dieren 
mag of mag aaien vanwege je astma?’). De vragen worden beantwoord op een 
5-punts schaal van score 1 'helemaal niet erg' tot score 5 ‘heel erg’. Daarnaast 
kan een kind ook aangeven dat een bepaalde vraag of situatie niet op 
hem/haar van toepassing is. De interne consistentie bleek goed te zijn 
(Cronbach's α 0,89, 95%-betrouwbaarheidsinterval 0,85-0,92). De interne 
consistentie van de domeinen waren goed tot acceptabel. De test-hertest 
betrouwbaarheid van het Pelikaan instrument bij kinderen met stabiele 
astmacontrole was goed (Inter Class Correlatie ICC = 0,88, 95%-BI 0,79-0,93, 
p <0,01). Ook de convergente en divergente validiteit van het Pelikaan 
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instrument waren over het algemeen in overeenstemming met onze a priori 
hypothesen. We zagen een negatieve matige correlatie tussen de Pelikaan 
score en de Paediateric Asthma Quality of Life Questionnaire (PAQLQ) (r = -
0,59, p <0,01). Het minteken kan worden verklaard doordat het Pelikaan 
instrument en de PAQLQ een omgekeerd scoring hanteren. De PAQLQ is één 
van de meest gebruikt kwaliteit van leven vragenlijsten binnen medisch 
onderzoek bij kinderen met astma. De cross-sectionele constructvaliditeit van 
het Pelikaan instrument was matig tot goed. Bovendien is het Pelikaan 
instrument in staat om onderscheid te maken tussen kinderen met 
gecontroleerde of ongecontroleerde astma (t = 3.20, p <0.01; Δ 0,64 Pelikaan 
score) en tussen kinderen met en zonder astma (t = 6,31, p <0,01; Δ 0,94 
Pelikaan score). De validiteit van het geïndividualiseerde deel bleek goed te 
zijn. Aspecten die door kinderen in de persoonlijke Top 3 werden gekozen, 
scoorden gemiddeld 0,95 punten (SD 0,95) hoger in het standaard deel van de 
vragenlijst dan niet-geselecteerde aspecten.  
In het algemeen is het Pelikaan instrument een betrouwbaarheid en 
valide kwaliteit van leven meetinstrument gebleken in een Nederlandse 
populatie van kinderen met astma tussen de 6 en 12 jaar. Of het instrument 
ook in staat is om responsiviteit (veranderingen in de astma-gerelateerde 
gezondheidstoestand) te laten zien, moet nog worden vastgesteld. Het 
evalueren van de validiteit en betrouwbaarheid van vragenlijsten, is een 
continu proces in diverse klinische populaties. De huidige resultaten 
rechtvaardigen het gebruik van het instrument in verdere studies om de 
klinische effectiviteit van het Pelikaan instrument te onderzoeken bij 
schoolgaande kinderen in Nederland. 
 
Hoofdstuk 3 gaat verder met een protocol voor een follow-up studie. 
Het protocol stelt twee gerandomiseerde gecontroleerde onderzoeken (RCT) 
voor naar de effectiviteit van het Pelikaan instrument in de klinische praktijk. 
Eén RCT zal worden uitgevoerd in de eerstelijnszorg en één in poliklinieken 
van Nederlandse ziekenhuizen. Beide studies hebben een vergelijkbare 
onderzoeksopzet met als doel om de resultaten te kunnen vergelijken. De 
studie in de eerstelijnszorg is een multilevel onderzoek met 170 kinderen met 
astma uit 16 huisartspraktijken. Alle kinderen in een praktijk worden 
toegewezen aan dezelfde behandelgroep. De studie in de gespecialiseerde 
zorg is een multicenter onderzoek in vijf ziekenhuizen met 100 kinderen met 
astma. Kinderen in een polikliniek worden willekeurig toegewezen aan de 
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interventiegroep of de gebruikelijke zorggroep. In beide studies zullen 
kinderen vier keer een bezoek aan de zorgverlener brengen tijdens een 
follow-up periode van negen maanden (aldus een frequentie van eens per 
drie maanden). De interventie bestaat uit een persoonsgerichte behandeling 
gebaseerd op zelfmanagement principes waarbij een verpleegkundige door 
middels gezamenlijke besluitvorming tracht de kwaliteit van leven van het 
kind met astma te verbeteren. Dit gebeurt middels de zes stappen, zoals 
eerder beschreven, en leidt tot een geschreven actieplan. De studie is 
geregistreerd en goedgekeurd door de Medisch ethische Commissie voor 
mensgebonden onderzoek van Arnhem en Nijmegen.  
Het is een sterke eigenschap van deze studie dat de Pelikaan 
interventie onderzocht wordt in verschillende gezondheidszorg settings. In 
de dagelijkse praktijk zien we vaak dat resultaten van interventiestudies naar 
een andere zorgsetting worden geëxtrapoleerd. Vanwege verschillen in 
organisatie, ernst van de ziekte, kenmerken van de patiënt en de zorg-
verlening tussen zorgsettings, kan het extrapoleren van onderzoeksresultaten 
leiden tot onnodige kosten zonder de gewenste gezondheidsuitkomsten.  
 
Hoofdstuk 4 presenteert een cluster-RCT in een Nederlandse populatie 
van 33 kinderen in negen huisartspraktijken met als doel om de effectiviteit 
te onderzoeken van Patiëntgerichte Zorg (PGZ, in English PCC; gebaseerd op 
de uitkomst van het kind op het Pelikaan instrument) op kwaliteit van leven. 
De primaire hypothese was dat aanvullende PGZ op de gebruikelijke zorg 
leidt tot een klinisch relevante verbetering in de kwaliteit van leven (gemeten 
door de Pediatrische Astma Quality of Life Questionnaire met gestandaar-
diseerde activiteiten, PAQLQ-s; ≥ 0,5 punten) bij kinderen met astma. De 
verwachting was kwaliteit van leven in minimaal 25% van de gevallen vaker 
zal verbeteren in de PGZ groep dan in de groep behandeld met gebruikelijke 
zorg (GZ). Huisartsenpraktijken werden toegewezen aan een behandelings-
groep en alle kinderen binnen een praktijk ontvingen dezelfde behandeling 
(GZ + PGZ n=15; GZ alleen n=14). Bij aanvang van het onderzoek vertoonden 
beide behandelingsgroepen reeds hoge PAQLQ-s scores en gunstige 
resultaten op secundaire uitkomstenmaten (zoals astma controle), waardoor 
er weinig ruimte voor verbetering was. Desalniettemin, toonden in beide 
groepen een aanzienlijk deel van de kinderen een klinisch relevante 
verbetering op de kwaliteit van leven na 9 maanden (GZ + PGZ 33% en GZ 
57%, respectievelijk). Logistische regressieanalyses van 29 deelnemers 
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(gemiddelde leeftijd 8,6 met SD 1.7, 18 jongens) leverde geen significante 
verschillen op tussen de behandelingen op zowel de primaire uitkomst (odds 
ratio OR 0,38, 95% CI 0,08, 1,69) als secundaire uitkomsten, met uitzondering 
van het PAQLQ-s Symptomen-domein in het voordeel van de gebruikelijke 
zorg groep (OR 0.20, 95% CI 0,04-0,97, dit is mogelijk een toevalsbevinding). 
Helaas heeft deze studie onvoldoende deelnemers, waardoor we de 
resultaten niet betrouwbaar kunnen interpreteren en deze studie enkel 
kunnen beschouwen als een proefonderzoek (i.e. pilot study), waarmee de 
haalbaarheid van een vergelijkbaar onderzoek of project wordt bepaald. 
Concluderend kunnen we zeggen dat we onvoldoende bewijs konden 
aanleveren om te stellen dat bestudeerde PGZ programma effectief is in het 
verbeteren van kwaliteit van leven bij kinderen astma in Nederlandse 
huisartspraktijken. Hoewel nader onderzoek naar de effectiviteit van 
persoonsgerichte zorg in de eerstelijns zorg nodig is, rijst de vraag of de 
huidige randvoorwaarden in de Nederlandse eerstelijns gezondheidszorg 
gunstig zijn en er behoefte is aan een dergelijk programma zoals geëvalueerd 
in deze studie onder patiënten en artsen.  
 
Hoofdstuk 5 van dit proefschrift rapporteert over de resultaten van 
een RCT in een Nederlandse populatie van kinderen met astma die behandeld 
worden in de gespecialiseerde gezondheidszorg. Het doel en de hypothese 
van deze studie waren gelijk aan de studie in de eerstelijn. Proefpersonen 
waren kinderen met astma uit vijf Nederlandse ziekenhuizen (GZ + PGZ n = 
42; GZ alleen n = 51). In beide groepen laat een aanzienlijk deel ≥ 0,5 punten 
verbetering zien op de PAQLQ-s scores (GZ + PGZ 52,4% en GZ 25,5%). 
Logistische regressieanalyses van 93 kinderen (gemiddelde leeftijd 9,0 jaar 
met SD 1.6, 57 jongens) toonde dat PGZ effectief is in het verbeteren van 
astma-specifieke kwaliteit van leven in een relevant deel van de kinderen met 
astma in ziekenhuizen (OR 3.2, 95% was CI 1,3-7,7), hoewel dit niet langer 
statistisch significant was na correctie voor covariaten (OR 2.6, 95% CI 0,9-
6,9). Op de meeste secundaire uitkomsten bleek geen verschil tussen 
behandeling met gecorrigeerde logistische en lineaire regressieanalyses 
(astmacontrole met C-ACT OR 1.3, 95% CI 0,5-3,5; HRQL van de ouders met 
PACQLQ OR 1.4, 95% CI 0,4-5,0), met uitzondering van de longfunctie 
gemeten met de pre-FEV1 als percentage van de voorspelde waarde (B 3.80, 
95% CI 0,14-7,46). Tot slot hebben we geconcludeerd dat hoewel er geen 
statistisch significante verbetering van de gezondheid gerelateerde kwaliteit 
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van leven bij kinderen met astma was in gespecialiseerde zorg door PGZ, een 
relevant deel van de kinderen in de interventiegroep klinische verbetering 
liet zien in vergelijking met de gebruikelijke zorg. Hierdoor zou de uitvoering 
van dit programma aanbevolen kunnen worden bij pediatrische poliklinieken 
in Nederland. 
 
In Hoofdstuk 6 beschrijven we het proces van PGZ in gespecialiseerde 
gezondheidszorg. Bijna alle kinderen voltooiden het Pelikaan instrument voor 
het geplande bezoek (91,3%). In het algemeen werd de PGZ interventie bij 
bezoeken volgens protocol (> 70%) uitgevoerd. Ondanks training van 
verpleegkundigen, lijkt er nog steeds ruimte voor verbetering te zijn met 
betrekking tot de persoonsgerichtheid: één op de vier actie plannen toont een 
discrepantie tussen de problemen van kinderen (volgens Pelikaan 
instrument) en het probleem dat behandeld tijdens met PGZ (bijvoorbeeld 
'medicijngebruik' werd in zeven gevallen aangepakt terwijl het niet door 
kinderen was geselecteerd en / of ruimte voor verbetering toonde). 
Bovendien was de formulering van behandeldoelen slechts in 25% van de 
actieplannen in overeenstemming met SMART principes. SMART betekent dat 
de doelen Specifiek, Meetbaar, Acceptabel, Realistisch en Tijdgebonden 
moeten zijn. Gemiddeld werden er twee tot zeven oplossingen per probleem 
in een actieplan geformuleerd en kinderen werden ook actief betrokken bij de 
uitvoering van deze acties (76,2%). Drie kwart van de gezinnen heeft de 
acties thuis uitgevoerd zoals geformuleerd in het actieplan. Ouders en 
verpleegkundigen vonden dat behandeling was verbeterd en dat het actieplan 
een (zeer) nuttig instrument was. We concludeerden dat het programma 
heeft aangetoond PGZ haalbaar en aanvaardbaar is in gespecialiseerde zorg. 
Verder onderzoek moet worden gedaan voor specifieke patiëntengroepen, 
bijvoorbeeld kinderen met comorbiditeit (zoals ADHD). Toekomstig 
onderzoek naar de uitvoering in de dagelijkse zorg en de kosteneffectiviteit 
wordt ook gerechtvaardigd. 
 
Hoofdstuk 7 bevat de algemene discussie. In dit laatste hoofdstuk 
worden de belangrijkste conclusies van de voorgaande hoofdstukken en hun 
relaties beoordeeld en het gebruik van patiënt-gerapporteerde 
uitkomstmaten (zoals het Pelikaan-instrument) in de dagelijkse praktijk is 
besproken. Daarnaast is de relevantie van de resultaten beschreven met 
betrekking tot toekomstig onderzoek en de implicaties voor de klinische 
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praktijk. Het voornaamste advies voor de klinische praktijk is om 
persoonsgerichte zorg te baseren op een samengestelde vragenlijst dat 
belangrijke astma-gerelateerde thema’s bevat, zoals astmacontrole, kwaliteit 
van leven, medicatiegebruik, e.d. Per persoon kunnen thema’s worden 
toegevoegd zoals psychosociale problematiek. Wanneer vragenlijsten digitaal 
zijn, kunnen deze tijds- en kostenefficiënt worden afgenomen. 
Vervolgonderzoek en richtlijnen over het gebruik van dergelijke tools zijn van 
belang om persoonsgerichte zorg effectief en gebruiksvriendelijk te maken. 
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Dankwoord 
 
Na een vierjarig promotie traject, is het boekje helemaal af en ben ik aan mijn 
dankwoord toegekomen. Promoveren is een weg met ups en downs, zoals 
menig promovendus zal weten. Maar je staat nooit alleen, want de gehele weg 
leg je af met vele collega’s, medepromovendi, familie en vrienden die je bereid 
zijn te helpen en te steunen. Waarschijnlijk ga ik dan ook een paar mensen in 
mijn dankwoord vergeten die het wel verdienen om erbij te staan. Bij deze wil 
ik dan ook in het algemeen iedereen bedanken die mij direct of indirect heeft 
gesteund bij het voltooien van dit proefschrift.  
 
Allereerst wil ik natuurlijk alle deelnemende ziekenhuizen en 
huisartspraktijken bedanken; huisartsen (R. Kievits, S. Roosink, A. Uijen, J. van 
den Hoogen, B. Houwman, R. Kollenburg, S. Hameleers, N. Scherpbier, I. 
Meekes), POH’s (E. de Gooijer, P. Teiwes, D. Melchers, A. van Engen, M. 
Gijsbers, T. van de Berg, C. Sanders, J. van Boxtel, J. van Hilten, N. Blom), 
kinderartsen (A. Vaessen-Verberne, A. Nieuwenhuis, L. van Veen, H. Brackel, J. 
Hendriks) en astmaverpleegkundigen (D. de Hond, D. Stevens, J. van Delft, J. 
Wiesemann, C. Linssen-Geven, M. van Enckevort, M. Cabooter). Dankzij hun 
motivatie, affiniteit en medewerking, is dit project mogelijk gemaakt. Zij 
hebben de vele gezinnen met kinderen met astma kunnen werven. 
Daarbij wil ik natuurlijk graag alle bereidwillige deelnemers bedanken, want 
zonder hen was dit resultaat niet tot stand gekomen. Zij stonden klaar om 
bijna een jaar lang vragenlijsten in te vullen en bezoeken af te leggen in 
huisartspraktijken en ziekenhuizen. Heel hartelijk dank voor jullie bijdrage! 
 
Uiteraard wil ik mijn promotor Chris van Weel, en copromotoren Lisette van 
den Bemt, Tjard Schermer en Peter Merkus bedanken. Zij hebben mij de 
mogelijkheid geboden dit onderzoek uit te voeren en mij in alle fases 
ondersteund en begeleid. Dank voor alle goede adviezen en voor de kritische 
blik die jullie op dit werk hebben geworpen. 
 
Chris, bedankt voor uw betrokkenheid en uw inzichten als huisarts en 
professor bij mijn project. Ik vond het fijn dat ik met u mocht samenwerken 
en stond altijd verbaast van uw snelle feedback, ongeacht waar ter wereld u 
zich bevond. 
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Lisette, ik wil je bedanken voor de onderzoekstijd die ik op Radboudumc 
mocht meemaken. Ik heb met enige hobbels deze periode doorlopen, maar 
kreeg in mijn laatste jaar een boost door het zien van de resultaten van al die 
jaren werk. Ik ben je dankbaar voor al het voorwerk en de voorafgaande 
projecten die jij binnen het Pelikaan project gedaan hebt. Je 
wetenschappelijke kritische blik en je accuratesse hebben body en diepgang 
gegeven aan onze werkwijze en de publicaties. Het was een hele ervaring dat 
ik het implementatieonderzoek van Pelikaan mocht uitvoeren. 
 
Tjard, gedurende mijn promotietijd ben je een onmisbare steun voor mij 
geweest. Ik wil je bedanken voor je zakelijke insteek, je verdiepende en 
opbouwende kritiek en je complimenten voor mijn werk. Hoewel feedback op 
artikelen soms lang op zich liet wachten, had je altijd goede suggesties en een 
positieve kijk op het werk ik inleverde. Daar heb ik veel aan gehad. 
 
Peter, u wil ik graag bedanken voor uw enthousiasme, ideeën en uw creatieve 
blik op het onderzoek. Ook hebben we, dankzij u, voldoende ziekenhuizen 
bereid gevonden om de inclusie van deelnemers te kunnen behalen. Ik vind 
het geweldig dat deze trial, dankzij uw hulp en inzet, tot een geweldig 
resultaat heeft geleid. Ik heb altijd plezierig met u samengewerkt. 
 
Daarnaast gaat mijn dank uit naar de onderzoeksassistenten Evelien 
Scheltinga-Klungel en Riet Cretier. Zij hebben mij bij het project geholpen met 
de logistiek en het invoeren van alle onderzoeksgegevens. Ik heb een zeer 
prettige en leuke samenwerking ervaren.  
 
En niet te vergeten al mijn andere collega’s bij programma ‘Astma & COPD’, 
Annelies Daanen, Erik Bisshof, Wouter van Dijk, Hilde Luijks, Joke Grootens-
Stekenburg, Lonneke Boer, Reinier Akkermans en alle andere collega’s, gang-
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aFigure 1: Flowchart of recruitment of family practices in the 
Netherlands for the Pelican project (a study with the aim to assess 
effectiveness of nurse-led individualised self management)
Not interested 
- 4 FP care networks with a total of ± 192 FP’s 
- 1 independent FP 
 
Reasons: 
- Research project is not in scope with goals/priorities of FP care 
network/FP 
- Participation in research project takes too much time 
 
 
Randomized (n=11) 
Information send to FP care networks (n=8) and independent general practitioners (FPs) (n=2) 
Excluded before start (n=1) 
Reason: too few patients 
agreed to participate 
  
 
Invitation letter send to individual general practitioners within interested practices  
+ phone call reminder (n=112) 
No response (n=28) 
Rejection of participation (n=73 ): lack of time investment (n=8), 
participating in other research projects (n=3), too few children with 
asthma in practice (n=3), not interested /no affinity (n=3), reason 
unknown (n=56). 
Intervention group (n=5) Usual care group (n=6) 
General practices in intervention 
group that started at baseline (n=4) 
General practices in usual group that 
started at baseline (n=5) 
General practices that received 
training on intervention (n=4) 
General practices analysed (n=5) 
Excluded before start (n=1) 
Reason: too few patients 
agreed to participate 
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Lost to follow-up (n=0) 
  
 
Lost to follow-up (n=0) 
  
 
General practices analysed (n=4) 
  
 
aTable 1: Characteristics of family practices that participated in 
the Pelican project (a study with the aim to assess effectiveness of 
nurse-led individualised self management intervention) 
 
 All  
(n= 9) 
n (%) 
Intervention 
group (n=4) 
n (%) 
Usual care 
group (n=5) 
n (%) 
Number of participants (that completed trial) 
 
29 
(100.0) 
15 (  51.7) 14 (  48.3) 
Number of family practitioners per practice    
   > 2 
   ≤2 
 
6 (  66.7) 
3 (  33.3) 
2 (  50.0) 
2 (  50.0) 
4 (  80.0) 
1 (  20.0) 
Structured asthma care 
   Not structured 
   For children 
   For adults 
 
6 (  66.6) 
1 (  11.1) 
2 (  22.2) 
 
2 (  50.0) 
1 (  25.0) 
1(  25.0) 
 
4 (  80.0) 
0 (  00.0) 
1 (  20.0) 
Frequency asthma care children 
   On indication (complaints) 
   Once a year 
   Twice a year 
 
6 (  66.7) 
1 (  11.1) 
2 (  22.2) 
 
3 (  75.0) 
1(  25.0) 
0 (  00.0) 
 
3 (  60.0) 
0 (  00.0) 
2 (  40.0) 
Mean duration of consultation 
   5-10 minutes 
   10-15 minutes 
   20-30 minutes 
 
 
1 (  11.1) 
7 (  77.8) 
1 (  11.1) 
 
1(  25.0) 
2 (  50.0) 
1(  25.0) 
 
0 (  00.0) 
5 (100.0) 
0 (  00.0) 
Practice nurse involved in asthma care 
   On indication 
   Protocol care (at least once a year) (a) 
   Unknown 
 
 
6 (  66.7) 
1 (  11.1) 
2 (  22.2) 
 
3 (  75.0) 
1(  25.0) 
0 (00.0) 
 
3 (  60.0) 
0 (  00.0) 
2 (  40.0) 
Delegation of  asthma care to practice nurse 
or assistant (n=6) 
   Complaints history 
   Control of inhalation technique 
   Control of therapy compliance  
   Discussing medication use  
   Discussing medication plan  
   Discussing trigger management  
 
 
 
4 (  44.4) 
6 (  66.7) 
5 (  55.6) 
4 (  44.4) 
0 (  00.0) 
5 (  55.6) 
 
 
2 (  50.0) 
4 (100.0) 
3 (  75.0) 
2 (  50.0) 
0 (  00.0) 
3 (  75.0) 
 
 
 
2 (  40.0) 
2 (  40.0) 
2 (  40.0) 
2 (  40.0) 
0 (  00.0) 
2 (  40.0) 
Include experienced quality of life in 
consultation 
  Yes, by asking 
  Yes, by a questionnaire 
 
 
 
9 (100.0) 
0 (  00.0) 
 
 
4 (100.0) 
0 (  00.0) 
 
 
5 (100.0) 
0 (  00.0) 
Include experienced asthma control in 
consultation 
  Yes, by asking 
  Yes, by a questionnaire (a) 
 
 
8 (  88.9) 
1 (  11.1) 
 
 
3 (  75.0) 
1 (  25.0) 
 
 
5 (100.0) 
     0 (   00.0) 
a. In one center, asthma children were structurally seen by the practice nurse, while in other 
centers children were treated by the family practitioner. They measured asthma control by 
means of the Child-Asthma Control Test (C-ACT). 
  
 
 
2a.  
2b.  
2c.   
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aFigure 2: Trends in childhood asthma patients (6-11yr) allocated to the 
self management intervention (n=15) and usual care (n=14) group in 
Dutch family practices of (a) asthma control (Asthma Control 
Questionnaire, ACQ; well controlled <1), (b) number of parent-reported 
asthma exacerbations, (c) work absenteeism of parents due to child’s 
asthma (in days) and (d) school absenteeism of child due to asthma (in 
days) over a 9-month follow-up period in the Pelican study. 
 
 
 
aTable 2. Results from linear regression analyses on health-related quality of life (HRQL) and asthma 
control of participants receiving enhanced usual care and patient-centred care at baseline and 9 months. 
Values are means (95% confidence interval) and regression coefficients (95% confidence intervals). 
 
CQ6 Asthma Control Questionnaire (with six questions), C-ACT Childhood Asthma Control Test, PAQLQ(s) Paediatric Asthma Quality of Life 
Questionnaire (standardised) 
*Baseline values are provided in Table 2.  
 Enhanced usual care Patient-centred care Difference between groups at 9 months 
Outcome 
(range in score) 
 
n 
Change in score 
in 9 months 
 
n 
Change in  score 
in 9 months 
Absolute 
difference 
between 
groups 
Uncorrected B P-value 
B adjusted for 
baseline values 
P-value 
Asthma-specific health-related quality of life of children    
PAQLQ(s) (1-7)* 51 0.2 ( 0.0  – 0.5) 42 0.6 (  0.4 – 0.8) 0.3 -0.01 (-0.40 – 0.38) 0.95 0.23 (-0.08 – 0.54) 0.14 
Emotions (1-7) 47 0.2 (-0.1 – 0.5) 41 0.4 (  0.2 – 0.7) 0.3 -0.02 (-0.36 – 0.32) 0.92 0.08 (-0.25 – 0.40) 0.63 
Symptoms (1-7) 51 0.1 (-0.1 – 0.3) 42 0.6 (  0.3 – 0.8) 0.5 -0.08 (-0.54 – 0.37) 0.72 0.35 (0.03 – 0.67) 0.03 
Activities (1-7) 45 0.3 (-0.1 – 0.6) 38 0.7 (  0.4 – 1.0) 0.4 0.12 (-0.34 – 0.58) 0.61 0.26 (-0.14 – 0.67) 0.20 
Asthma control    
C-ACT (0-27) 40 0.6 (-0.7 – 1.9) 36 2.8 (  1.6 – 3.9) 2.1 -0.33 (-2.43 – 1.78) 0.76 1.40 (-0.30 – 3.10) 0.10 
ACQ6 (0-6) 50 -0.1 (-0.4 – 0.2) 39 -0.4 (-0.7 - -0.0) -0.3 0.04 (-0.42 – 0.50) 0.87 -0.14 (-0.55 – 0.27) 0.51 
  
aTable 3. Psychosocial functioning of participants receiving enhanced usual care and patient-
centred care at baseline and 9 months. Values are number (and percentage) of participants at 
baseline and improvement at 9 months compared to baseline unless stated otherwise. 
 
 Enhanced usual care (n = 51) Patient-centred care (n = 40) Difference between groups at 9 months 
 Baseline 9 months Baseline 
9 
months 
Δ in % 
positive 
group 
shift 
Linear regression analysis 
Outcome 
(range) 
Border- 
line 
Abnormal 
Positive 
group 
shift* 
(n=50) 
Border-
line 
 
Abnormal 
 
Positive 
group 
shift 
(n=37) 
 B P 
B adjusted for 
baseline values 
P 
SDQ score 
total 
(0-40)† 
5 (9.8) 10 (19.6) 8 (16.0) 6 (15.0) 8 (20.0) 6 (16.2) 0.2 -0.8 (-3.3 – 1.8)‡ 0.55 - 1.3 (-3.1 – 0.5) 0.17 
Emotional 
problems (0-
10) 
9 (17.6) 13 (25.5) 7 (14.0) 5 (12.5) 13 (32.5) 9 (24.3) 10.3 -0.2 (-1.2 – 0.8) 0.65 - 0.5 (-1.4 – 0.4) 0.30 
Conduct 
problems 
(0-10) 
4 (7.8) 5 (9.8) 6 (12.0) 8 (20.0) 4 (10.0) 8 (21.6) 9.6 -0.0 (-0.7 – 0.6) 0.92 - 0.3 (-0.8 – 0.3) 0.34 
Hyperactivity
/inattention 
(0-10) 
4 (7.8) 13 (25.5) 4 (8.0) 3 (7.7) 9 (22.5) 4 (10.8) 2.8 -0.1 (-1.4 – 1.3) 0.92 0.2 (-0.6 – 0.9) 0.69 
Peer 
relationship 
problems  
(0-10) 
4 (7.8) 9 (17.6) 5 (10.0) 0 (0.0) 6 (15.0) 4 (10.8) 0.8 -0.4 (-1.2 – 0.4) 0.28 - 0.4 (-1.0 – 0.1) 0.14 
Prosocial 
behaviour 
(0-10) 
0 (0.0) 3 (5.9) 1 (2.0) 3 (7.5) 1 (2.5) 0 (0.0) -2.0 0.2 (-0.4 – 0.9)¶ 0.46 0.3 (-0.2 – 0.7) 0.21 
SDQ Strengths and Difficulties Questionnaire, * A positive group shift is defined as a child that was divided in the borderline or abnormal group at baseline and no longer considered 
to have problems after nine months or shifted from the abnormal to the borderline group, †  total SDQ score is the sum of the domain emotional problems, conduct problems, 
hyperactivity and peer relation problems, ‡ lower score represents less problems, ¶ higher score represents more prosocial behaviour.  
 
 
 
 
 
 
 
 
 
 
Missing values enhanced usual care group month (m) 1 (1), 2 (4), m3 (1), m4 (4), m5 
(4) , m6 (1), m7 (3), m8 (9), m9 (0), missing values patient-centred care group m1 (1), 
m2 (1), m3 (0), m4 (8), m5 (7), m6 (3), m7 (1), m8 (6), m9 (1) 
Missing values enhanced usual care group month (m) 1 (2), 2 (5), m3 (2), m4 (5), m5 (5) 
, m6 (2), m7 (4), m8 (10), m9 (1), missing values patient-centred care group m1 (2), m2 
(1), m3 (0), m4 (9), m5 (7), m6 (4), m7 (2), m8 (7), m9 (1) 
  
 
 
 
 
 
 
 
Missing values enhanced usual care group month (m) 1 (2), 2 (5), m3 (2), m4 (5), m5 
(5) , m6 (2), m7 (4), m8 (10), m9 (1), missing values patient-centred care group m1 
(2), m2 (1), m3 (0), m4 (9), m5 (7), m6 (4), m7 (2), m8 (7), m9 (1) 
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The Pelican Project is a study in the Netherlands with the objective to 
improve health-related quality of life and asthma control of children 
with asthma.
 This thesis ‘Meeting the needs of children with asthma’ presents 
and discusses research on the validity of the Pelican instrument (a health- 
related quality of life questionnaire) and the effectiveness of patient-
centered care based on this instrument. The studies were carried out 
from 2008 to 2014 at the Department of Primary and Community Care 
at Radboudumc Nijmegen.
